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Abstract 
Objectives 
 To assess two cohorts of children exposed to adverse/atypical in utero 
environments. The first group was born to mothers with chronic renal disease 
in pregnancy (PORD). The second group was born after pre implantation 
genetic diagnosis/screening (PGD/PGS). The aim was to describe the health 
of these two groups of children in terms of physical/neurodevelopmental and 
behavioural well being (in relation to a matched control group of children 
born to healthy mothers). 
 To assess any impact from having a child whilst undergoing treatment for 
chronic renal disease on the psychological health of the mother and/or 
maternal child bonding/relationships. 
 To consider specific factors in the management of maternal renal disease 
!,05,)627) ,28+) %+$+(+-0"#9) +::+5(9) "&) (,+) 5,0$%'9) "#(5"6+) ;+.1.) :+(2$) %-#1)
exposure) 
 To assess any impact of the difficulties of having a child after PGD/PGS, 
which can often be stressful for couples, on the psychological health of the 
parents / or parent-child bonding/ relationships. 
 
Methods 
 Two population based case control studies of 176 children (and their 
families): One of  24 children born to mothers with chronic renal disease in 
pregnancy and one of 49 children born after preimplantation genetic 
diagnosis/screening.Controls were 37 children born to well mothers without 
renal disease and 66 children born after natural conception.  
Outcome measures included: 
 A full physical examination of the child, which included assessment of 
growth and general health. 
 An assessment of development using Griffiths Mental Development 
Scales. 
 Questionnaire-based to assessment of parent child relationships 
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Results 
 Study and control children in both cohort studies were comparable for growth 
parameters and neurodevelopmental scores as assessed by the Griffiths Scales 
of Mental Development. 
 The children showed no between group differences in the temperamental 
characteristics perceived by mothers. There was no evidence of more stress 
amongst study group mothers or evidence of impaired bonding between 
mother and child in comparison with controls.  
 The PGD group had a significantly higher score on the warmth-affection sub-
scale, and significantly lower score on the aggression-hostility and rejection 
sub-scales than the control group. 
 The PORD group demonstrated more externalising behavioural difficulties. 
although the study reported that families (with renal disease) were more likely 
to be from lower socio-economic backgrounds. Significantly fewer vaginal 
deliveries were reported for mothers with renal disease and their infants were 
more likely to experience neonatal morbidity. 
 
Summary of findings from the PO RD and PG D/S studies.  
PO RD study 
The results of this study were generally reassuring for the families where the mother 
have chronic renal disease and have had children. 
Study and control children were comparable for growth parameters and 
neurodevelopmental scores as assessed by the Griffiths scales of mental development. 
Numbers were small. However the data does provide reassurance to a group of 
mothers with a variety of renal disease that there was no effect related to maternal 
disease or medications used on growth and development of the children. 
The study highlights significant differences in externalising behaviour (e.g. rule 
breaking and aggressive behaviour) between the study and the control groups. The 
numbers involved were small and further studies would be needed to establish this. 
The result might relate to the comparative social disadvantage (as assessed by the 
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social class classification) seen in a higher proportion of PORD mothers than control 
mothers. 
There was no difference in the temperamental characteristics perceived by mothers in 
study and control groups. There was no evidence of more stress amongst mothers 
with renal disease or evidence of impaired bonding between mother and child in 
comparison with controls.  
The number of cases in the study was insignificant to provide strong evidence about 
the relation of severity of renal failure and outcome of the children. This was further 
compounded by difficulties in gathering maternal data from case notes. 
Even though there were only eight mothers post transplant and the study provided 
some preliminary data to suggest that the well-being of these children were 
comparable with that of children born to well mothers. However, further larger 
studies are needed in the future. 
 
PG D study 
This study is the first detailed study of children born after PGD world wide who were 
over a year of age and provides provisional reassurance that these children are healthy 
in comparison to naturally conceived children.  
Growth parameters and neurodevelopmental scores were comparable in the study and 
the control group, providing reassuring information for couples who have undergone 
the procedure and also future couples who will be undergoing the procedure. The 
children studied did not show any temperamental, behavioural or emotional 
difficulties.  
The PGD group had significantly higher scores on the warmth-affection sub-scale, 
and significantly lower scores on the aggression-hostility and rejection sub-scales 
than the control group. There was also no indication of increased levels of stress 
related to parenting. 
 
Conclusion 
 The studies in this thesis are reassuring in terms of physical and 
neurodevelopmental health of children born to mothers after chronic renal disease in 
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pregnancy and of children conceived following pre implantation genetic 
diagnosis/screening and their family relationships. 
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Chapter 1 
 
1. Foreword 
 
Normal development may be disrupted by early adverse environmental influences; 
individuals who survive may have to cope with potentially damaging consequences. 
Additionally, the effects of environmental challenges in early life and the responses 
required to deal with them may have long-term effects into adulthood (Gluckman et 
al.. 2005d). Barker et al. have clearly shown that the quality of fetal life can have 
profound effects on future well being of offspring (Barker et al.. 2002;Barker 
2004;Poulter 2001a). 
The early phase of life in many species is characterized by the presence of responses 
to environmental stimuli. This developmental plasticity is important in generating a 
range of phenotypes suitable for different environments thus promoting the 
perpetuation of the genotype (Bateson 2001;Bateson et al.. 2004). The human fetus 
and infant are no different from most other mammalian species in this respect and can 
respond to nutritional imbalance and other adverse influences by changing their 
developmental and growth trajectories (Gluckman & Hanson 2004a). The processes 
involved may include induction of attributes that adapt the individual for the type of 
environment in which he or she is likely to live later in life. Development of an 
individual obviously depends on both his or her genes and the environment, but the 
precise character of the interplay between the developing individual and its 
environment is critical. At each phase of development the organism may be sensitive 
to particular environmental cues with the effects of its responses impacting on 
subsequent stages of development (Gluckman et al.. 2005c). Developmentally 
disruptive events in response to environmental stimuli can irreversibly interfere with 
embryonic development and, depending on their nature, may have deleterious effects 
either in utero and/or after birth. Generally, such events act by interfering with a 
developmental process during periods of vulnerability, such that structural deficits 
may emerge, although more subtle effects will be harder to detect. The stimulus may 
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be a drug, ionizing radiation, a major environmental shift such as hyperthermia or 
hypoxia, disease, or a gross nutritional disruption (e.g. folate deficiency leads to 
neural tube defects) in humans and other mammals. In mammals, environmental 
influences that have long-term consequences can operate even on the pre-ovulatory 
oocyte and pre-implantation embryo (Gluckman et al.. 2005b). This increases the 
concerns about the possible long term effects of human in vitro fertilisation (Jackson 
et al.. 2004). Several explanations have been offered for the long-term effects on the 
offspring of an altered maternal environment (Gluckman & Hanson 2004b;Hales & 
Barker 2001;Hattersley & Tooke 1999;Singhal et al.. 2003). Growth as measured at 
birth is a proxy for in-utero growth and prenatal experience.  
In the studies described in this thesis there are two distinct exposures of interest. In 
the larger study the health of babies/young children born after Preimplantation 
Genetic Diagnosis was investigated in a cross sectional study in considerable detail. 
Using the same protocol another smaller study was conducted looking at the health of 
children aged eight or under whose mothers had had chronic renal disease in 
pregnancy.
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Chapter 2 
 
2. Introduction 
 
2.1 The Paediatric outcome in maternal renal disease in pregnancy study (PO RD 
study) 
 
2.1.1 Introduction to the PO RD study 
 
The editorial comment "children of women with renal disease used to be born 
dangerously or not at all E not at all if their doctors had their way," ( 1975), reflects 
an early view of the effect of kidney disease on pregnancy. In 1971 Confortini et al. 
(Confortini et al.. 1971) reported the first conception and successful delivery  in a 
woman on maintanance haemodialysis (HD). The first successful pregnancies 
following maternal renal transplantation were reported in 1963 (MURRAY et al.. 
1963) .The donor and recipient were identical twin sisters. The child born turned 48 
years old on March 10, 2006 (McKay & Josephson 2006f). Subsequent progress in 
management of end stage renal disease, ultimately by means of renal transplantation, 
has resulted in a lot more women living their lives into child bearing years. Such 
women were often discouraged from having a family due to concerns about posssible 
adverse effects on renal grafts and on the potential offspring (Willis et al.. 2000f). 
 
2.1.2 Pregnancy in women with moderate or severe renal insufficiency 
 
The outcome and the consequences of pregnancy in women with impaired renal 
function are still debated. Fertility and ability to sustain an uncomplicated pregnancy 
generally relate to the degree of functional impairment and the presence or absence of 
hypertension (Lindheimer, Grunfeld, & Davison  2007).  
In an update of renal disorders in pregnancy, John M Davison divides women 
arbitrarily into three categories (Davison 2001c): Refer to table 2.1: 
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Table 2.1 Categories of chronic renal disease 
 
He reported that women in Group 1 always have adequate gestational increments in 
Renal Plasma Flow (RPF) and Glomerular Filtration rate (GFR) which are markers of 
increased renal haemodynamics in pregnancy. In this group the obstetric outcome and 
the long-term renal prognosis for mothers were good. In groups 2 and 3 the increase 
of renal haemodynamics in pregnancy was less predictable and the long-term renal 
prognosis was uncertain. Many mothers, however, suffer significant renal function 
loss during pregnancy, with an accelerated decline post-delivery. However in groups 
1 & 2 obstetric success is more likely because of better fetal surveillance and 
advances in neonatal intensive care facilities (Davison 2001h). He highlighted 
hypertension, which if significant and poorly controlled still continues to be an 
indicator of bad prognosis for mother and baby (Davison 2001b)  
 
F2809"&'9)#G%2(+),01,$01,(+%)2)90&1$+)5+&(-+)9(#%7)*7)H2-) et al. (Bar et al.. 2000b). 
This study from Israel analysed types and frequencies of short and long-term (2 years 
after delivery) maternal and neonatal complications in three patient subgroups. The 
patient groups were 38 patient with primary renal disease (46 pregnancies), 24 IDDM 
patients with diabetic nephropathy (24 pregnancies) and 24 patients with functional 
renal allograft (42 pregnancies). Most of them had mild renal impairment. Successful 
"*9(+(-05) "#(5"6+)!29) %+:0&+%) 29) I2) $08+) ,+2$(,7) 0&:2&() !0(,"#() 9+8+-+) ,2&%052G) J)
7+2-9) 2:(+-) %+$08+-7'.) /#55+99) !29) -+G"-(+%) 0&) KLM) ":) G2(0+&(9) !0(,) G-062-7) -+&2$)
disease, 96% of IDDM patients with diabetic nephropathy and 89% of patients with 
functional renal allograft. Factors found to be predictive of successful outcome were 
absence of pre existing hypertension in all groups, low preconception serum uric acid 
level in primary renal disease patients, a long interval from transplantation to 
conception and use of low dose prednisone in renal transplant patients. They 
Serum creatinine (Scr) Renal Function 
NOJP)Q6"$R$)"-)O.S)mg/dl 
(Gr 1) 
Preserved or only mild impairment of renal 
function 
125-250 µmol/l or 1.4-2.8 mg/dl(some use 220 
µmol/l or 2.5 mg/dl as the cut-off) 
(Gr 2) 
Moderate renal insufficiency, 
>250 µmol/l or 2.8 mg/dl 
(Gr 3) 
Severe renal insufficiency 
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concluded that worse pregnancy outcome occurred in women with moderate or 
severe renal insufficiency. The findings from the study are summarised in the tables 
2.2, 2.3 and 2.4. 
 
Table 2.2: Short Term pregnancy outcome in the study group. 
 Group  
 Primary Renal 
Disease 
Diabetic 
Nephropathy 
Renal 
Transplantation 
p value 
Superimposed  
pre eclampsia 
10(22%) 11(46%) 7(17%)  0.05 
Preterm delivery (%) 10(22%) 4(17%)  26(62%) 0.01 
IUGR(%) 6(13%)  5(21%)  14(33%) <0.05 
Caesarean delivery(%) 11(24%) 15(62.5%) 15(36%) 0.001 
Hospitalisation in 
NICU(%) 
2(4.4%) 1(4.2%)  14(33%) 0.02 
Stillbirths (%) 0 1(4.2%)  2(7%) N.S 
 
Bar, Ben-Rafael, Padoa et al., 2000 
 
 
 
Table 2.3: Long term (two years after delivery) outcome in the study groups. 
 Group  
 Primary Renal 
Disease 
Diabetic 
Nephropathy 
Renal 
Transplantation 
p value 
Significant increase 
in serum creatinine 
(>1mg per dl) (%) 
2(5%) 0 4 (15%) NS 
End-stage renal disease 0 0 3(11%) NS 
Severe handicap or  
late infant death (%) 
1(2.2%) 2(8.4%) 2(7%) NS 
Bar, Ben-Rafael, Padoa et al., 2000 
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Table 2.4: Characteristic and short- and long term pregnancy outcome in patients 
with moderate or severe renal insufficiency in the study groups. 
 Group 
 Primary Renal Disease Renal Transplantation 
No of patients 4 9 
No. of pregnancies 5 14 
Mean age (years) (range) 28.5 + 2.1 (25-30) 29.4 + 3.6 (22-35) 
No. with pre-existing hypertension 1(25%) 7(78%) 
Superimposed pre-eclampsia 1(25%) 2(22%) 
Preterm delivery 2(50%) 8(89%) 
Still births (%) 0 0 
Significant increase in Serum 
creatinine (>mg/dl) (%) 
1(25%) 4(44%) 
End-stage renal disease 0 3(33%) 
Severe handicap or late infant death 0 1(11%) 
Bar, Ben-Rafael, Padoa et al., 2000 
 
T,+)5,0$%-+&'9)!+$$)*+0&1);2*9+&5+)":)9+8+-+),2&%052G)0&)(,+):"-6)":)5+-+*-2$)G2$97C)
*$0&%&+99C) %+2:&+99) "-) $2(+) %+2(,U) !+-+) %+(+-60&+%) 0&) 2) 5$0&05) 0&) (,+) 5,0$%-+&'9)
hospital (no details available) affiliated with the study centre. No details of the 
assessments or data regarding the health of the children were described in the paper 
(Bar et al.. 2000a). 
Jungers and colleagues report (1997) from France was in accord with the wide 
consensus that pregnancy in women with renal disease and normal or near normal 
renal function is most often successful and usually does not result in deterioration of 
the maternal renal condition (Jungers et al.. 1997c). This was supported by several 
other studies in the past (Abe et al.. 1985;Barcelo et al.. 1986;Jungers et al.. 
1986;Jungers et al.. 1987;Jungers et al.. 1991;Katz et al.. 1980;Packham et al.. 
1989;Surian et al.. 1984). Jungers et al. reported a similar outcome in 1995 in a large 
series of women with primary glomerulonephritis whose serum creatinine was below 
0.11 mmol/l at the start of pregnancy. In contrast, outcome of pregnancy in terms of 
both fetal and maternal outcome was much worse in women with primary renal 
disease whose renal function was significantly compromised at conception. Fetal loss 
rate (not taking into account first trimester abortions) as high as 16-33% was reported 
by Hou et al. 1985, (Becker et al.. 1986;Imbasciati et al.. 1986). There were high 
proportions of premature deliveries and low birth weight infants. In addition the 
authors also reported that pregnancy markedly accelerated the underlying maternal 
-+&2$)%09+29+.)V#&1+-9')(Jungers et al.. 1997b)retrospective analysis of 43 pregnancies 
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in women with moderate to severe chronic renal failure during the 20-year period 
from 1975-1994 showed the following: Tables 2.5 and 2.6 
 
Table 2.5: Maternal characteristics and fetal outcome with respect to serum 
creatinine level at start of pregnancy (after Jungers et al. 1997) 
Scr (mmol/l) Group I 
(0.11-0.20) 
Group II 
(>0.20) 
p value 
No. of pregnancies 28* (30 fetuses) 15  
Status at conception    
Age (years) 25.6± 0.6 28.7± 0.8 0.003 
MAP (mmHg) 98± 2 103±3 0.16 
Haemoglobin (g/dl) 12.3± 0.2 10.9± 0.3 <0.001 
Scr (mmol/l) 0.143± 0.004 0.254± 0.019 <0.001 
Fetal outcome    
1st trimester abortion 1 (3%) 4 (27%) 0.04 
Stillbirth  5 (17%) 3 (20%) NS 
Live born infants 24/30* (80%) 8/15 (53%) 0.02 
preterm delivery 14/24* (58%) 4/8 (50%) NS 
birth weight 2437 ± 128 2246 ± 156 NS 
Corrected live birth rate** 24/29 (83%) 8/11 (73%) NS 
* Including 2 sets of twin 
** Not considering first-trimester abortions 
 
Table 2.6: Fetal outcome with respect to the period of observation (after Jungers  et 
al. 1997) 
Observation period Period I 
(1975-1984) 
Period II 
(1985-1994) 
p value 
No. of pregnancies 20 23 (25fetuses)*  
Status at conception    
Age (years) 26.3 ± 0.8 27± 0.7 NS 
MAP (mmHg) 103±2 97± 2 0.03 
Scr>0.20 mmol/l 6/20 (30%) 9/23 (39%) NS 
Haemoglobin (g/dl) 11.7 ± 0.3 12 ± 0.3 NS 
Fetal outcome    
1st trimester abortion 3 (15%) 2 (8%) NS 
Stillbirth  6 (30%) 2 (8%) 0.11 
Live born infants 11/20 (55%) 21/25* (84%) 0.048 
preterm delivery 4/11 936%) 14/21* (67%) 0.14 
birth weight 2648 ± 138 2211± 174 0.08 
Corrected live birth rate** 11/17 (65%) 21/23 (91%) 0.053 
* Including 2 sets of twin   
** Not considering first-trimester abortions 
 
The study concluded that fetal outcome in patients with impaired renal function had 
improved in recent times due to improvements of obstetric and neonatal care, 
improved blood pressure control and multidisciplinary care of such mothers by teams 
of nephrologists and obstetricians. However, the risk of fetal loss and accelerated 
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decline of maternal renal disease still remained especially with a creatinine clearance 
at conception is lower than 25-30ml/min/1.73m2. 
Jones and Hayslett (Jones & Hayslett 1996a) performed a study to ascertain maternal 
complications, immediate and long term effects of the pregnancy on underlying 
disease and outcome of pregnancy in women with moderate or severe renal disease at 
the beginning of pregnancy. They highlighted that the fetal survival was moderately 
(overall fetal survival rate was 93%) reduced and more than half the pregnancies were 
associated with obstetric complications. Growth retardation, prematurity and maternal 
complications were identified as factors which were most often responsible for 
caesarean section and admission to a neonatal unit. The table 2.7 below summarises 
the findings from the study: 
 
Table 2.7: Outcomes of 82 pregnancies and neonatal complications 
 
* Data on birth weight were available for only 76 of the 82 pregnancies 
 
Variable Value 
Preterm delivery (<37 wks) < no. (%)     48(59) 
Induction of labour < no. (%)      8(10) 
Delivery by Caesarean section < (%)     48(59) 
 Indication  
  Fetal distress      4 
  Intrauterine growth retardation    11 
  Macrosomia      1 
  Dystocia     
 Breech position      
2                                                  
2 
  Maternal renal deterioration    5 
  Maternal hypertension and pre eclampsia   11 
  None reported      12 
Mean (±SD) birth weight < g*      2239 + 839 
Small for gestational age (<10th percentile) - no. (%)   28 (37) 
Death < no. (%)        6(7) 
            Stillbirth < rate per 1000 births     49 
            Neonatal death < rate per 1000 births    24 
Admission to neonatal intensive care unit - no. (% of live born infants)  
  
28(37) 
            Indication  
              Prematurity, IUGR or both     25 
              Sepsis       1 
                         Unknown      2 
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The study included a follow up of nearly all mothers for 12 months after delivery and 
showed the following: 
 Pregnancy related loss of renal function (a loss occurring during pregnancy or 
within six weeks after delivery) in nearly half of all cases. 
 23% of these (10% of total series) women were rapidly progressing to end-
stage renal failure within six months of delivery. 
 Excluding the women with accelerated progression to end stage renal failure, 
the postpartum serum creatinine concentration was comparable to that of 
women with stable renal function during pregnancy. This was a generally 
positive message for women contemplating pregnancy.  
However, the effect of renal disease on the growth and development of the surviving 
infants was not evaluated any further than the 12 months.  
While the studies above provided useful guidelines for counselling women with pre-
existing renal insufficiency about their prospects of a successful pregnancy and the 
effect of pregnancy on their underlying disease, there was no long term follow up 
data regarding the health and development of children born to these mothers.  
 
2.1.3 Pregnancy in women on dialysis 
 
Pregnancy used to be a rare occurence in women on dialysis. Several factors 
contributed: hyperprolactinemia causes anovulation often manifest in these women as 
amenorrhoea, oligomenorrhoea or polymenorrhea (Redrow et al.. 1988). In women 
who do ovulate and menstruate regularly, abnormal endometrial maturation may 
prevent implantation. Furthermore, an uraemic environment is detrimental to the 
developing embryo (Ginsburg & Owen 1993;Gomez et al.. 1980). In 1971 Confortini 
et al. (Confortini et al. 1971) reported the first successful pregnancy in a woman on 
chronic hemodialysis (HD). Although still uncommon, the incidence of pregnancy in 
women on dialysis may be increasing. In 1980 the European Dialysis and Transplant 
Association (EDTA) reported a pregnancy incidence of 0.9% (1980b). Recent 
publications report pregnancy in 1<7% in women on chronic dialysis (Bagon et al.. 
1998b;Chao et al.. 2002b;Hou 1994a;Okundaye et al. 1998a;Rizzoni et al.. 
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1992;Souqiyyeh et al.. 1992;Toma et al.. 1999d). The true frequency of conception is 
unknown because many pregnancies in dialysed patients probably end in early 
spontaneous abortion, and there is also a high therapeutic abortion rate (Davison 
2001i).  
Nowadays, pregnancy in contemporary women on dialysis is more likely to be 
successful, with 30<50% of pregnancies resulting in delivery of a surviving infant 
(Holley & Reddy 2003g). Premature delivery, intrauterine growth retardation, 
polyhydramnios, and maternal hypertension remain common complications. 
Newborn weight and survival appear to be influenced by dialysis dose. Thus 
increasing total weekly dialysis time during pregnancy via increased frequency of 
treatments leads to a longer gestation, higher infant birth weight, and more viable 
pregnancies (Bagon et al.. 1998a;Okundaye, Abrinko, & Hou 1998b;Rizzoni et al. 
1992)  
 
The following tables summarise recent reports of pregnancy in women on chronic 
dialysis. 
 
Table 2.8: Incidence and outcome of pregnancy in women on chronic HD (Modified 
from Holley J L. & Reddy SS, 2003 (Holley & Reddy 2003e) ) 
 
Reference Year 
No. of 
pregnancies/no. 
of women 
Incidence 
of 
pregnancy 
Surviving 
infants 
Neonatal 
deaths 
Spontaneous 
abortion 
Souquiyyeh 
MZ et al.  
1992 27/380 7% 30% E E 
Hou SH  1994 58/1281 1.5% 37% 5% 44% 
Okundaye I et 
al.  
1998 184/6230 2.2% 40% 3% 46% 
Bagon JA et 
al.  
1998 15/1472 1% 50% 13% E 
Toma H et al..  1999a 172/5000 3.4% 49% 5% 12% 
Chao A-S et 
al.  
2002 18 E 50% 17% E 
a Detailed information on 74 pregnancies;  
E, not reported. 
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Table 2.9: Duration and complications of pregnancy in women on chronic HD 
(Modified from Holley J L. & Reddy SS, 2003 (Holley & Reddy 2003d) ) 
 
Reference No of 
pregnancies 
Mean 
pregnancy 
(weeks) 
Mean 
newborn 
weight 
Incidence of 
polyhydramnios 
Incidence of 
maternal 
hypertension 
Caesarean 
section 
deliver ies 
Okundaye 
I et al.  
184 32.4 ± 4.6 E E 79% E 
Bagon JA 
et al.  
15 E 1164 (700<1900) 62% E 8 (53%) 
Toma H et 
al..  
68 31.9 1543.5 ± 671.9 (530<2856) 33% 42% E 
Chao A-S 
et al.  
18 32 1542 (512<1660) 46% 72% 6 (46%) 
E, not reported. 
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Table 2.10: Complications and Outcomes of Pregnancy in Chronic haemodialysis Patients (Modified from Reddy SS and 
HolleyJL, 2007) (Reddy & Holley 2007c) 
E not reported 
 
 
 
 
 
 
 
 
 
 
Refences 
Author 
Year No. of 
treated 
pregnancies 
Mean 
Pregnancy 
(weeks) 
Mean 
newborn 
Birth 
weight 
Mternal 
hypertension 
(%) 
Incidence 
polyhydramnios 
% 
Caesearean 
Section 
Fetal/neonatal 
Deaths (%) 
Surviving 
infants No. 
(%) 
Bagon 1998 15 30.6 1164g 
(700-
1600g) 
62 E 53 5(33) 10 (67) 
Romao 1988 14 32.3±2.6 
(27-36) 
1400 ± 579 
(720-
2650g) 
50 36 (67) 8 out 
of 12 
known 
3 (21) 11 (79) 
Toma 1999 54 31.9± 1544 ± 672 
(530-2856) 
35 44 E 18(33) 36 (67) 
Chao 2002 13 32 1542 (512-
1660) 
72 46 46 4 (31) 9 (69) 
Kazancioglu 2002 3 31 1250 67 67 67 1(3) 2(67) 
Eroglu 2004 7 32 (26-36) 1400 (420-
2640) 
E 29 57 1(14) 6 (86) 
Hasse 2005 5 33 1765±554 40 40 80 0(0) 5(100) 
A report from a series of three successful pregnancies in women with chronic 
kidney disease (Brem et al.. 1988a), two of whom were treated with 
haemodialysis, stated that all infants were premature and had low birth 
weights. The infants were azotaemic immediately after birth, which rapidly 
resolved, as the fetal renal function was good. An osmotic diuresis caused 4-
8% drop in weight in the first 48 hours of life. This led to hypokalaemia and 
volume contraction in the infants. There were no major growth or 
developmental abnormalities in these children in the first year of life, but there 
was no reported long-term follow up (Brem et al.. 1988b). 
While most pregnant dialysis patients have been on haemodialysis HD, case 
reports and surveys also detail successful pregnancies in women on chronic 
peritoneal dialysis (PD) (Hou 2001;Hou 1994c;Jakobi et al.. 1992;Okundaye, 
Abrinko, & Hou 1998d) The incidence of pregnancy in women on PD is two 
to three times lower than that of women on HD. 
As debate continues about the advisability or not of pregnancy in dialysis 
patients, more and more women are choosing to take the chance because 
childbearing and parenthood are important rehabilitation goals (Davison 
2001a). There are no explicit studies that describe the health of infants or 
children born to mothers having on-going haemodialysis or peritoneal 
dialysis. The above papers gave little or no details of child outcome. 
 
2.1.4 Pregnancy in women with renal transplant 
 
When human organ transplantation was first developing, the physicians 
worried about the potential teratogenicity of the immunosuppressive drugs 
used in these mothers and pregnancy was ill advised (McKay & Josephson 
2006c). Despite these concerns, approximately 14,000 births worldwide have 
been reported among women with transplanted organs, the most common 
being renal transplant. With ongoing improvements in surgical, 
immunological and medical management of transplant patients many more 
pregnancies are now occurring (McKay & Josephson 2006d). Pregnancy is 
now an expected benefit afforded to women by organ transplantation.  
Fertility in women with chronic renal failure is low due to a combination of 
factors like loss of libido, ovarian dysfunction, anovulatory vaginal bleeding, 
amenorrhea and high prolactin levels (Zingraff et al.. 1982). After renal 
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transplantation there is rapid restoration of renal, endocrine and sexual 
function (Davison & Bailey 2003f). 
Information about pregnancy in recipients of solid-organ transplant came from 
voluntary registries, case reports and retrospective centre studies. Three 
registries offered data about pregnancy outcomes: the National 
Transplantation Pregnancy Registry in the United States, the European 
Dialysis and Transplant Association Registry and the United Kingdom 
Transplant Pregnancy Registry (McKay & Josephson 2006e). Most 
Transplantation centers have advised that conception was safe after the second 
post transplantation year, assuming that the graft functioned well. Criteria as 
set out in the European Best Practice Guidelines IV which women with renal 
transplant need to meet were: stable serum creatinine level of 1.5mg/dl 
;OWWX6"$R$U)"-)$+99)2&%)2)-2(+)":)#-inary protein excretion less than 500mg per 
day ( 2002b). 
@&) 2&) #G%2(+) ":) IY+&2$) %09"-%+-9) 0&) G-+1&2&57'C) V",n M Davison (Davison 
2001j) reported that outcome of pregnancy is directly related to the following: 
a) Better allograft function 
b) Low steroid dosage before conception 
c) Longer time interval between transplant and conception 
d) Transplanted kidney comes from a living donor.  
However, a recent report from the UK transplant pregnant registry stated that 
there was no statistically significant difference between the proportion of 
successful pregnancies in cadaveric and live donor transplant recipients 
(Sibanda et al.. 2007g). 
About 1 in 50 women of child bearing age with a functioning renal transplant 
becomes pregnant (Lindheimer, Grunfeld, & Davison  2007). Women with 
renal allografts who conceived had a high incidence of maternal and fetal 
complications. About 25% of pregnancies miscarried or were terminated; of 
the remainder 95% or more were successful (Davison & Bailey 2003e). John 
Davison and David Bailey summarised from their report in August 2003 the 
following maternal and fetal complications: refer to tables 2.11 and 2.12 
(Davison & Bailey 2003d). 
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Table 2.11: Pregnancy outcomes in renal allograft recipients (modified from 
Davison and Bailey 2003) 
 
First Trimester Lossess (n = 81)    22.5% 
 Miscarriage     13% 
 Termination     9% 
 Ectopic pregnancy    0.5% 
Pregnancies beyond 1st trimester (n = 296) 
 Live births     97% 
 Stillbirths     2% 
 Neonatal deaths     1% 
 
Three hundred and seventy<seven pregnancies in 261 renal allograft recipients. 
(US National Transplantation Register) 
 
Table 2.12: Maternal risks of renal transplantation and immunosuppression 
(modified from Davison and Bailey 2003) 
 
Increased risk of ectopic pregnancy 
Hypertension and pre-eclampsia 
Bacterial and viral infections consequent to immunosuppression 
Toxic effects of immunosuppressant drugs 
Pelvic osteodystrophy 
Increased likelihood of operative delivery 
 
Table 2.13: Fetal risks of renal transplantation and immunosuppression 
(modified from Davison and Bailey 2003) 
 
Intrauterine growth restriction, hypoxia and death 
 
Preterm delivery 
Preterm labour 
Preterm premature rupture of membranes 
Preterm delivery because of maternal complications 
Toxic effects of immunosuppressnat drugs 
Depressed haemopoiesis 
Immune deficiency 
Chromosome aberrations in leucocytes 
Adrenocortical insufficiency 
Infection 
Cytomegalovirus 
Hepatitis B 
Bacterial sepsis 
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Davison (Davison 2001f) also stated that there were increased rates of late 
pregnancy maternal hypertension (30%), preterm delivery (45-66%) and fetal 
growth restriction (upto 40%). Some of these problems may be on the rise 
with the use of cyclosporin and more recent immunosuppressive agents.Refer 
to table 2.14: 
 
Table 2.14: A total of 424 livebirth outcomes in female renal transplant 
recipients reported to the National Transplantation Pregnancy Register  
Modified from Armenti et al. (Armenti et al. Graft2000;3:59-63) 
 
       CsA Neoral    Tacro 
 
Live births(n)      350 57    17 
Gestational age (mean) (weeks)   35.9 35.8    33 
Birthweight(mean) (g)    2485 2449    2151 
Premature(<37weeks)(%)    52 51    63 
Low birthweight(<2500 g) (%)   46 54    63 
Caesarean section (%)     51 48    44 
Newborn complications (%)    40 49    53 
Neonatal deaths (within 30 days of birth) (%) 1 0    6 
 
 
CsA, Sandimmune brand cyclosporin; Neoral,Neoral brand cyclosporin;  
Tacro,tacrolimus, FK506 or Prograf. 
 
2.1.5 Complications reported in pregnancies post renal transplant 
 
A . Neonatal complications 
 
A .1 Neonatal morbidity 
Neonatal morbidity is mainly a consequence of prematurity (50% of babies) 
and growth restriction (54% babies were low birth weight i.e. <2500gm) 
(Sibanda et al.. 2007f) which may be co-existing. There is an association 
between low birth weight, birth within two years of transplantation 
(Cunningham et al.. 1983) and cyclosporin therapy (Armenti et al.. 
2002;Armenti, Moritz, & Davison 1998b). 
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A .2 Adrenal insufficiency 
Penn et al. reported evidence of adrenocortical insufficiency and lymphopenia 
in two infants born to mothers with renal transplant (Penn et al.. 1971b). Both 
the infants had hyponatraemia, hyperkalemia and lymphopenia. One infant 
became hypotensive and lethargic and required treatment with corticosteroids. 
The possibility of thymic hypoplasia was raised. Both the infants made full 
recovery without immediate residual problems. There was also a report of 
twin pregnancy where both infants had lymphoid hypoplasia and hypoplasia 
of adrenal cortex at post mortem (Lower et al.. 1971). 
 
A .3 Neonatal infections 
Neonatal bacterial infection was infrequent and when encountered it 
responded appropriately to therapy. Pregnant allograft recipients are 
predisposed to viral infections because of immunosuppression. Heaptitis B 
and cytomegalovirus are particularly associated with renal transplant mothers 
and pose a risk both for the fetus and neonate. However the rate of these 
infections are not reported in the literature. Evans in 1975 (Evans, McCollum, 
& Valdimarsson 1975) reported congenital CMV infection after maternal 
renal transplantation. There is also one report of an infant developing 
asymptomatic antigenemia in a mother who was HBsAg positive (Salant et al.. 
1976).  
 
B . E ffects of maternal transplant related medications 
 
Chromosomal abnormalities were seen in neonatal white blood cell following 
maternal treatment with azothioprine. These may persist for up to two years. 
(Davison & Bailey 2003c;Leb, Weisskopf, & Kanovitz 1971). Longer lasting 
effects in other tissues are possible (Scott, Branch, & Holman 2002b). In 
female infants germ cells develop before birth and thus there is a theoretical 
risk that the immunosuppressants used in mothers might have a long term 
+::+5() "&) (,+) 5,0$%'9) ""57(+9.) T,#9) (,+-+) remains at least a possibility that 
children born to women with transplants may suffer from malignant disease, 
immune compromise and abnormal reproductive performance (Davison & 
Bailey 2003b). Experiments in female mice given 6-mercaptopurine during 
pregnancy show that many of the female offspring may be sterile or if they do 
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become pregnant, have smaller litters and more dead fetuses than the off 
spring of mothers who had not received the drug (Reimers & Sluss 1978). 
Only prolonged follow up of the children born to transplant patients will 
provide an answer as to whether similar problems may occur in humans 
(Penn, Makowski, & Harris 1980a). Immunosuppression of the fetus is a 
possible adverse effect. Tests showing a depressed immune response have 
been described in infants born to renal tansplant recipients. Some of these 
abnormalities persisted at one year but without any apparent accompanying 
morbidity (Schena et al.. 2002) 
Scott and colleagues (Scott, Branch, & Holman 2002a) stated that 
immunosuppressive agents readily crossed the placenta during the 
development of the fetus and its immune system. But the effects of the agents 
may not become evident until the offspring reaches adulthood. They reported 
a case of a 23-year-old daughter of a renal allograft recipient, who was 
+ZG"9+%) (") 2[2(,0"G-0&+) 2&%)G-+%&09"&+) (,-"#1,"#() ,+-)6"(,+-'9) G-+1&2&57.)
The daughter had stiff joint when 8 years old and developed ulcerative colitis 
when 16 years old. This daughter went on to have two pregnancies, one 
complicated by autoantibodies and fetal death and the other by systemic lupus 
erythematosus and preeclampsia, but with the birth of a preterm male infant. 
This raised the question whether autoimmune or reproductive disorders should 
be expected in daughters of transplant recipient. The authors recommended a 
52#(0"#9)2GG-"25,3)IG2-+&(,""%)627)&+8+-)*+)!0(,"#()-09A)0&)1+&+-2(0"&9)(,2()
:"$$"!) (-2&9G$2&(2(0"&) *#() (,+) -09A9) 2-+) #&5+-(20&'.) T,+-+) 09) "&+) 529+) -+G"-()
associating maternal tacrolimus with neonatal cardiomyopathy (Vyas et al.. 
1999) . Scott and colleagues have suggested that fetal exposure to 
immunosuppressives causes abnormalities that may be associated with later 
development of autoimmune disease. Autoantibodies were not found in four 
children exposed in utero to azathioprine or in seven children exposed to 
cyclosporine(Classen & Shevach 1991;Pilarski, Yacyshyn, & Lazarovits 
1994). 
Overall there is no definite pattern of fetal abnormalities identified with the 
use of maternal corticosteroids, azathioprine or cyclosporin A in either animal 
models or in human infants (Blowey & Warady 1998;Hou 1999c;Mason et 
al.. 1985;Reinisch et al.. 1978). 
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C . Neonatal deaths 
 
Early fetal loss by miscarriage was reported in 11% of pregnancies in the UK 
Transplant Pregnancy Registry and most recent figure from the NTPR is 14% 
(Sibanda et al.. 2007e).There is no clarification regarding spontaneous and 
therapeutic abortions. In a follow up study by Willis et al., (Willis et al.. 
2000e) of children of renal transplant recipient mothers, reported 2 neonatal 
deaths representing 3.5% of the live births. Incidence figures of ectopic 
pregnancy, intrauterine fetal death and still-birth in the UK Transplant 
Pregnancy Registry are each 2% or less. However, the total number of 
patients in the registry were too small to compare with the general population. 
 
2.1.6 Report of pregnancy outcome post renal transplant from Royal F ree 
Hospital 
 
Thompson et al.'9)(Thompson et al.. 2003a) study from the renal department 
of the Royal Free Hospital in London looked into graft, fetal and maternal 
outcomes of pregnancy in their renal transplant patients and compared their 
results with those of the large national transplant registries. The mean time 
from transplantation to pregnancy was 6.5 years, with unfavourable outcome 
in women who conceived within 1 year of transplant. There was 41% of fetal 
growth restriction (FGR) and 33% of infants were small for gestational age. 
FGR was associated with maternal hypertension, pre-pregnancy serum 
5-+2(0&0&+) \) OWWX6"$R$) ;O.P61R%$UC) 52$50&+#-0&) 0&,0*0("-9) 2&%) (,+) #9+) ":)
52-%0"9+$+5(08+) ]) *$"5A+-9.) ^-+1&2&57) ,2%) 2) %+$+(+-0"#9) +::+5() "&) (,+) 1-2:()
:#&5(0"&) 0&) G2(0+&(9) !0(,) 9+-#6) 5-+2(0&0&+) _) OPPX6"$R$) ;1.75mg/dl). The 
obstetric, maternal and fetal outcomes are as summarised in tables 2.15 and 
2.16. 
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Table 2.15: Obstetric outcomes and maternal outcomes (modified from 
Thompson et al.  2003) 
 
Pregnancy outcome (n=48) 
Live births     32 (68%) 
Miscarriages     6 (12%) 
Terminations     6 (12%) 
Ectopics      2 (4%) 
Stillborn      2 (4%) 
Mean age at time of pregnancy   30 yrs 
      (19-39 yrs) 
 
Mean time between TPx    6.5 yrs  
and pregnancy     (0.5-24 yrs) 
 
Complications (n=27) 
Urinary tract infections in    26%(7) 
pregnancy 
Pre-pregnacy hypertension   77% (21) 
Preeclampsia     29% (8) 
 
Delivery mode (n=32) 
Caesarean section    59% (19) 
Forceps      22% (7) 
Vaginal      19% (6) 
 
Graft outcome (n=30) 
Rejection during pregnancy   0% 
Graft dysfunction during pregnancy  16% 
Graft dysfunction persisted   20% 
(>6months) post pregnancy 
Graft loss <2 yrs post partum   3.3% 
   
Table 2.16 : Neonatal outcomes (modified from Thompson et al.  2003) 
 
Neonatal outcome   RFH     NTPR 2001 UKTPR 
 
Pre-term delivery (< 37 weeks)  56.5%        52%    49% 
Mean gestational age   34.9 weeks 36 weeks    --- 
Mean birth weight   2204 g  2493 g     --- 
Low birth weight (< 2500 g)  50%  45%     54% 
Very low birth weight (< 1500 g)  20%       18% 
Fetal growth restriction   40.7%        8% 
Small for gestational age   33% 
(< 10th percentile) 
    
RFH, Royal Free Hospital; NTPR 2001; UKTPR 1999  
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2.1.7 What has been reported so far about children of renal tranplant 
recipient mothers? 
 
Women with renal transplants have been discouraged to contemplate 
pregnancy due to concerns about the possible adverse effects on the children. 
There has been very little robust data available on the outcome of offspring of 
such women although there was evidence for both good and bad outcomes 
(Burleson et al.. 1983;Hou 1999b;Korsch et al.. 1980i;Rasmussen et al.. 
1981).  
The following table summarises the studies which have reported follow up of 
children born following renal transplantation: 
 
Table 2.17 Summary of studies of children born after renal transplant 
Author Year No of children 
studied 
Health evaluation of 
children 
Control group 
Korsch et 
al.(Korsch et al.. 
1980h) 
1980 10 children. Age at 
assessment varied 
from10 month < 
6yr 8 month 
All children had 
normal physical 
examination. 
No  
Pahl et al.(Pahl et 
al.. 1993b) 
1993 10 out of 26 
children born. Age 
at assessment or 
duration of follow 
up not specified.  
One child with 
hepatoblastoma 
requiring excision. 
No  
Ghahramani et 
al.(Ghahramani, 
Attaipour, & 
Ghods 1993) 
1993 13 live born 
followed for 36 
month 
All children had 
normal physical 
examination. 
No 
Bar et al.(Bar et 
al.. 1996b) 
1996 29 children. Age at 
assessment or 
duration of follow 
up not specified. 
Two children reported 
handicapped, no 
specific details given. 
No 
Willis et al.(Willis 
et al.. 2000d) 
2000 48 children aged 
between 9 month 
and 18 years. 
General health was 
unremarkable. Cerebral  
palsy(1), claw hand 
(1), asthma(2), 
recurrent URTI(1) 
Yes  
 Sgro et al.(Sgro 
et al.. 2002f) 
2002 32 live born 
children between 3 
month and 
11years. 
IDDM (1), asthma (2), 
recurrent otitis media 
(1) 
Yes  
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2.1.8 Psychological aspects of pregnancy in mothers with renal 
transplant: 
 
In a review of psychological issues in women with renal disease Kimmel and 
Patel (Kimmel & Patel 2003) stated that chronic renal disease may prevent the 
patient from playing roles she desires to maintain or perceives herself capable 
of accomplishing, or may limit her abilities compared to her premorbid status. 
Illness may also impair libido, sexual and reproductive function. Patients can 
adapt to these challenges by achieving success in several domains including 
maintaining employment, functioning in marital, familial and societal 
contexts, achieving parenthood and enjoying recreational activities. Otherwise 
disability, marital discord, family dysfunction and substance abuse can result. 
They suggest that women take the added burden of homemaking, child rearing 
and care taking activities within the family. Childbirth and bringing up 
children is often an important concern for women with renal disease. 
Diminished chances of successful pregnancy is often an important issue in the 
life of young women of reproductive age with renal disease. 
Davison and Bailey (Davison & Bailey 2003a) pointed out that many women 
choose parenthood in an effort to re-establish a normal life in the face of a 
serious chronic illness. In certain situations this may bring them into conflict 
with their medical supervisors so that some women do not seek obstetric or 
medical advice until already pregnant. This often gives rise to ethical and 
clinical management dilemmas. There need to be more detailed studies to 
understand  the psychology of women who pursue parenthood despite 
substantial risk to their own health and that of their unborn children (Stotland 
& Stotland 1998). 
Parenthood is one of the criteria describing the quality of life after renal 
transplantation (Moon et al.. 2000b). However, even up to the1980s such 
women were strongly advised against planning a family. From the study of 
BM Korsch et al. from US, we see that a significant number of mothers were 
urged by families and physicians to terminate their pregnancies because of 
concerns about the possibility of graft rejection and birth defects in future off 
spring. Following the birth of their child, some mothers were persuaded to 
undergo tubal ligation to avoid future pregnancies and associated risk. It is to 
be noted that two women who did undergo this procedure later regretted the 
 36 
decision and one sought reversal of the procedure. It is interesting to note 
from this report from 1980 that none of the allograft recipient parents were 
concerned about their life expectancy or future health as a result of being 
transplant patients. Most of them reported that they were enjoying parenthood, 
engaging in age- appropriate activities and coping appropriately with various 
stresses in their lives (Korsch et al.. 1980g). The authors had also expressed 
concerns about the fact that female allograft recipients often met with 
intensive, dogmatic and negative attitutes toward their pregnancies. Often 
advice was given to these mothers without exploration of their own 
preferences.  
Another study by Penn et al.  (Penn, Makowski, & Harris 1980b) highlighted 
that uncertain life expectancy of patients is a huge concern. Those desiring 
parenthood had to be warned that they may not live long enough to rear their 
children to adulthood and may leave their spouses with the problem of raising 
their children (Makowski 1976;Penn et al.. 1971a) although a single parent 
raising children is not always a problem. 
Follow up of children of renal transplant recipient mothers by Willis et al. 
(Willis et al. 2000c) highlighted numerous psychological issues arising in 
families where the mother had undergone renal transplantation, which may  
influence the development of a child. This included maternal anxiety 
regarding her own health as well as the health of her children. The authors did 
not specifically assess this psychological aspect but observed that many 
mothers were worried about the possibility of renal disease in their children, 
often not discussing the issues openly with their physicians. A lot of these 
mothers were precluded from breast feeding because of the medications they 
!+-+)(2A0&1.)T,+-+)09)0&5-+290&1)BG-+99#-+D)0&)(,+)5"66#&0(7)-+12-%0&1)*-+29()
:++%0&1)2&%)(,09)627)2%8+-9+$7)2::+5()2)!"6+&'9)G+-5+G(0"&)":),+-)6"(,+-0&1 
9A0$$9.) `,0$%-+&'9) 2&Z0+(7) 5"&5+-&0&1) (,+)6"(,+-9'9) ,+2$(,) ;0$$&+99C) G"(+&(02$)
graft failure or early death) may influence child psychological adjustment and 
behaviour.  
Similar concerns have been expressed about women on dialysis in a recent 
update from Reddy and Holley (Reddy & Holley 2007b). Although the 
success of pregnancy is now more likely in women on dialysis, the burden on 
the women and her family is significant. This is not only during pregnancy but 
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also after delivery, when the mother must continue with dialysis and is also 
faced with the challenge of caring for an often premature infant. 
Over the decades the medical profession has developed a more open- minded 
approach towards allograft recipients who wish to become pregnant. This has 
been helped by evidence of increasingly better outcome of pregnancies in this 
group and further studies looking into long term follow up of children born to 
mothers with renal transplant may jusitfy an even more optimistic outlook. 
This overview sets the scene for the need for the PORD study. The objectives 
of the study were: 
1. To assess a cohort of children born to mothers with chronic kidney 
disease and describe their health in terms of 
physical/neurodevelopmental and behavioural well being (in relation 
to a matched control group of children born to healthy mothers). 
2. To assess any impact of the difficulties of having a child whilst 
undergoing treatment for chronic kidney disease on the psychological 
health for the mother / or maternal child bonding/ relationships. 
3. To consider specific factors in the management of maternal chronic 
A0%&+7) %09+29+) !,05,) 627) ,28+) %+$+(+-0"#9) +::+5(9) "&) (,+) 5,0$%'9)
outcome (e.g. fetal drug exposure) 
Hypothesis of the study was: 
Children born to mothers with chronic kidney disease were expected to have 
the following complications in comparison to age matched children born to 
well mothers: 
a. Reduced longitudinal growth  
b. Greater occurrence of difficult temperament and emotional or 
behavioural problems 
c. Possible effects on neurodevelopment. 
These effects would be a continuum from healthy children to those with the 
above morbidity depending on antenatal exposures/ disease severity. 
Families where children are born to mothers with chronic kidney disease 
would experience the following: 
a. Differences in maternal bonding. 
b. More stress in parent child relationship. 
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c. Other difficulties in parenting (related to the pressures of renal disease 
and treatment). 
Sub hypothesis: 
a. The severity of effects would be directly related to the severity 
(stage) of chronic renal failure. 
b. Different effects would be observed in children of renal transplant 
recipients. 
 
 
Statement of research questions for the study were: 
We wished to establish the following: 
a. What are the physical and neurodevelopmental outcomes for a 
representative cohort of these children? 
b. Are there difficulties with maternal bonding and parenting skills with 
these mothers when compared with in relation to matched controls? 
(Do these mothers experience more difficulties with maternal bonding 
and parenting skills than their matched controls 
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2.2 Health outcomes of children born to parents who have had pre-implantation 
genetic diagnosis/screening (PG D/PGS) pilot study (PG D study) 
2.2.1 Introduction to PG D study 
While the problem of infertility has affected humanity for as long as there have been 
human beings, the technology required to fertilise a human egg in an environment 
outside the human body only became available in recent times.  
Infertility is regarded as a health problem (WHO, Reproductive Health Strategy 
2004) and affects approximately every 6th couple in Western Countries. It is however 
not a public health issue in every country. The number of infertile couples is on the 
rise: partly associated with advanced maternal age (delayed maternity) and 
subsequent poor quality gametes, possibly also due to related lifestyle habits and 
environmental factors (Soini et al.. 2006g). 
In 1977, Dr. Robert Edwards and Dr. Patrick Steptoe pioneered IVF (in vitro 
fertilisation) procedure. Thanks to their work, Louise Brown, the world's first baby to 
be conceived in vitro, was born in the UK on July 25, 1978 amid intense controversy 
over the safety and morality of the procedure (Edwards, Steptoe, & Purdy 
1980;Steptoe & Edwards 1978a). She gave birth on December 20, 2006 to a baby 
boy, who was conceived naturally. To date more than one million babies have been 
born world wide following assissted reproductive techniques (Sutcliffe & Ludwig 
2007). 
Preimplantation genetic diagnosis (PGD) is a procedure, which was developed in the 
early 1990's, in which embryos obtained through in vitro fertilization (IVF) are 
analyzed for a genetic %09"-%+-)*+:"-+)(,+)I#&2::+5(+%')+6*-7"9)2-+)06G$2&(+% in the 
woman's uterus. As such, PGD is a very early form of prenatal diagnosis (PND) 
(Braude et al.. 2002). In Britain, as in most of Europe, Preimplantation genetic 
diagnosis (PGD) refers to the removal of a single cell from an embryo generated in 
vitro for genetic testing to diagnose a recurrent, serious, heritable condition and 
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thereby to avoid the implantation of affected embryos. The technique is used by 
fertile couples, as an alternative to prenatal diagnosis to avoid the abortion of an 
affected fetus. However, in the United States, PGD also includes what most 
Europeans call "preimplantation screening": screening of the embryos of infertile 
couples for sporadic chromosomal aneuploidies, in order to improve the likelihood of 
implantation and reduce the risk of miscarriage. In Britain PGD practices are strictly 
regulated by the Human Fertilisation and Embryology Authority (Braude 2006). The 
worlds of genetic testing and assisted reproduction have converged with the advent 
of PGD and debates into different aspects of the technique and its evolving uses will 
continue. 
 
2.2.2 H istory of Pre implantation Genetic Diagnosis (PG D) 
In 1967, Robert Edwards and David Gardner reported the successful sexing of rabbit 
blastocysts, setting the first steps towards PGD (Edwards & Gardner 1967a). In 
many mammalian species, sex chromatin can be identified in a high proportion of 
interphase nuclei of somatic cells in adult females but not in males. Edward and 
Gardner suggested that identification of sex chromatin in a high proportion of 
trophoblast nuclei would allow them to classify these as a female and its relative 
absence would indicate a male. The sexing of 4-5 day live blastocysts could be useful 
in excercising some control over the sex ratio of offsprings, as embryos of this age 
and older can be transferred into receipient females. They also mention that for this 
vital technique to be of practical use , the embryos must be able to continue normal 
development and  survive to full term after transfer to a recipient female. They had 
also suggested the possibility of attempts to control sex linked disorders in man using 
this technique (Edwards & Gardner 1967b). 
It was not until the 1980s that human IVF was fully developed, which coincided with 
the development of the highly sensitive polymerase chain reaction (PCR) method of 
DNA/gene amplification. Handyside and collaborators' first successful attempts at 
testing embryos were in October 1989 with the first births in 1990 (Handyside et al.. 
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1992) although the preliminary experiments had been published some years earlier 
(Coutelle et al.. 1989;Handyside et al.. 1990a;Holding & Monk 1989). In these first 
cases of PGD, PCR was used for sex determination for patients carrying X-linked 
diseases.  
PGD has been possible as a result of a number of ground breaking techniques:  
i. The ability to fertilise a human egg in vitro and culture the zygote to reach at 
least day 4 of preimplantation development (Gardner & Lane 1997);  
ii. The ability to remove a single blastomere safely from the cleavage stage 
embryo and also not compromise further development of the embryo (Hardy 
et al.. 1990;Tarin & Handyside 1993);  
iii. The ability to amplify minute quantities of DNA using PCR so that genetic 
analysis can be performed (Sermon et al.. 1996;Strom et al.. 1994;Tsai 1999).  
Since then, its use and popularity has grown steadily. PGD is one of the most rapidly 
developing techniques in reproductive medicine (Fragouli 2007a). 
The following table summarises key developments leading up to IVF and subsequent 
development: 
Table 2.18: Key Development in assissted reproduction 
Year Event Key  Investigators 
1880 First attempt at IVF in mammalian eggs Schenk 
1890 First succesful egg recovery from rabbit Heap 
1893 First successful embryo culture Onanoff 
1930 First successful IVF in mammalian eggs resulting in live birth Pincus 
1952 Time of ovulation established in human beings by 
laparoscopy 
Rock 
1971 First human blastocyst seen in vitro Steptoe and Edwards 
1972 Mouse embryo successfully cryopreserved and thawed with 
survival 
Wilmut 
1978 Birth of Louise Brown, first human born after IVF Steptoe and Edwards 
1983 First pregnancy after replacement of cryopreserved embryo Trounson 
1990 Preimplantation genetic diagnosis first described Handyside 
1992 ICSI developed in human beings Palermo 
Reproduced with permission from: Sutcliffe AG. IVF children: the first generationEassisted 
reproduction and child development. London: Parthenon Publishing Group, 2002. 
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2.2.3 The procedure of preimplantation genetic diagnosis 
Preimplantation genetic diagnosis (PGD) is a method by which embryoes formed 
through IVF can be tested for single gene disorders or chromosome abnormalities 
prior to embryo transfer. PGD became available only as a consequence of extra 
corporeal (in vitro) fertilisation. PGD uses standard assisted reproduction techniques 
such as controlled ovarian stimulation, oocyte retrieval, in vitro fertilisation (IVF) / 
intracytoplasmic sperm injection (ICSI), and in vitro embryo culture (Ogilvie et al. 
2005;Pickering et al.. 2003). The fertilised egg undergoes reductive cell division 
(refer to figures 1 & 2) and reaches the 8 celled stage around day 3 post fertilisation. 
On day 4 morula formation takes place and the embryo reaches the blastocyst stage 
on day 5. 
The blastocyst has an inner cell mass which will become the fetus and a clearly 
differentiated trophectoderm which will form the extraembryonic tissue (Ogilvie et 
al. 2005). PGD uses the biopsy material from either the oocyte or the developing 
embryo. The biospsied material is tested for the genetic condition in question or 
screened for chromosomal aberrations and aneuploidy. Only unaffected embryos (no 
more than two) are transferred to the uterus. The first and second polar bodies may 
also be biopsied (Rechitsky et al.. 1999;Verlinsky et al.. 1990;Verlinsky et al.. 
1998). 
 
 43 
 
 44 
This is a labour intensive procedure and can not be used for conditions where the 
father carries the genetic disorder. However it has the advantage of removing non < 
functional material and thus is less invasive and damaging than embryo biopsies. The 
most commonly used technique is to biopsy single blastomeres from embryos on day 
3 (De & Van 2001;Veiga et al.. 1997). Material for genetic testing may also be taken 
from the embryo at the blastocyst stage. This yields a larger amount of material for 
testing than polar body or blastomere biopsy. The disadvantage of this procedure is 
that the culture conditions may not allow all embryos to progress to blastocyst stage. 
Also a blastocyst must be transferred to the uterus before hatching on day 6, thus 
limiting the time available for genetic testing. For genetic testing Polymerase Chain 
Reaction (PCR), a technique using amplification of specific sequences is used. 
Alternatively, Fluorescent In Situ Hybridisation (FISH) may be applied to the genetic 
matrerial (Ogilvie et al. 2005). FISH is a cytogenetic technique that can be used to 
detect and localize the presence or absence of specific DNA sequences on 
chromosomes. It uses fluorescent probes that bind to only those parts of the 
chromosome which show a high degree of sequence similarity.  
2.2.4 Applications of the procedure of Preimplantation genetic diagnosis (PG D) 
2.2.4.1 Preimplantation genetic diagnosis (PG D) 
PGD was introduced more than 10 years ago to allow couples who had a high risk of 
having affected children with genetic disease, to avoid the difficult situation of 
prenatal diagnosis followed by termination of pregnancy (Taylor & Braude 1994). 
PGD provides information for such couples on which to base their decision - the 
1+&+(05) ,+2$(,) ":) (,+) +6*-7".) @() ,29) 108+&) (,+9+) 5"#G$+9) (,+) B-+2$09(05) 2$(+-&2(08+)
reproductive option to gamete donation, adoption or continuing to play reproductive 
-"#$+((+D)(Braude 2001). PGD was first applied to perform sex selection using PCR 
for X-linked disease (Handyside et al. 1990). It is now offered for a variety of single 
gene defects (Wells & Sherlock 1998), chromosomal imbalances (Conn et al.. 
1998;Scriven et al.. 2000) and for sex selection for X-linked disease. PGD can be 
used in any of >1000 genetic tests now available. A number of these indications are 
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controversial. The following are the general types of PGD testing (Fragouli 
2007;Grace et al.. 2006;Sermon et al.. 2007): 
 Autosomal single gene disorders: 
o  ?#("9"62$) -+5+9908+)]- thalassemia, cystic fibrosis, spinal muscular 
atrophy, Tay-Sachs disease, and sickle cell disease. 
o Autosomal dominant Epidermolysis bullosa, Myotonic dystrophy type 
OC) a#&(0&1("&'9) %09+29+C) 267$"0%) G"$7&+#-"G2(,7C) `,2-5"(-Marie-
T""(,)%09+29+C)25,"&%-"G$2902)2&%)>2-:2&'9)97&%-"6+. 
 Chromosomal rearrangements (inherited chromosomal abnormalities): 
Robertsonian Translocation (male and female carrier), reciprocal 
translocation carriers, sex chromosome aneuploidy, pericentric inversion, 21q 
11 deletion 
  Specific sex-linked diseases like Duchenne Muscular Dystrophy, Fragile <X 
syndrome, haemophilia A, Anderson Fabry disease, Incontinentia pigmenti, 
Alport syndrome, Wiskott- Aldrich syndrome and many more. 
2.2.4.2 Preimplantation genetic screening 
^-+06G$2&(2(0"&)1+&+(05)95-++&0&1);^b/U)2$9")-+:+--+%)(")29)I2&+#G$"0%7)95-++&0&1'C)
I$"!)-09A)^bF')"-)IPGD-?/')09)52--0+%)"#():"-)%0::+-+&()0&%052(0"&9)(,2&)^bF)#90&1)
different methods. Here instead of single gene probes, FISH is used to look for 
aneuploidy. PGS is carried out for infertile couples undergoing IVF to prevent the 
transfer of embryos having obvious chromosomal abnormality/abnormalities, with 
the hope that this will improve pregnancy outcome. From the report of the 10th 
Annual Meeting of the International Working Group on Preimplantation Genetics, 
Italy, June 2000 (Report of 10th Annual meeting, International Working Group of 
Preimplantation Genetics 2001), one of the major clinical applications of PGD was 
preselection and transfer of aneuploidy - free oocytes and embryos in cases of 
assisted reproduction. The Working Group (Report of 10th Annual meeting 
International Working Group of Preimplantation Genetics 2001) reported more than 
1500 clinical cycles with at least 400 clinical pregnancies. Most of these (90%) were 
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from Chicago, Saint Barnabas and Bologna centres. These three centres have 
reported the birth of more than 300 healthy babies following the procedure, but there 
are no details of the assessments of children available from the reports.  
To improve the outcome of IVF, aneuploidy testing with PGS is currently being done 
for an increasing number of indications. They are as following: 
 Advanced maternal age  
 Poor prognosis women with previous history of chromosomal rearrangement 
 Repeated spontaneous abortions 
 Multiple IVF failures  
 Certain abnormalities of cytoplasmic maturation of oocytes and spermatozoa.  
The 10th anniversary report of PGD identified 1500 PGD cycles worldwide for poor 
prognosis IVF patients, showing that aneuploidy pre selection contribute 
significantly to improved outcome in pregnancy transfer rate. This was 27% better 
in the group with advanced maternal age than in younger women. Preliminary 
follow up study (no details provided) of more than 300 babies born following the 
procedure confirmed the relative accuracy of preimplantation aneuploidy testing. 
Several other studies have reported a significant improvement in pregnancy rate. A 
recent study of women with repeated abortions, by Munne et al. reported a 
pregnancy rate of 50% following PGD compared with a abortion rate of 17% 
(Munne et al.. 2005). Another study by Munne et al. showed that PGD significantly 
reduces pregnancy loss in infertile couples. It also showed that mean pregnancy loss 
for PGD group was significantly lower compared with the non-PGD group (Munne 
et al.. 2006). 
Although there is a steady rise of PGS, the debate about the place and importance of 
this technique continues (Soini et al. 2006). The use of PGS has increased 
significantly during recent years in IVF cases without any family history of affected 
offspring (e.g. with no heritable genetic disorder), mainly with the hope of 
improving the outcome of IVF. This group includes women of advanced maternal 
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age or cases where embryos have repeatedly failed to implant and women who have 
had recurrent miscarriages (not related to constitutional chromosomal aberrations) 
(Soini et al. 2006). A recent multi centre, randomised, double blind, controlled trial 
from Amsterdam reported that PGS did not increase but instead significantly 
reduced the rate of on going pregnancies and live births after IVF in women with 
advanced maternal age (Mastenbroek et al.. 2007). Shahine and Cedars from San 
Francisco reported in 2006 that PGD did not increase pregnancy rates in patients at 
risk for aneuploidy and suggested larger randomised controlled studies before PGD 
could routinely be recommended as a means of increasing pregnancy rates in 
patients with advanced maternal age, recurrent pregnancy loss and recurrent IVF 
failure (Shahine & Cedars 2006). 
2.2.4.3. Preimplantation genetic diagnosis-H L A typing 
Preimplantation genetic diagnosis (PGD) of single gene disorders, combined with 
HLA matching, represents an innovation in reproductive medicine. The provision of 
B9280"#-)90*$0&19D)*7)^bF),29)*++&)2) ("G05)":)9+8+-+ controversy; some criticising 
(,09) 29) 2) 9(+G) ("!2-%9) B%+901&+-) *2*0+9D.) ^`Y) G-"("5"$9) 2-+) #9+%) (") G-"80%+)ac?)
typing for each embryo. This is done with the intention of matching the embryo to a 
sick sibling in the family (Verlinsky et al.. 2001;Verlinsky et al.. 2004b). This 
embryo is transferred with a hope of establishing pregnancy and thus to provide cord 
blood stem cells and bone marrow to treat the sick sibling. This approach is 
particularly valuable for ß-thalassaemia, Fanconi anaemia and other life threatening 
conditions that require an HLA compatible haematopoietic stemcell donor 
(Fiorentino et al.. 2004). Opinion is divided regarding the appropriateness of this 
application of PGD. A number of groups have addressed this issue (Fiorentino et al. 
2004;Rechitsky et al.. 2004;Van, V et al.. 2004). 
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2.2.4.4. Preimplantation genetic diagnosis cycles for non-medical (social) sex 
selection 
The report of the ESHRE PGD Consortium data collection VI reported PGD cycles 
:"-)I9"502$)9+Z0&1'.)T,09),29)108+&)-09+)("),#1+)5"&(-"8+-90+9)(Ray et al.. 2002). Sex 
selection for other than medical reasons has lead to controversy and debate ( 
2003;Baldwin 2005;Dahl 2005;Harris 2005). Attitudes towards pre-conception sex 
selection for social and family balancing reasons vary amongst cultures. The 
European convention on Human Rights and Biomedicine, Article 14, explicitly bans 
sex selection for other than health purposes ( 1997). Some have raised the question of 
B-+G-"%#5(08+)$0*+-(7D)2&%)=#+9(0"&)(,+)1+&+-2$)*2&)!,0$+) they fail to see the moral 
wrongness of social sexing or family balancing (Dahl 2005). The Human Genetics 
Commission in the UK has recommended that PGD should not be used for trait or 
sex selection such that the procedure and its governing bodies could be accused of 
eugenics. 
2.2.5 Results and outcome of Preimplantation Genetic Diagnosis 
The reliability of PGD as a diagnostic tool is well established and the error rate in 
diagnosis though low has been reported (Sermon et al.. 2005; Sermon et al. 2007). 
The major drawbacks of PGD are the relatively high cost and that the procedure 
itself leaves fewer available embryos for transfer (2007). PGD and PGS are still 
rather rare procedures owing to high technical demands, costs, relative low 
pregnancy rate and strict licensing in many countries. Very few studies have looked 
at an integrated analysis of technological, patient related, ethical and economic 
aspect of the procedures. Results from 10 years data collection from the Netherlands 
did not report any PGD misdiagnoses, none of the babies had any congenital 
anomalies and it was suggested that PGD is a reliable and successful method with 
pregnancy rate similar to IVF and ICSI (de Die-Smulders et al.. 2004).  
A systematic review from New Zealand reviewing the quantifiable harms and 
benefits of PGD observed that the incidence and nature of obstetric and neonatal 
complications after PGD were comparable to those reported after IVF alone. Most 
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complications were thought related to the risks of multiple gestations (Marjoribanks, 
Farquhar, & Marshall). The incidence of major birth abnormalities was about 3.8%, 
similar to that reported after IVF alone. The review concluded that even though PGD 
appears promising it is important not to overstate its potential.  
The 6th report of the ESHRE PGD consortium (Sermon et al., 2007) reported an 
increasing number of cycles, pregnancies and babies from an increasing number of 
participating centers. There had been an increase in the number of PGS cycles. At 
birth PGD babies had characteristics that were similar to those of ICSI babies. No 
specific complication of pregnancy or malformation was noted in this population. 
The characteristics of the babies at birth were comparable to and the main 
complications were related to effects of multiple pregnancies. 
2.2.6 Risks of Preimplantation Genetic Diagnosis 
PGD uses the usual techniques of ART followed by biopsy of the embryo. As there 
has been very little follow up of the health and well being of children born after the 
procedure, there are concerns regarding the safety of the procedure. New ART 
techniques like the biopsy in PGD and PGS, microinjection in ICSI as well as 
possible effects from culture media are feared to be detrimental for embryo 
development and for the health and well being of the children. Many of the existing 
or possible applications of PGD are at the interface of reproductive medicine and 
clinical genetics. 
A . Risks related to A R T 
There are ongoing concerns about the possible adverse outcomes in children born 
after ART. Multiple gestations where both mother and fetus are at risk (Adashi et al. 
2003), structural anomalies and long term health effects (Bonduelle et al. 
2005;Hansen et al.. 2005;Klemetti et al.. 2005) are some of the concerns raised. 
Several studies on the safety of the techniques have been published, but most have 
been short term or small. Larger reviews suggested slightly elevated risk of birth 
defects in children born after ART (Kurinczuk et al. 2004). 
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The concerns about possible adverse effects of ART on children and mothers remain 
a matter of controversy (Hansen et al. 2005). Several studies on adverse effects have 
been performed, but the methods and patient materials are often not comparable and 
conclusions have been diverse. The target groups have often been too small to give 
reliable conclusions (Soini et al. 2006) .  
Risks to the mother related to multiple gestations included hypertensive disorders, 
pre-eclampsia, thromboembolism, UTI, anaemia and haemorrhage (placental 
abruption, placenta previa) and fluid overload in association with parenteral tocolysis 
(Wennerholm 2003). Risks of still birth and early post natal deaths are increased. 
Obstetric, neonatal and long term consequences of multiple gestations for the health 
of ART children are enormous, resulting mostly from premature birth and low birth 
weight (Wennerholm 2003). Cerebral palsy is one of the most significant 
neurological impairments associated with multiple births and increases 
proportionately with the number of fetuses (Wennerholm 2003). This has prompted 
the reduction of the multiple pregnancy rates to be a high priority for ART 
programmes. ESHRE has set recommendations from 2000 where this acts as a 
B5-0(+-0"&)":)?YT)+Z5+$$+&5+D)(Hazekamp et al.. 2000). 
Several studies and reviews have tried to evaluate the risk of adverse effects of ART 
on the child. The results are partly controversial and also inconclusive (Soini et al. 
2006). Multiple gestation was clearly a major risk. Many of the other causes of 
demonstrated adverse effects were unknown, although studies had suggested a link 
especially with ICSI. Hansen et al. concluded that infants conceived following 
IVF/ICSI are twice as likely to have major birth defects when compared to naturally 
conceived infants (Hansen et al.. 2002). It is not clear why IVF conceived singletons 
do worse compared to their naturally conceived counterpart in terms of perinatal 
outcomes (Schieve et al. 2002). Data from Danish National registries on obstetric 
outcomes and neurological sequelae of vanishing twins showed significantly 
increased risk of preterm birth, low birth weight and cerebral palsy (Pinborg et al. 
2004). A Finnish study concluded that neonatal outcome after IVF conception is 
worse compared to general population infants, comparing mothers of similar age, 
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parity and social class mainly due to the large number of multiple births. The study 
could not identify the cause of an increased incidence of heart malformations which 
did not appear to be related to multiple births (Koivurova et al.. 2002b).  
Review of relevant studies from the US (Hampton 2004) suggested no overall 
association between ART per se and rates of serious malformations. However the 
review highlighted that there is: 
1) evidence that ART is associated with some adverse neonatal outcomes (low birth 
weight, perinatal mortality, premature births also in singleton pregnancy); 
 2) suggestive evidence of an association between ART and congenital imprinting 
disorders like Angelman syndrome and Beckwith- Wiedemann syndrome. 
3) evidence of no association with paediatric cancer or adverse psychological and 
developmental outcomes.  
An international multicentre cohort study was designed to examine both birth defects 
and mental development in children born after ICSI, IVF and natural conception. The 
study included 1500 children from five European countries who were followed up to 
age of 5 years. The study concluded that singleton IVF children were more likely to 
need health care support when compared to singletons born after natural conception. 
The overall conclusions were reassuring, apart from the slightly higher rate of 
congenital abnormalities in ICSI children (Bonduelle et al. 2005).  
A large Danish study (Lidegaard et al. 2005) , reported that childhood cancers, 
mental diseases, congenital syndromes and developmental disturbances occurred 
with equal frequencies in a group of 6052 IVF children and 442,349 singleton non 
IVF children. There was no association between ART and retinoblastoma as had 
been previously suggested (Moll et al.. 2003). However Lidegaard and colleagues 
reported an 80% increased risk of cerebral palsy amongst IVF children. A Swedish 
population based study concluded that there was an increased risk for congenital 
malformations after IVF, regardless of the technique used which is mainly due to 
parental characteristics (Kallen et al. 2005). The safety of ART, which is inherent to 
PGD, has not been well studied at an epigenetic level. Epigenetic is a phenomenon 
where modifications of the DNA methylation and/or chromatin structure underlie 
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changes in gene expression and phenotype characteristics. Disturbances of epigenetic 
reprogramming may influence gene expression and phenotype characteristics.  
There have been concerns about genetic, congenital and developmental abnormalities 
in children born after transfer of ICSI embryos (Bondulle et al. 2004;Braude & 
Rowell 2003;Golombok 2002).   
B . Risks related to embryo biopsy 
PGD procedures requiring PCR (defined in section 2.2.3) require ICSI for technical 
reasons to avoid DNA contamination, whereas in PGD requiring FISH, conventional 
IVF can be used. Blastomeres at the 4 < 12 cell stage are not identical, but express 
different regulatory proteins. Certain patterns of fragmentation results in partial or 
complete loss of regulatory proteins, which in turn affects the developmental 
potential of the biopsied embryo. Thus, removal of one or two cells from the embryo 
might theoretically involve a risk of impaired development of the embryo and a 
potential risk to the offspring. There is very little follow up data from children who 
were born after PGD/PGS. One study published in 2004 (Verlinsky et al.. 2004a), 
reviewed the 12 year exper0+&5+) ":) (,+) !"-$%'9) (,-++) $2-1+9() ^bF) 5+&(-+9) 2&%)
analysed the clinical outcome of PGD in USA and Italy. They reported that more 
than 6000 clinical cycles had been performed worldwide, resulting in the birth of at 
least 1000 children. The birth prevalence of congenital malformations in these 
children was in the range of 5-6%  that was not different from population 
prevalence. There is no data on the outcome of the children born during the 12 years. 
However a report from Chicago in 2000 (Strom et al.. 2000) concluded that data 
from 109 children born after PGD by polar body removal did not show any 
detrimental effects of the procedure. Data on perinatal outcome was collected by 
parental reporting and confirmed by telephone interview and chart review when 
indicated. If infants were more than 6 months old, a follow up telephone interview 
was carried out to establish that the babies were appropriately achieving their 
developmental milestones.  
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Bonduelle et al. have performed many international follow up studies of ICSI 
(Bonduelle et al.. 2003;Bonduelle et al.. 2002;Bondulle et al. 2004;Sutcliffe et al. 
2002). The ESHRE PGD Consortium will in future collate data from centres that 
take care of the complete PGD cycle, from patient referral to transfer and follow up 
of the babies (Sermon et al. 2007). Many professional organisations have stressed the 
need for systematic long term follow up studies on the children born after ART and 
PGD. The problem with follow up studies is however that only a minority of parents 
want to inform their children about the use of ART, which raises issues of informed 
consent. There needs to be ways to encourage parents to participate in follow up 
studies relating to health and development of their children (Soini et al. 2006). 
The development of reproductive sciences and genetics has given a new dimension 
to ART: as aptly stated in a United Nations Educational, Scientific and Cultural 
d-12&092(0"&'9);efg/`dU)-+G"-()"&)^bF)2&%)b+-6-c0&+)@&(+-8+&(0"&)":)JhhWC)I@ij)
aims at having a child, PGD aims at having a healthy child and PGD/human 
leukocyte antigen (HLA) testing aims at ,280&1)2),+2$(,7)2&%),+$G:#$)5,0$%')(Soini et 
al. 2006). Evidence for the efficacy, reliability and safety of PGS is still limited but 
growing (Briggs et al.. 2000;Sermon et al. 2005;Wilton 2002). 
2.2.7 Neurodevelopmental and socio-emotional developmental outcome of 
children born after PG D/PGS 
At the beginning of this study there was no follow up data, which had looked into the 
outcome of children born specifically after PGD/PGS. This was partially because of 
the fact that PGD still remained a novel technique. Thus there was no report of how 
PGD/PGS might affect neuro- and socio-emotional development of this group of 
children.  
A recent review by K.J. Middelburg and colleagues (Middelburg et al.. 2008) states 
that the effect of assisted conception on the developing human brain is still not clear, 
even though the procedures of in vitro fertilization (IVF) and intracytoplasmic sperm 
injection (ICSI) were introduced more than 25 and 15 years ago, respectively 
(Palermo et al.. 1992;Steptoe & Edwards 1978). Since then many studies have been 
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conducted on the neurodevelopmental outcome (an umbrella term covering 
neuromotor, cognitive, speech/ language and behavioural outcome) of children born 
following ART techniques, but not on newer methods like PGD. 
Middelburg and colleagues (Middelburg et al.. 2008) reported that in general, the 
follow-up studies showed no consistent differences in neuromotor, cognitive, 
language and behavioural development between children born following IVF/ICSI 
and natural conception. They reported that IVF/ICSI per se does not increase the risk 
for CP, but that an increased risk for CP is related to the association of assisted 
conception with other risk factors, such as preterm birth. It was also reassuring that 
no major neurodevelopmental delay or clinically relevant behavioural problems were 
reported. 
Studies looking into the psychological wellbeing of children born following assisted 
reproductive techniques are many (Colpin et al..1995;Colpin & Soenen 
2002;Golombok et al.. 2001;Hahn & DiPietro 2001;McMahon et al.. 1997;van Balen 
1998). Burns (Burns 1990) argued that parents who had difficulty in conceiving 
might become emotionally over-invested in their long-awaited child, and other 
authors have suggested that those who become parents after a period of infertility 
may be overprotective of their children, or may have unrealistic expectations of 
them, or of themselves as parents (Hahn & DiPietro 2001;McMahon et al.. 1997;van 
Balen 1998). Additionally, it has been predicted that the stress of infertility and its 
treatment may lead to psychological disorder and marital dysfunction for those who 
become parents following IVF (McMahon et al. 1997). 
However a review by Susan Golombok and Fiona MacCallum (2003) (Golombok & 
MacCallum 2003;McMahon et al.. 1997) stated that contrary to the concerns that had 
been raised regarding the potentially negative consequences of IVF for parenting, 
studies of these families have generally found IVF parents to be well adjusted and to 
have good relationships with their children. The review also stated that the children 
themselves, showed no evidence that they are at risk for cognitive impairment. The 
social and emotional development of IVF children also appeared to be within the 
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normal range. In an investigation of the psychological well-being of ICSI children 
(Place & Englert 2003), the Strengths and Difficulties Questionnaire (Goodman, 
1994) was completed by parents and teachers. ICSI children showed no evidence of 
raised levels of emotional or behavioural problems compared with IVF and naturally 
conceived children.  
Frances Gibson and Catherine McMahon in 2004 (Gibson & McMahon 2004) 
reported that assisted conception following infertility had little adverse impact on 
parental wellbeing and parenting skills. The subtle differences identified were not in 
the realm of clinical problems, but reflected realistic concerns and attitudes in the 
context of a long and sometimes high-risk path to achieving parenthood. The 
children appeared to have secure attachment relationships with their parents in 
childhood and behavioural adjustment was mostly comparable with naturally 
conceived peers.  
A recent report from Belgium by Nekkebroeck and colleagues looked into the mental 
and developmental outcome of two year old children born after PGD/S 
(Nekkebroeck et al.. 2008). This was very similar to our study but published one 
month later and thus the second study after ours in the literature. The study 
concluded that children conceived after PGD/PGS showed similar mental and 
developmental outcomes at the age of two when compared to children conceived 
after ICSI or naturally. However this study did not address any child behavioural or 
parent child/family functioning issues. 
This overview sets the scene for the need for the PGD study. The objectives of the 
study were: 
4. To assess a group of PGD/PGS-born children and describe their health in 
terms of physical/neurodevelopmental and behavioural well being (in relation 
to a matched control group of children born to parents who did not undergo 
preimplantation genetic diagnosis). 
 56 
5. To assess any impact of the difficulties of having a child after PGD/PGS, 
which can often be stressful for couples, on the psychological health for the 
parents / or parent-child bonding/ relationships. 
6. To consider whether this protocol can then be expanded to a national study of 
PGD/PGS outcome. 
Hypothesis of the study was: 
Children born to couples who have had pre-implantation genetic diagnosis are 
expected to be as healthy when compared to age-matched naturally conceived 
children.  We did not expect to see any of the following effects that will be looked 
for: 
a. Reduced longitudinal growth  
b. Greater occurrence of difficult temperament and emotional or behavioural 
problems 
c. Possible effects on neurodevelopment. 
 
Families where children were born post PGD/PGS however may experience the 
following: 
a. Differences in maternal bonding. 
b. More stress in parent child relationship. 
c. Other difficulties in parenting (related to the pressures of IVF, PGD/PGS and 
treatment). 
Statement of research questions of the study were: 
a. What are the physical and neurodevelopmental outcomes for an initial 
consecutive cohort of these children? 
b. Are there difficulties with maternal bonding and parenting skills with these 
mothers when compared with in relation to matched controls? (Do these 
mothers experience more difficulties with maternal bonding and parenting 
skills than their matched controls? 
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Chapter 3 
 
3. Methods 
 
3.1 Methods of PO RD study  
3.1.1 Development of the study design and supervision 
Study design 
This was a population-based (from a hospital database), case-control study carried 
out in the London. It took approximately one year from the idea for the project to 
commencement of data collection. In addition to writing a protocol (see Appendix) it 
was necessary to identify families who were eligible to participate in the study and to 
obtain ethical approval for the study.  
Supervision 
It was decided to establish a steering committee for the project, which would consist 
of my supervisor (AGS), and physicians from the Renal Medicine department at the 
Royal Free Hampstead NHS Trust (Prof. S. Powis, Clinical Director, Dr. B 
Thompson, Consultant Physician). The steering committee met three monthly 
between July 2004 till Jan 2006 to assist and advise on all study matters including 
recruitment of patients, funding, presentation of findings, technical advice on data 
collection and ethical matters. Regular monthly meetings were held with my 
supervisor (AGS) and in addition frequent ad hoc phone calls were necessary with 
steering committee members on particular issues.  
E thics approval 
The Joint UCL/UCLH committees on the Ethics of Human Research (Committee 
Alpha) granted the study ethics approval. The REC reference number is 05/Q0502/35 
dated 9th June 2005. 
Power 
Power calculation for primary outcome: 
b-0::0(,'9)952$+9)":)6+&(2$)%+8+$"G6+&(),28+)2)6+2&)95"-+)":)Ohh);2&%)5,0$%-+&)52&)
be assessed from ages 1 month to 7 years 11 months). We wished to detect a 5 point 
or more drop in the mean scores with the affected population/group. With a 2 sided 
test and at a significance level of 0.05 
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a) An equally sized sample of cases vs. controls requires 99 children per group 
to achieve 90% confidence. 
b) Should there be only 75 recruited per group we would have 80% confidence 
of a difference. 
Power calculation for secondary outcome: 
Considering known data on birth weights in children born to mothers with chronic 
renal disease, we should need to recruit only 10 children per group (case: control) to 
have 100% confidence of significant difference between the groups on the basis of 
existing knowledge which suggest a large discrepancy between groups. (C.f. mothers 
with Chronic Renal Failure: mean birth weight (gms):2239 ± 839 .Mothers on 
dialysis: mean birth weight (gms) 1543 ± 671. Transplanted mothers: mean birth 
weight (gms) 2204). 
The power of the test, given an effect size corresponding to a 5 point difference 
between the two groups, with a sample of 24 cases and 37 controls is 0.54. The low 
power associated with such analysis means that results should be interpreted 
cautiously. 
Statistics 
The power analysis for the PORD study indicated that the power to detect any 
differences or association would be low. The use of individual t-tests and chi-squares 
was employed as the power of larger multivariate test would be too low. Therefore 
caution should be exercised in the interpretation of the PORD results as the low 
power may lead to a Type II error (failing to find a significant effect that exists in the 
population) and the multiple tests may lead to a Type I error (finding a significant 
+::+5()%#+)(")5,2&5+U.)?&7)G)82$#+)":)N)h.hP)!29)(2A+&)29)901&0:052&(. 
 
3.1.2 Method of Recruitment to the study 
The departmental database manager identified from the database of the Renal 
Department at the Royal Free Hampstead NHS Trust women with renal disease who 
had reported a pregnancy. The renal service is a combined unit caring for mothers 
from the Royal Free and Middlesex hospital units. After detailed search using the 
renal database and hospital PAS system it was first made certain that each women 
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had a live child as a result of the pregnancy before efforts were made to contact the 
family. Where there was any doubt about whether the child was alive, the family was 
not contacted. It was decided to recruit singleton children between their first and 
eight birthdays. This age range was chosen to allow use of the Griffiths Mental 
Development Scales for Children aged 0-8 years. It was anticipated that the revised 
2-8 year scale of Griffiths Mental Development Scales could be used but due to delay 
in publication of the scales and validation of data, the study was commenced using 
the Griffiths 0-2 years (revised 1996) scales and the existing Griffiths 2-8 years scale. 
After discussion with my supervisor and with his knowledge of the difficulties 
previously found in recruiting normally conceived control children of higher order 
births for other studies and because of known confounders which can affect 
developmental outcome of twins and higher order births it was decided to recruit only 
singleton children for the PORD study. Qualifying families were contacted by post to 
obtain written informed consent to participate (or not).  Due to Ethics Committee 
constraints it was not possible to enquire as to why non-participants chose so. 
Families who did not respond to two written request to participate were considered 
non-participant. Occasionally families did wish to participate but it was not 
practicable for them to attend due to work /childcare/related issues. These were not 
considered further in the study analysis.  
 
3.1.3 Case Definition 
a. Children 
Children below the ages of 8 years were eligible whose mothers were known to have 
chronic kidney disease or who had a renal transplant at the point of positive 
pregnancy test.  
 
b. Renal disease in Mothers 
Chronic kidney disease in mothers was be categorised as Stages 1 - 5 depending 
upon their glomerular filtration rate as per the US National Kidney Foundation 
Kidney Disease Quality Outcomes Initiative classification of stages of chronic 
kidney disease (Nation Kidney Foundation , clinical practice guidelines 2002b) 
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Table 3.1 Stages of Chronic renal failure 
Stage Descr iption G lomerular filtration rate (G F R) in 
ml/min/1.73m2 
1 Kidney damage with normal or 
high GFR 
≥ 90 
2 Kidney damage with slightly 
low GFR 
60 - 89 
3 Moderately low GFR 30 < 59 
4 Severe low GFR 15 < 29 
5 Kidney failure < 15 or dialysis 
Chronic kidney disease is defined as either kidney damage or glomerular filtration 
rate <60 ml/min/1.73m2 for ≥3 months. Kidney damage is defined as pathological 
abnormalities or markers of damage, including abnormalities in blood or urine tests 
or imaging studies.  
From our database review we had estimated that maternal cases were split across 
stages 1-5 approximately equally. However, during the study it was evident that it 
would be difficult to classify study cases as above mainly due to lack of information 
from case notes and also due to the fact that all mothers were not screened or 
followed up in the same manner. Thus we divided them into categories of renal clinic 
attended i.e. general nephrology, renal transplant and chronic renal failure. 
 
c. Study families 
All eligible families were contacted using a standard letter approved by the local 
ethics committee and derived from the study protocol (appendix).  
From our combined database an estimate was made of at least 150 families with 
children less than eight years who could be potentially recruited for the study. 
Out of an original cohort of 150 qualifying children, only 80 living within the London 
region were eligible for the study. The other 70 families were not eligible as the 
child/children were over 8years or the family had moved and was no longer in 
London and logistically it was difficult to organise participation. Of the 80, a total of 
35 (44%) responded to the invitations and finally 24 (30% of eligible children) born 
between August 1997 and October 2005 were subsequently seen for assessment. 
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d. Controls 
In order to attain a one to one ratio of study to control children, the local child health 
database was used to recruit control children. Children were identified from the 
Regional Interactive Child Health System (RICHS) which was a community database 
system of some 500,000 children then used by 9 North < East London Primary Care 
Trusts (PCTs). The details kept included: demographic; birth; immunisations; 
examinations; medical details e.g. ICD 10 codes and health professional involvement. 
Control families were contacted using a standard letter approved by the local ethics 
committee and derived from the study protocol (appendix). Two control children 
were approached for each index case, as it is anticipated there would only be 50% 
participation rate amongst approached controls. Written consent was obtained from 
all participating control families and they were assessed in an identical manner to 
study children. 
 
3.1.4 Exclusion and inclusion cr iteria for children in the existing database 
a. Exclusion cr iter ia 
Children aged over 8 years, children whose mother tongue was not English and 
families not living in mainland UK were not recruited; as they were not eligible for 
Griffiths Mental Development Testing (this has an upper age limit of 7 yrs 11 
months). 
b. Inclusion cr iter ia: 
Children recruited were singleton and born to mothers with chronic renal disease. 
(See above) 
3.1.5 Matching 
Control children were matched with cases for age, sex, social class (according to 
Office of National Statistics classification), gestational maturity and race. All children 
were singleton. 
 
3.1.6 Benefits of assessment 
Families who agreed to take part in the study were given the opportunity to discuss 
medical and behavioural concerns with the paediatrician at the time of assessment. 
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The families were also advised that they could contact the investigators at any time in 
the future if there were any further concerns of a paediatric nature, regardless of 
relevance to the study per se. 
During the course of the assessment, no previously unrecognised medical problems 
were discovered. However, many parents discussed concerns sometimes behavioural, 
which were addressed to the best ability of the paediatrician and if necessary 
appropriate referrals were initiated. This was perceived as very helpful to the parents 
who often were in doubt about the nature of the problem and also the appropriateness 
of referral to other services. 
 
3.1.7 Data collection and recording  
A data collection form was designed. In order to make data entry systematic and more 
concise a series of fixed numeric lists were designed enabling most collected 
information to be entered in numeric form (see appendix). Arrangements were made 
to enter raw data into a computer database for subsequent analysis. An appropriate 
data input programme using File Maker Pro version 5 was designed by Hui Jayne Lim 
(Research assistant) after piloting the format on 6 cases. It was necessary to develop 
standardised criteria for this data input (see Appendix). This method of standardised 
data collection allowed later statistical analyses more readily to be performed. Data 
!29)(-2&9:+--+%)2&%)-+G+2(+%$7)*25A+%)#G)0&)(,+)>+%052$)/5,""$'9)5"6G#(+-)`+&(-+.)
Data were initially collected with individual identifiers but stored for analysis in an 
anonymised format. 
The following data were collected: 
a. Socio-demographic details 
For each participating biological parent the following details were obtained: 
 Age 
 Marital status was recorded according to category: married, single, divorced, 
separated or cohabiting. 
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equivalent; A-level or equivalent; University entry or equivalent; Degree and 
Higher degree.  
 Occupations 
 Social class was then ascertained according to the Office of National Statistics 
classification. This is a scale for classifying people into five groups 
(represented by roman numerals), one subdivided, based on occupation. 
(Formerly Registrar General's Social Class). 
 Smoking categorised as non-smoker, 1-5 cigarettes per day, 6-10 cigarettes 
per day, 11-20 cigarettes per day, 20+ cigarettes per day, or pipe/cigar smoker. 
 Drinking categorised as units per week. 
 In all the above an unknown category was allowable. 
 
b. Perinatal details 
Details of maternal illnesses, obstetric complications and medications taken during 
pregnancy were also recorded. 
Mothers were asked if they smoked or drank alcohol during the pregnancy; if so, the 
amount was quantified. Alcohol consumption was recorded as the number of units 
consumed per week. 
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persons providing adult support for mother during the pregnancy. 
Details of delivery included the date of delivery, gestation at delivery in weeks and 
days; whether the labour commenced spontaneously or required induction or, as in 
some cases, there was no labour (elective caesarean section); and the type of delivery- 
classified as normal vaginal, forceps/ventouse, planned caesarean or emergency 
caesarean section and unknown 
 
c. Neonatal details 
The following were recorded: sex, birth weight in grams, birth length in cms, birth 
head circumference in cms and Apgar scores obtained from the parent held Personal 
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child health record. If details were missing, and where possible information was 
obtained from other parent-provided sources. 
Records were made of the need for resuscitation at birth and for admission to the 
neonatal unit. If admission to a neonatal unit was required, then the length of stay 
and the reason(s) for admission were recorded. The need for and length of ventilation 
if any was recorded. Neonatal illnesses were recorded using a defined list and 
congenital anomalies were classified as major or minor using ICD 10 (International 
Classification of Diseases 10, World Health Organisation, Geneva 1992). Minor 
defects were considered to be those that posed no significant health or social burdens 
2&%) 62l"-) %+:+5(9) !+-+) (,"9+) (,2() 5"#$%) 2%8+-9+$7) 2::+5() (,+) 5,0$%'9) ,+2$(,) "-)
development. 
The type of feeding was recorded as exclusive breast feeding, formula or mixed. The 
length of exclusive breast feeding was noted. The number of adults providing support 
for the baby and family was recorded including parents. 
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3.1.8 The assessment 
A single paediatrician (IB) assessed all the children using a standardised protocol. 
The children were assessed in a child friendly environment. A quiet room (within the 
Royal Free and University College Medical School) was used to assess the child and 
0&(+-80+!) (,+) G2-+&(;9U.) T,+) 5,0$%'9) ,+01,(C) !+01,(C) "550G0(") frontal head 
circumference (for children up to 5 years) and blood pressure were measured in the 
out patient clinic of the Department of Paediatrics and Child Health, Royal Free 
Hampstead NHS trust. The physical assessment was also carried out in the same 
place in a dedicated clinic room.  This was followed by the developmental 
assessment, which involved the administration of the Griffiths Mental Development 
Scales.  
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questionnaire during interview with the parents. This included socio-demographic 
details and past medical history including perinatal, neonatal and childhood data. 
The paediatrician also recorded all physical findings on this form.  
 
3.1.8.1 Physical assessment  
a. General physical examination 
A general medical examination was performed on all the children. This included 
cardiovascular, respiratory, ear nose and throat, abdominal and skin assessment. 
Neurological examination including gross motor skills was also performed. Attention 
was also paid to the dentition, hair and skeleton. The genitalia were examined. 
Testicular descent was checked for in male children. 
 
b. Congenital anomalies 
The children were examined carefully for evidence of congenital abnormalities and if 
found these were recorded according to the International Classification of Diseases 
(ICD-10) 
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c. Growth 
All children were measured for height, weight and occipito-frontal head 
circumference. Height was measured using a portable stadiometer recommended by 
the Child Growth Foundation. Weight was measured using electronic scales. Centiles 
for height and weight were then calculated using a computer programme (L-grow®), 
standardised for a UK cohort of children (LGROW 1998) 
If the child co-operated the blood pressure was measured using DinamapTM Compact 
T model of automated BP measuring instruments (standardised for use in children of 
all weights/ages). However, it was soon evident that quite a few younger children did 
not want this done. 
 
d. Audiometry and vision 
It was planned to test hearing of each child using a portable pure tone audiometer. 
Results were recorded as normal, abnormal, no cooperation, difficult to assess, not 
done. Distance vision was examined in children over 5 years using Snellens charts. 
Squints were examined by using the cover test.  
a"!+8+-)0()!29)9""&)+80%+&()(,2()6"9()5,0$%-+&)%0%&'(C)5"-cooperate with the hearing 
and vision tests. There were also difficulties with the noise levels in the rooms used 
for assessments. Thus parents were asked about any concerns relating to hearing and 
vision. 
 
3.1.8.2 Psychological assessments 
The age appropriate Griffiths Mental Development Scales (Griffiths 1996) was 
administered to all children in the study. 
 
3.1.8.3 Parental questionnaires to assess family functioning 
The mothers of all participating children were asked to complete four questionnaires 
relating to family functioning. The questionnaires were posted to the family along 
with the appointment letter for the assessment. The mothers were requested to 
complete the questionnaires at home. The parents were provided with pre paid reply 
envelope to return the questionnaire or they brought them along on the day of the  
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assessment. The psychologist scored the returned questionnaires and the numerical 
scores were added to the computer database. If the questionnaires were not returned, 
a reminder was sent to the parents with a second copy of the questionnaires. Copies 
of the questionnaires are provided in the appendix  
 The following questionnaires were completed by the mothers: 
1. Child Behaviour Checklist for ages 1½-5 and ages 6-18 (Achenbach & 
Rescorla 2001) 
2. The Carey Temperament Scales (Second Edition)(Carey 2005) 
3. The parenting Stress Index /Short form (Abidin 1990)(Abidin 1990) 
4. The Parental Acceptance and Rejection Questionnaire (Rohner and Khaleque 
2005)( 2005b)  
5. General Health Questionnaire: GHQ-28 (Goldberg and Hillier 
1979)(Goldberg & Hillier 1979b) 
 
The above tools were used after discussion with Prof Barnes: Psychological 
supervisor to the project. These tools have been used in a very similar study 
conducted in the department previously (Peters 2005) and also in European 
multicentre studies (Barnes et al. 2004). Even though the scales were American they 
have been used in several Europan studies with ease and consistent results. However, 
there does remain the concern of using the tools in a UK based population study. 
Some of the questionnaires were lengthy with the print often unfriendly; however 
none of them took more that 15-20 minutes tocomplete.  
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3.1.9 Descr iption of measures used 
 
a. The Griffiths Mental Development Scales 
Each child was tested using the revised Griffiths Mental Development Scales from 
birth to 2 years (1996 Revision) and the Griffiths Mental Development Scales from 
birth to eight years (1984). The Griffiths Mental Development Scales from birth to 2 
years re-standardised in the United Kingdom in 1996 to reflect the child rearing 
practices, social habits, racial groupings and other socio-demographic factors 
pertinent to modern day Britain. The extended 2-8 years Griffiths scales had been 
undergoing an update with re-standardising and validation. This process was taking 
much longer than expected, so these scales could not be used in this study. The 
Griffiths Mental Development Scales (GMDS 1954, 1979, 1984) were developed by 
Dr. Ruth Griffiths to assess the developmental level of children from birth to two 
years of age on five subscales, namely: 
 Subscale A: Locomotor 
 Subscale B: Personal-social 
 Subscale C: Hearing and Language 
 Subscale D: Eye and Hand Co-ordination 
 Subscale E: Performance 
During the 1960s the scales were expanded to cover from birth to eight years 
(Griffiths 1970) and a sixth subscale was added 
1. Subscale F: Practical Reasoning 
The scales have full stringent statistical requirements of reliability and validity. In 
the GMDS for 0-2 years each subscale is based on a mean of 100 and S.D. of 16 and 
the total scale is based on a mean of 100 and S.D. of 12. The GMDS for birth to 
eight year the total of scales have a General Quotient of 100.18 and S.D. of 12.76. 
 
b. Child Behaviour Checklist for ages 1½-5 and ages 6-18 
The CBCL/1½ - 5 a revision of the CBCL/2-3 (Achenbach, 1992) < can be 
completed by parents, parent surrogates or others who see a child in a family setting. 
The check -list requests demographic information about the child and asks 
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respondents to indicate their name and their relationship to the child, such as mother, 
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respondent is then asked to rate 99 problem items as 0 for not true of the child, 1 for 
somewhat or sometimes true, and 2 for very true or often true, based on the 
preceding two months. For several items, respondents are asked to provide 
descriptions of the problems. In addition item 100 requests respondents to write any 
additional problems that were not previously listed. 
Following the items to be rated, the CBCL/1!- 5 provides open-ended items that 
ask the respondent to describe any illnesses or disabilities that the child has, what 
concerns the respondent most about the child and the best things about the child. The 
responders thus provide not only ratings that are scored on the scales to be described 
later but also descriptive information specific to the child who is being assessed. The 
scales are designated as Syndrome Scales of Emotionally Reactive, 
Anxious/Depressed, Somatic Complaints, Withdrawn, Sleep Problems, Attention 
Problems and Aggressive Behaviour. In addition to the syndrome scale, the CBCL 
1!- 5 can be scored in terms of two broad groupings of syndromes designated as 
Internalising (four syndromes on the left side of the profile) because it comprises 
problems that are mainly within the self and Externalising (two syndrome on the 
right hand side of the profile) because it comprises problems that mainly involve 
conflicts with other people and their expectations of the child. 
The CBCL/6- 18 is a revision of the CBCL/4-18 (Achenbach 1991). It is completed 
by parents, parent surrogates or others who see a child in a family setting. The list 
requests demographic information about the child and asks respondents to indicate 
their name and their relationship to the child, such as mother, father, foster parent or 
"(,+-)-+$2(0"&9,0G.)^2-+&('9)"55#G2(0"&)09)&"(+%.)T,+)-+9G"&%+&()-2(+9)+25,)G-"*$+6)
item as 0 = not true, 1= somewhat or sometimes true and 2= very true or often true 
based oh the preceding 6 months. The respondent then completes the competence 
items on pages 1 and 2, followed on page 2 by open ended items for describing the 
5,0$%'9)0$$&+99+9)2&%)%092*0$0(0+9C)!,2()5"&5+-&9)(,+)-+9G"&%+&()6"9()2*"#()(,+)5,0$%)
and the best things about the child. The responders thus provide not only ratings that 
are scored on the scales to be described later but also descriptive information specific 
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to the child who is being assessed. The CBCL/6-18 identifies the competencies and 
problems reported for the child. The competence scales are designated as activities, 
social and school scales which add up to CBCL total competence score.  
The CBCL /6-18 also have syndrome scales comprising of the problem items. The 
scales are designated as Anxious/Depressed, Withdrawn/Depressed, Somatic 
Complaints, Social Problems, Thought Problems, Attention Problems, Rule 
Breaking Behaviour and Aggressive Behaviour. 
In addition to the syndrome scale, the CBCL/6-18can be scored in terms of two 
broad groupings of syndromes designated as Internalising (three syndromes on the 
left side of the profile) because it comprises problems that are mainly within the self 
and Externalising (two syndrome on the right hand side of the profile) because it 
comprises problems that mainly involve conflicts with other people and their 
expectations for the child. 
 
c. The Carey Temperament Scales (Second Edition) 
 
The Carey Temperament scales comprise a series of behavioural rating instruments 
developed by William B Carey and associates for assessing temperamental 
characteristics in infants and children up to the age of 12 years. The questionnaire is 
a measure of nine NYLS (New York Longitudinal Study) temperament 
characteristics: activity level, rhythmicity, approach-withdrawal, adaptability, 
intensity, mood, attention span and persistence, distractibility and sensory threshold. 
The questionnaire contains up to 100 items, each rated on a 6 point scale of 
frequency ranging from almost never to almost always. When tabulated the items 
scores yield a category score for each of the nine areas which can be compared to the 
norms for the category. In addition general perceptions for each category are 
included and compared to the ratings as well as an overall impression of difficulty. 
Finally, diagnostic clusters of easy, intermediate low, slow to warm up, intermediate 
high and difficult are made based on the overall profile seen in the questionnaire. 
The following questionnaires were used 
1. Early Infancy Temperament Questionnaire for 1 to 4 month old infants. 
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2. Revised Infant Temperament Questionnaire for 4 to 11 month old infants. 
3. Toddler Temperament Scale for 1-2 year old children. 
Although the questionnaires assess the same temperament characteristics at each 
level, the situations (context) in which the items are rated are changed to be 
2GG-"G-02(+):"-)(,+)5,0$%'9)%+8+$"G6+&(2$)$+8+$.)H+52#9+)":)(,+)G975,"6+(-05)5-0(+-02)
for inclusion, items were rejected if they did not correlate with their assigned scales 
for any given age level. 
 
d. The parenting Stress Index /Short form (Abidin 1990) 
 
This questionnaire is based on the theory that the three measured subscales influence 
parenting behaviour. 
 
 
F igure 3.1: Theoretical Model for the Parenting Stress Index (Abidin 1990) 
 
The questionnaire included 36 items with a 5-point agree/disagree response scale. 
The responses measure the three subscales of the Parental Distress, Parent-Child 
Dysfunctional Interaction and Difficult Child Behaviour. The sum of these three 
scores represents the total parenting stress score. Parents with a total score above 90th 
percentile have clinically significant levels of stress. 
This questionnaire also includes a defensive reporting scale. This is to assess possible 
parental bias in their responses. A parent with an extremely low score is either trying 
to portray a very competent individual or is detached in their role as parent or is an 
extremely competent parent. 
Parent <Child 
Dysfunctional 
Interaction 
Parenting 
Behaviours 
Child 
Outcomes 
Difficult 
Child 
Parental 
Distress 
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e. The Parental Acceptance and Rejection Questionnaire (Rohner and 
Khaleque 2005) 
Parental acceptance-rejection theory (PARTheory) is an evidence based theory of 
socialisation and lifespan development that attempts to predict and explain major 
causes, consequences and other correlates of parental acceptance and rejection within 
the United States and worldwide. It attempts to answer 5 classes of questions divided 
into 3 sub theories: personality, coping and socio-cultural sub theory.  
The Parental Acceptance-Rejection Questionnaire (PARQ) is a self-report instrument 
designed to measure in%080%#2$9')G+-5+G(0"&9)":)G2-+&(2$)255+G(2&5+);0.+.)(,+)!2-6(,)
dimension of parenting). It is a bipolar dimension, with acceptance defining one end 
of the continuum and parental rejection defining the other.  
All versions of PARQ consist of four scales:  
1. Warmth and affection 
2. Hostility/aggression 
3. Indifference /neglect  
4. Undifferentiated neglect 
All versions and forms of PARQ are nearly identical except for verb tense (present or 
past tense) and referent (father or mother version of the PARQ). We used the parent 
PARQ and the adults were told to reflect on the way they now treat their children. 
Respondents were told not to dwell for any length of time on any given item. The 
"*l+5()":)(,09)(+9()09)(")1+()-+9G"&%+&(9'):0-9()"8+-2$$)-+25(0"&.)T,+)-+9G"&%+&(9)!+-+)
reminded that there is no right or wrong answer to any item. The respondent should 
ideally complete it in one sitting without distraction. It takes between 10-15 minutes 
to complete the questionnaire.  
The questionnaire uses the following response format: Almost always true, 
Sometimes true, Rarely true, Almost never true. In order to minimize yea-saying/nay-
saying and other forms of response set bias, nearly half the items on the standard 
PARQ must be reverse scored to create a total acceptance rejection score. 
 
f. General Health Questionnaire: G H Q-28 (Goldberg and H illier 1979) 
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This is a self administered 28 item screening instrument designed to detect current 
mental health problems in the general population. The GHQ-28 provides four 
dimensions, measuring somatic symptoms, anxiety and insomnia, social dysfunction 
and severe depression. 
 
Summary 
The assessment protocol is summarised in the following flow chart: 
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Counselling advice for 
mothers considering 
pregnancy for RCOG? 
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3.2 Methods of PG D study  
3.2.1 Development of the study design and supervision 
Study design 
This was a population-based (from fertility clinics), case-control study carried out in 
the London area. It took approximately six months from the idea for the project to 
commencement of data collection. In addition to writing a protocol (see Appendix) it 
was necessary to identify families who were eligible to participate in the study and to 
obtain ethical approval for the study.  
Five centres with established PGD programmes in London were contacted for 
agreement to participate. Of these five centres, four agreed to help recruit patients.  
Supervision 
It was decided to establish a steering committee for the project, which would consist 
of my supervisor (AGS), and obstetricians from the four participating PGD centres 
which are the following: 
1. Mr. M Taranissi: Consultant, Assisted Reproductive and Gynaecology Centre 
2. Prof. G. Grudzinskas : The London Bridge Fertility, Gynaecology and 
Genetics Centre 
3. Mr. H Abdalla: Consultant, Lister Fertility Clinic, Lister Hospital 
4. Mr. O Ozturk: Consultant, The Assisted Conception Unit, University College 
Hospital, 
The steering committee has met three monthly between July 2006 till June 2007 to 
assist and advise with all study matters including recruitment of patients, funding, 
presentation of findings, technical advice on data collection and ethical matters. 
Regular monthly meetings were held with my supervisor (AGS) and in addition 
frequent ad hoc phone calls were necessary with steering committee members on 
particular issues.  
E thics approval 
The Joint UCL/UCLH committees on the Ethics of Human Research (Committee A) 
granted the study ethics approval. The REC reference number is 06/Q0505/27 dated 
23rd August 2005. 
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Power 
Power calculation for primary outcome: 
b-0::0(,'9) 952$+9)":)6+&(2$)%+8+$"G6+&(),28+)2)6+2&) 95"-+)":)Ohh)2&%)+25,)":) (,+)
five subscales have a mean value of 100 and a SD of 10.8 (and children can be 
assessed from ages 1 month to 24 months). The power calculation was done at the 
conception of the study as follows: 
We wished to detect a 5 point or more drop in the mean scores with the affected 
population/group. With a 2 sided test and at a significance level of 0.05 
a. An equally sized sample of cases vs. controls required 99 children per group 
to achieve 90% power to detect a difference. 
b. Should there be only 75 recruited per group we would have 80% power to 
detect a difference. 
The power of the test, given an effect size corresponding to a 5 point difference 
between the two groups, with a sample of 49 cases and 66 controls is 0.78. 
Statistics 
Statistical analyses were conducted using SPSS for Windows 15.0. Between group 
differences on continuous variables were analysed using t-tests and means and 
standard deviations are reported. Chi-square tests were used for categorical variables 
and frequencies and percentages are reported. Where continuous variables were 
expected to be highly correlated, such as separate subscales, multivariate analysis of 
variance (MANOVA) was used and the between<groups effects were reported. 
MANOVA was used to for the analysis of the subscales of the Griffiths Scale, the 
Parenting Stress Index, the Parental Acceptance-Rejection Questionnaire, and the 
Toddler Temperament Questionnaire. The omnibus test was used to determine if 
there were overall effects, and between-subjects tests were used to identify those 
variables where differences were. 
 
3.2.2 Method of Recruitment to the study 
 
The respective centres identified families who would be eligible to participate in the 
study. To preserve confidentiality the parents were initially contacted by their PGD 
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clinic and were requested to write to the researchers indicating willingness to 
participate. Once the families had responded indicating their willingness to 
participate, they were contacted by a research assistant in the Department of Child 
Health offering appointments suitable for the family. It was decided to recruit 
children between their first and fifth birthdays. This age range was chosen to allow 
use of the Griffiths Mental Development Scales for Children aged 0-8 years and it 
was also evident from the responses received that most children born after PGD were 
within this age range (ages of 0-5 years). It was anticipated that the revised 0-8 year 
scale of Griffiths Mental Development Scales could be used but due to delay in 
publications of the scales and validation of data, the study was commenced using the 
Griffiths 0-2 years (revised 1996) scales and Griffiths 2-8 years scale. This was done 
to avoid delay in assessments of children.  
There were some families who responded indicating their unwillingness to 
participate. Due to Ethics Committee constraints it was not possible to inquire as to 
why non-participants chose so. Families who did not respond to two written request 
to participate were considered non-participant. Occasionally families did wish to 
participate but it was not practicable for them to attend due to work /childcare related 
issues. These were not considered further in the data analysis.  
 
3.2.3 Case Definition 
a. Children 
Children below the ages of 8 years who were born following preimplantation genetic 
screening or diagnosis were eligible to participate. 
b. Study families 
All eligible families were contacted using a standard letter approved by the local 
ethics committee and derived from the study protocol (appendix).  
A combined estimate from the four PGD centres suggested there were at least 100 
children less than eight years who could potentially be recruited for the study. Of an 
original cohort of 100 qualifying children, only 70 living within the London Region 
or just outside were eligible for the study. Of these 70 a total of 49 (70%) born 
between October 2002 and January 2007 were subsequently seen for assessment. 
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c. Controls 
Naturally conceived children were recruited from local nurseries to provide a control 
group. The London based Multiple Birth Foundation was approached for recruitment 
of twin controls. Children who had emigrated, who were born less than 32 weeks 
gestation or whose mother tongue was not English were not approached. Control 
families were contacted using a standard letter approved by the local ethics committee 
and derived from the study protocol (appendix). Two control children were 
approached for each index case, as it was anticipated there would be only 50% 
participation rate amongst potential controls. Written consent was obtained from all 
participating control families and they were assessed in an identical manner to study 
children. 
 
3.2.4 Exclusion and inclusion cr iteria for children in the existing database 
a. Exclusion cr iter ia 
Children aged over 8 years were not recruited; as they were not eligible for Griffiths 
Mental Development Testing (this has an upper age limit of 7 yrs 11 months). They 
were also excluded if their mother tongue was not English or they were no longer 
living in mainland United Kingdom. 
 
b. Inclusion cr iter ia 
Children who were born following Pre implantation genetic diagnosis or screening 
were included.  
 
3.2.5 Matching 
Control children were matched with cases for age, sex, social class (according to 
Office of National Statistics classification), gestational maturity and race.  
 
3.2.6 Benefits of assessment 
Families who agreed to take part in the study were given the opportunity to discuss 
medical and behavioural concerns with the paediatrician at the time of assessment. 
The families were also advised that they could contact the investigators at any time in 
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the future if there were any further concerns of a paediatric nature, regardless of 
relevance to the study per se. 
During the course of the assessment, no previously unrecognised medical problems 
were discovered. However, many parents discussed concerns sometimes behavioural, 
which were addressed to the best ability of the paediatrician and if necessary 
appropriate referrals were initiated. This was perceived as very helpful to the parents 
who often were in doubt about the nature of the problem and also the appropriateness 
of referral to other services. 
3.2.7 Data collection and recording 
A data collection form was designed. In order to make data entry systematic and more 
concise a series of fixed numeric lists were developed enabling most collected 
information to be entered in numeric form (see appendix). Arrangements were made 
to enter raw data into a computer database for subsequent analysis. An appropriate 
data input programme using File Maker Pro version 5 was designed by Hui Jayne Lim 
(Research assistant) after piloting the format on 6 cases. It was necessary to develop 
standardised criteria for this data input. This method of standardised data collection 
allowed later statistical analyses more readily to be performed. Data were transferred 
2&%)-+G+2(+%$7)*25A+%)#G)0&)(,+)>+%052$)/5,""$'9)5"6G#(+-)5+&(-+.)F2(2)!29)0&0(02$$7)
collected with individual identifiers but stored for analysis in an anonymised format. 
The following data were collected:  
1. Socio-demographic details 
For each participating biological parent the following details were obtained: 
 Age 
 Marital status was recorded according to category: married, single, divorced, 
separated or cohabiting. 
 ^2-+&('9)+%#52(0"&2$)$+8+$)52(+1"-09+%)0&(")&"):"-62$)=#2$0:052(0"&9k)b`/g)"-)
equivalent; A-level or equivalent; University entry or equivalent; Degree and 
Higher degree.  
 Occupations 
 Social class was then ascertained according to the Office of National Statistics 
classification. This is a scale for classifying people into five groups 
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(represented by roman numerals), one subdivided, based on occupation. 
(Formerly Registrar General's Social Class). 
 Smoking categorised as non-smoker, 1-5 cigarettes per day, 6-10 cigarettes per 
day, 11-20 cigarettes per day, 20+ cigarettes per day, or pipe/cigar smoker. 
 Drinking categorised as units per week. 
In all the above an unknown category was allowable. 
 
2. Perinatal details 
Details of maternal illnesses, obstetric complications and medications taken during 
pregnancy were recorded. 
Mothers were asked if they smoked or drank alcohol during the pregnancy and if so, 
the amount was quantified. Alcohol consumption was recorded as the number of units 
consumed per week. 
d(,+-) %2(2) "*(20&+%) 0&5$#%+%) 6"(,+-'9) 0&(+&(0"&) (") *-+29() :++%) 2&%) (,+) &#6*+-) ":)
persons providing adult support for mother during the pregnancy. 
Details of delivery included the date of delivery, gestation at delivery in weeks and 
days; whether the labour commenced spontaneously or required induction or, as in 
some cases, there was no labour (elective caesarean section); and the type of delivery- 
classified as normal vaginal, forceps/ventouse, planned caesarean or emergency 
caesarean section and unknown. 
 
3. Neonatal details 
Y+5"-%9) ":) (,+) 5,0$%'9) 9+ZC) *0-(,)!+01,() 0&) 1-269C) *0-(,) $+&1(,) 0&) 569C) *0-th head 
circumference in cms and Apgar scores were obtained from the parent held child 
record. If the details were missing, the parents were asked if they had other records 
from which this information could be obtained. 
Records were made of the need for resuscitation at birth and for admission to a 
neonatal unit. If admission to a neonatal unit was required, then the length of stay 
and the reason for admission were recorded. The need for and length of ventilation 
was recorded. Neonatal illnesses were recorded using a defined list and congenital 
anomalies were classified as major or minor using ICD 10 (International 
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Classification of Diseases 10, World Health Organisation, Geneva 1992). Minor 
defects were considered to be those that posed no significant health or social burdens 
2&%) 62l"-) %+:+5(9) !+-+) (,"9+) (,2() 5"#$%) 2%8+-9+$7) 2::+5() (,+) 5,0$%'9) ,+2$(,) "-)
development. 
The type of feeding was recorded as exclusive breast feeding, formula or mixed. The 
duration of exclusive breast feeding was noted. The number of adults providing 
support for the baby and family was recorded including parents. 
 
3.2.8 The assessment 
Children who were aged up to 5 years and their parents were assessed by a single 
"*9+-8+-) ;@HU)*$0&%+%) (") (,+)5,0$%'9)5"&5+G(0"&)9(2(#9) 0&)2)5,0$%) :-0+&%$7)"#(G2(0+&()
setting, using a standardised protocol. Blinding was achieved by a separate 
researcher approaching families for recruitment. The informed consent process also 
0&8"$8+%) :"-+!2-&0&1) :260$0+9) &"() (") -+8+2$) (,+) 5,0$%'9) 5"&5+G(0"&) 9(2(#9) (") (,+)
G2+%02(-0502&.)T,+)5,0$%'9),+01,(C)!+01,()2&%)"550G0("):-"&(2$),+2%)50-5#6:+-+&5+);:"-)
children up to 5 years) were measured in the out patient clinic of the Department of 
Paediatrics and Child Health, University College Hospitals NHS Trust. The physical 
assessment was also carried out in an adjacent dedicated clinic room.  This was 
followed by the developmental assessment, which involved the administration of the 
Griffiths Mental Development Scales.  
?:(+-) (,+) 5,0$%'9) 299+996+&() (,+) G2+%02(-0502&) 5"6G$+(+%) 2) 1+&+-2$) 6+%052$)
questionnaire during interview with the parents. This included socio-demographic 
details and past medical history including perinatal, neonatal and childhood data. 
The paediatrician also recorded physical findings on this form.  
 
3.2.8.1 Physical assessment 
a. General physical examination 
A general medical examination was performed on all the children. This included 
cardiovascular, respiratory, ear nose and throat, abdominal and skin assessment. 
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Neurological examination including gross motor skills was also performed. Attention 
was also paid to the dentition, hair and skeleton. The genitalia were examined in the 
children. Testicular descent was checked for in male children. 
 
b. Congenital anomalies 
The children were examined carefully for evidence of congenital abnormalities and if 
found these were recorded according to the International Classification of Diseases 
(ICD-10) 
c. Growth 
All children were measured for height, weight, occipito-frontal circumference. 
Height was measured using a portable stadiometer recommended by the Child 
Growth Foundation. Weight was measured using electronic scales. Centiles for 
height and weight were then calculated using a computer programme (L-grow®), 
standardised for a UK cohort of children (LGROW 1998) 
 
3.2.8.2 Psychological assessments 
Each child was tested using the Griffiths Mental Development scales. 
 
3.2.8.3 Parental questionnaires to assess family functioning 
The mothers of all participating children were asked to complete four questionnaires 
relating to family functioning. The questionnaires were posted to the family along 
with the appointment letter for the assessment. The mothers were requested to 
complete the questionnaires at home. The parents were provided with a pre paid 
reply envelope to return the questionnaires or they brought them along on the day of 
the assessment. The psychologist scored the returned questionnaires and the 
numerical scores were added to the computer database. If the questionnaires were 
not returned, a reminder was sent to the parents with a second copy of the 
questionnaires. Copies of the questionnaires are provided in the appendix  
The following questionnaires were completed by the parents:  
1. Child Behaviour Checklist for ages 1½-5(Achenbach & Rescorla 2000)  
2. The Carey Temperament Scales (Second Edition)(Carey 2005)  
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3. The parenting Stress Index /Short form (Abidin 1990)(Abidin 1990)  
4. The Parental Acceptance and Rejection Questionnaire (Rohner and Khaleque 
2005)( 2005a) 
5. General Health Questionnaire: GHQ-28 (Goldberg and Hillier 
1979)(Goldberg & Hillier 1979a) 
 
3.2.9 Descr iption of measures used 
The Griffiths Mental Development Scales 
Child Behaviour Checklist for ages 1½-5  
The Carey Temperament Scales (Second Edition) 
The parenting Stress Index /Short form (Abidin 1990) 
The Parental Acceptance and Rejection Questionnaire (Rohner and Khaleque 
2005)  
General Health Questionnaire: G H Q-28 (Goldberg and H illier 1979) 
 
All the above measures have already been described in the previous section. 
 
Summary 
The assessment protocol is summarised in the following flow chart: 
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Chapter 4 
 
4. Results  
 
4.1 Results of PO RD study 
 
4.1.1 Children studied 
 
Out of an original cohort of 150 qualifying children, only 80, living within the 
London Region were eligible for the study. The other 70 children were not eligible as 
the child/children were over 8 years or the family had moved and was no longer in 
London and logistically it was difficult to organise participation. Of the 80 a total of 
35 (44%) responded to the invitation and finally 24 (30%) children born between 
August 1997 and October 2005 were subsequently seen for assessment. 
Reasons for non-participation were: some families were unwilling to participate even 
though they acknowledged the invitation, families had moved abroad, families had 
moved and were not traceable, families were unwilling to travel in order to be seen, 
the family did not attend mutually arranged appointments, family declined but the 
reasons for not doing so were not provided (for ethical reasons it was not possible to 
ascertain reasons for non participation). 
Naturally conceived children were recruited using the local child health database. 
Children were identified from Community Child Health System which is a 
community database system with 500,000 children within a group from North 
London presently involving 9 Primary Care Trusts (PCT). Replies were received 
from 130 parents of control children. 55 of them were ineligible because of, age and 
birth order. Children who had emigrated, who were born less than 32 weeks gestation 
or whose mother tongue was not English were not approached. Finally 37 (49 % 
participation rate) control children were assessed. Families who had shown interest 
initially were often unable to attend due to the distance they were required to travel; 
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birth to new baby in family, ill health of mother and/or child etc. 
 
4.1.2 Matching 
 
Study children were well matched for age and sex.. There were similar proportions of 
parents in social classes I, II and III within each conception group. 
 
Table 4.1.1 Matching characteristics of study children: 
 PO RD Control p value 
Mean (SD) age at 
assessment 
(months) 
38.56 (21.31) 44.58 (29.44) 0.36 
Sex (male) 
F requency (%) 
13(50) 16(43) 0.404 
Mean gestational 
age at birth in 
weeks(SD) 
37.04 (4.11) 39.81 (1.77) 0.001 
 
There was no significant difference between the study and control groups in terms of 
child age at evaluation (Mean PORD = 36.56months, Mean control = 44.58 months; 
p = 0.995) and the age of evaluation ranged from 8 years 6 months to 3 years 9 
months. 
 
4.1.3 Maternal socio-demographic data 
 
There was no difference in the maternal ages between the PORD and the control 
groups. The mean age of PORD mothers were 37.63 years (SD 6.170) compared to 
(,+) 5"&(-"$) 6"(,+-9') 21+) ":) WL.Km) 7+2-9) ;/F) S.WJSU.) T,+) 1-"#G9) !+-+) &"()
significantly different (t = 1.00; df =59; p = 0.32 NS).  
Mothers with renal disease came from a lower socioeconomic background; 7 (29%) 
mothers from the PORD group were either in social class IV or below compared to 
only 1 (3%) mother in the control group, who was in social class IV. The difference 
was statistically significant with p<0.01. 
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Three (13%) mothers from the PORD group had education levels equivalent to A 
level and below compared to 6 (17%) mothers in the control group. The difference 
was not statistically significant. Thus control group mothers were as likely to have a 
university entry level education and an overall higher educational degree compared 
to PORD mothers.  
Mothers from the PORD group were more likely to be married (100%) compared to 
the control mothers (86%). However the difference was not statistically significant 
The number of mothers who smoked was fewer in the PORD group (none) compared 
to the control group (3%). The difference was not statistically significant. 
Current alcohol consumption was less in the mothers in the PORD group compared 
to the mothers in the control group.   The difference was significant with p<0.05. 
The maternal socio demographic details are summarised in Table 4.1.2 
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Table 4.1.2 Maternal socio demographic details 
 PO RD Mothers Control Mothers p value 
Maternal age in 
years (SD) 
37.04 (4.11) 39.81 (1.77) 0.001 
Maternal social 
class 
No. (%) No. (%)  
1 7 (29) 16 (43) 
2 7 (29) 13 (35) 
3N 2 (8) 7 (19) 
3M 1 (4) 0 
4 2 (8) 1 (2.7) 
5 5 (21) 0 
Maternal education No. (%) No. (%)*  
 -University entry 
exam or higher 
21 (87.5) 30 (81) 
Subgroups:   
-Higher degree 3 (12.5) 17 (46) 
-Degree  13 (54) 12 (32) 
-University entry 5 (20.8) 1 (2.7) 
-A-level 0 4 (10.8) 
-GCSE/O-level 1 (4) 2 (5) 
-No qualification 2 (8) 0 
Maternal smoking No. (%) No. (%)  
-Current smoker 0 1 (3) 0.42 
Marital status No. (%) No. (%)*  
-married 21 (87.5) 27 (75) 
-single 0 3 (8.3) 
-separated 0 2 (5.6) 
-divorced 0 0 
-living together 3 (12.5) 4 (11) 
-widow 0 0 
Maternal alcohol 
consumption 
   
-alcohol units (SD) 1.27 (2.73) 3.47 (4.61) 0.04 
*data missing from one control mother 
 
4.1.4 Paternal socio demographic data 
 
There was no significant difference in social class between paternal groups.  
Five (23%) of fathers from the PORD group had education levels equivalent to A 
level and below compared to 3 (9%) fathers from the control group. The difference 
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was not statistically significant. Thus fathers from both the groups were as likely to 
have a university entry level education and an overall higher educational degree.  
There was no significant difference between the numbers of children that the fathers 
in each group had from previous relationships.  
Current alcohol consumption differed between groups with PORD fathers less likely 
to drink than the control group of fathers. Current alcohol units in the PORD group 
was 3.18 (SD 5.04) and in the control group it was 6.16 (SD 6.24). The difference 
was not statistically significant. 
Smoking was more common in the PORD group of fathers when compared with the 
control group however the result was not statistically significant (PORD 13 % vs. 
Control 6% p=0.34 NS). 
In some cases the information regarding paternal socio demographic details were 
provided by the mother of the child. This meant that in a few cases, the data was not 
available. Missing data is indicated in the tables. 
The paternal socio demographic details and missing data are summarised in Table 
4.1.3. 
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Table 4.1.3 Paternal socio demographic detail 
 PO RD fathers 
(n=24) 
Control Fathers  
(n=37) 
p values 
Paternal social 
class 
No. (%) No. (%)  
1 9 (37.5) 18 (49) 
2 7 (29) 13 (35) 
3N 1 (4) 3 (8) 
3M 6 (25) 2 (5.4) 
4 0 0 
5 1 (4) 1 (3) 
Paternal 
education§ 
No. (%) No. (%)  
 
-University entry 
exam or higher 
17 (77) 31 (91) 
Subgroups: No. (%) No. (%) 
-Higher degree 4 (18) 8 (23.5) 
- Degree 9 (41) 18 (53) 
-University entry 4 (18) 5 (21) 
-A-level 4 (18) 2 (6) 
-GCSE/O-level 1 (.5) 1 (3) 
-No qualification 0 0 
Paternal 
smoking 
No. (%) No. (%)*  
-Current smoker 3 (13) 2 (6) 0.34 
Paternal alcohol 
consumption 
No (%) No. (%)  
-alcohol units 
(SD) 
3.18 (5.04) 6.16 (6.24) 0.06 
§ Data missing from renal and control group 
* Data missing from one control father 
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4.1.5 Maternal Renal Disease 
 
The mothers in this study had a variety of renal disorders. From the renal database 
of the Royal Free Hospital they were broadly divided in three main categories: 
 Transplant  
 Chronic renal failure 
 General Nephrology 
 
F igure 1 Distribution of maternal renal disease 
8
3
16
Transplant 
CRF
General Nephrology
 
The general nephrology conditions included various diagnoses: focal segmental 
glomerular sclerosis, absent kidney (?congenital), single hypertrophied kidney, 
autoimmune renal disorder, IgA nephropathy, proteinuria, haematuria, raised 
blood pressure, nephritis, pyeloplasty, reflux nephropathy with nephrectomy and 
reimplantation of ureters, renal stones <secondary to increased oxalate level. None 
":)(,+)6"(,+-9')!+-+)G-+1&2&()!,0$+)"&)%02$7909)*#()"&+)6"(,+-)-+=#0-+%)%ialysis 
post pregnancy. 
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The following was the interval between transplant and conception in the group of 
mothers with renal transplant 
 
Table 4.1.4 Mothers with renal transplant 
 
Cases 
studied 
Interval to 1st 
Pregnancy (in years) 
Interval to 2nd 
pregnancy (in years) 
Further transplant 
following pregnancy 
1 11 from 1st transplant < 2 from 2nd 
transplant* 
Yes, 8 years from 1st 
pregnancy 
2 5 from 2nd transplant* - Yes, 3 years from the 
1st pregnancy 
3 2 7* No  
4 2 6* No 
5 <2* - No 
6 8 14* No 
7 12* 15 No 
8 12 15* No 
 
*The actual children who were assessed in the current study. 
 
There were some data available about the renal function of the mothers prior to 
conception. However a lot of the data was incomplete as it proved very difficult to 
+Z(-25()%2(2):-"6)(,+)6"(,+-9')6+%052$)&"(+9.)d:(+&)&"(+9)!+-+)60990&1)2&%)&"()
found, notes were often incomplete with missing data and also serial monitoring 
was not often done.  
Women with renal disease also had other medical problems. They were: 
hypothyroidism, acoustic neuroma; urinary tract infections, anorexia nervosa, 
depression, atopic illnesses like asthma, hay fever and eczema, migraine, 
musculoskeletal problems like back pain, scoliosis (associated with increased 
frequency of chest infection) and joint problems, epilepsy secondary to tuberous 
sclerosis, hypertension, pancreatitis and diabetes. 
Values of creatinine prior to conception ranged from 63- 176. Haemoglobin levels 
ranged from 11-15.8. Most mothers had mild proteinuria; severe proteinuria was 
rare. 
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4.1.6 Health of PO RD mothers in Pregnancy  
 
Illness in pregnancy/obstetric complication: 
The number of illnesses/obstetric complications reported by mothers during 
pregnancy was slightly higher in the PORD group compared to the control group 
(PORD 46% vs. Control 27%; p= 0.13). The difference was not statistically 
significant. The PORD mothers reported the following common illnesses: 
hypertension (n=6), pre eclampsia (n=1), proteinuria (n=3), chest infection (n=1), 
diabetes (n=1), urinary tract infection (n=3), hyperemesis (n=2). The control 
group mothers reported the following illnesses: hypertension (n=1), infection 
(n=1), urinary tract infection (n=1), diabetes (n= 1), musculoskeletal problem 
(n=5). There were no statistically significant differences in the pattern of illnesses 
reported in pregnancy by the two groups of mothers. 
 
Medications used: 
The numbers of medication used in pregnancy was greater in the PORD group 
compared with control mothers. The difference was statistically significant with p 
<0.01. The differences were mainly accounted for by use of immunosuppressant 
medications the mothers with renal transplant were on. These included 
azathioprine, cyclosporin, tacrolimus, prednisolone and mycophenolate mofetil. 
Mothers with renal disease were also on antihypertensive medications, 
atorvastatin, antibiotics and iron supplement. The control mothers were on 
medications like insulin, thyroxine, aspirin, antibiotics, iron supplement and anti-
D antibodies (short tem use). The use of medications like common analgesics, 
antacids, antibiotics and vitamins were similar in each group. 
 
Smoking/Alcohol consumption 
Smoking in pregnancy was reported in 1 mother from the control group (3%); 
none of the PORD mothers smoked in pregnancy. There was no difference noted 
between maternal groups for alcohol consumption in pregnancy. None of the 
mothers in either group were reported to consume alcohol in pregnancy.  
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Support in pregnancy 
The number of adults available to support mothers during pregnancy was higher 
in the control group compared to the PORD group mothers (PORD 83% vs. 
control 100%; p= 0.01). The difference was statistically significant p<0.01. 
 
Breast feeding: 
Intention to breast feed was significantly higher in the control group with 33 
(94%) of mothers wanting to breast feed compared with 15 (65%) of the renal 
mothers wanting to breast feed. This was significantly different p<0.01. However 
a lot of these mothers were precluded from breast feeding because of the 
medications they were on and were often strongly advised against breast feeding.  
 
Type of labour 
The PORD mothers were less likely to have spontaneous onset of labour when 
compared with the control group of mothers (PORD 60% vs. Control 79%, 
p=0.14). The difference was not statistically significant. Incidence of caesarean 
sections, planned and emergency was higher in the PORD group. There was also a 
significant difference in instrumental deliveries with 5 (20.8%) of PORD mothers 
having instrumental deliveries compared with 2 (5.4%) of control mothers. 
Control mothers were most likely to have normal vaginal delivery and 
significantly fewer vaginal deliveries were reported for the cases. 
There was some missing data for perinatal results as indicated in the tables. The 
numbers involved are small, often missing data from a single child. This missing 
information is often due to parental difficulty recalling specific information. 
Health of PORD mothers in pregnancy are summarised in tables 4.1.5; 4.1.6 and 
4.1.7 
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Table 4.1.5 Details of health of mothers in pregnancy 
 PO RD 
mothers 
(n=24) 
Control  group  
(n=37) 
p value 
No. (%) No. (%)  
I llness in pregnancy 11 (46) 10 (27) 0.13 
Medications taken during 
pregnancy 
17 (71) 7 (19) 0.001 
Alcohol consumption in 
pregnancy 
      - current drinker 
0 0  
Smoking in pregnancy 0 1 (3)  
Intention to breast feed* 
- Yes 
- No 
 
15 (65) 
8 (35) 
 
33 (94) 
2 (6) 
 
0.001 
Adult support for mother§ 
- yes 
- No 
 
20 (83) 
4 (17) 
 
37 (100) 
0 
 
0.01 
Labour 
- spontaneous 
- induced 
- no labour 
 
12 (50) 
8 (33) 
4 (17) 
 
26 (70) 
7 (19) 
4 (11) 
 
0.14 
Method of delivery n 
- vaginal 
- Forceps/ventouse 
- Planned caesarean  
- Emergency 
caesarean 
 
 
9 (37.5) 
5 (20.8) 
4 (16.7) 
6 (25) 
 
27 (73) 
2 (5.4) 
4  (10.8) 
4 (10.8) 
 
 
0.04 
Gestational age at birth < 
weeks Mean (SD) 
37.04 (4.11) 39.81 (1.77) 0.001 
*Missing data from one PORD mothers & 2 control mothers 
§Missing data from 3 control mother 
n There was a significant association between group and mode of delivery (X2 = 
8.29, df= 3, p= 0.04)  
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Table 4.1.6 Illness in pregnancy/obstetric complications 
 
 
Table 4.1.7 Medications in pregnancy 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 PORD mothers Control group 
Hypertension 6 1 
Pre eclampsia 1 0 
Proteinuria 3 0 
Infection 1 1 
Hyperemesis 2 0 
Diabetes  1 1 
Urinary tract infection 3 1 
Musculoskeletal problems 0 5 
 PORD mothers Control group 
Antibiotics 2 1 
Antihypertensive 4 0 
Azathioprine 4 0 
Cyclosporin 4 0 
Tacrolimus 3 0 
Mycophenolate mofetil 2 0 
Steroids (Prednisolone) 6 0 
Heparin 0 1 
Insulin 0 2 
Thyroxine 0 3 
Iron 1 1 
Atorvastatin  2 0 
Others 2 3 
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4.1.7 Neonatal Results 
 
There was significant difference in the distribution of gestational age in the two 
groups studied. The PORD group had a significant lower gestational age 
(gestational age for PORD 37.04 (S.D 4.11) vs. control 39.81(S.D 1.77)). This 
was statistically significant p<0.01.  
The PORD group also had lower birth weight, and higher number with birth 
weight less than 2500g (birth weight (gms) PORD 2842.57 (S.D 886) vs. control 
3414.07 (S.D 488); p <0.05.  
PORD children were more likely to require resuscitation after birth when 
compared to the control group; PORD 6(25%) vs. control 3 (8%); the result did 
not reach statistical significance. 
The number of babies admitted to the neonatal unit was different in the two 
groups. 8 babies (33%) born after PORD were admitted to the neonatal unit 
compared to 3 babies in the control group (8%). This difference was clinically 
significant p < 0.05. The duration of stay in the neonatal unit differed in the two 
groups. In the PORD group 6 (25%) babies spent > 7 days in the neonatal unit 
compared to 2 (5%) babies from the control group, p = 0.782. There were 
inadequate numbers in the two groups to compare the significance of stay in 
&+"&2(2$)#&0()0&)(+-69)":)$+&1(,)":)9(27)\)m)%279.) 
Ventilation occurred more commonly in the PORD group though this difference 
was not statistically significant. In the PORD group 4 (17%) babies got ventilated 
compared to 1 (3%) in the control group, p= 0.052. Two of the babies in the 
PORD group were ventilated for 1 and 2 days respectively because of 
prematurity. The ventilatory support required was minimal. The other two babies 
were ventilated for 15 and 30 days. These two babies were premature and had 
respiratory distress and sepsis. The baby in the control group who was ventilated 
was delivered prematurely at 31 weeks by emergency section secondary to 
maternal placental abruption and was only ventilated for half a day. 
 Reasons for admission to the neonatal unit included a range of common neonatal 
problems. There was a difference seen between groups, with more control babies 
(10 (27.5%) with reported neonatal illnesses when compared with the PORD 
group 3 (12.5%). The types of illnesses that affected the children as neonates also 
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varied. Some of these illnesses did not necessarily require admission to a neonatal 
unit. 
Mothers from the PORD group were less likely to exclusively breastfeed their 
babies than mothers from the control group. Nine (39%) mothers from the PORD 
group did not exclusively breast feed for at least one month compared to 4 (11%) 
mothers in the control group, this was statistically significant p <0.01. Of the 
mothers who chose to breast feed, the length of exclusive breast feeding was 
similar between groups. 
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Table 4.1.8 Neonatal details 
 PO RD 
(n= 24 ) 
F requency (%) 
Control 
(n= 37 ) 
F requency (%) 
p 
value 
Male 13 (50) 16 (43) 0.404 
Birth weight 
Mean (SD) 
2842 .6 (886) 3414.0 (488) 0.002 
Resuscitation  
Yes/No 
Yes 6 (25) Yes  3 (8) 0.070 
No  18 (75)) No 34 (92) 
Admission to NNU 
Yes/No 
Yes  8 (33) Yes  3 (8) 0.012 
No  16 (67) No  34 (92) 
Length of stay on NNU 
Not admitted 
1-7 days 
> 7 days 
 
16 (67) 
2 (8) 
6 (25) 
 
34 (92) 
1 (3) 
2 (5) 
 
Ventilation required  
 
Yes  4 (17) Yes  1 (3) 0.052 
No  20 (83) No  36 (97) 
Neonatal illness 
 
Yes  3 (12.5) Yes  10 
(27.5) 
 
No  21 
(87.5) 
No  27 (73) 
Type of feeding 
-exclusive breast 
-mixed 
-formula 
 
14 (61)* 
3 (13) 
6 (26) 
 
32 (86.5)* 
2 (5.5) 
2(5.5) 
 
 
0.011 
Length of exclusive 
breast feeding 
-not applicable 
<4weeks 
-5-8 weeks 
-9-12 weeks 
>12 weeks 
 
 
18 
3 
1 
4 
23 
 
 
29 
3 
2 
4 
26 
 
 
 
Adult support for 
mother 
-Yes 
-No 
 
47 (96) 
2 (4) 
 
52 (78.8) 
14 (21) 
 
* Missing data from both groups 
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4.1.8 Physical assessment 
Hospital admissions were similar in the PORD group compared to the control 
group (PORD 2(8%) vs. Control 3(8%) p = 0.975). Number of illnesses reported 
by parents were more common in the control group compared to the PORD group 
(PORD 7 (29%) vs. Control 29 (78%): p = 0.000). Illnesses were classified into 
respiratory tract infections, common childhood infections, fractured bones, 
gastrointestinal, atopic (eczema, asthma) and other illnesses. Of these, there was a 
trend towards control group children having atopic illnesses, chicken pox, 
common childhood infections and fractured bones more commonly than the 
PORD group. 
Childhood medication use was similar between the groups.  
There was no difference between the two groups regarding surgery. General 
examination of both groups did not reveal any abnormalities apart from three 
control children with undescended testicle, tight foreskin (which was 
asymptomatic) and eczema respectively. Two children from the PORD group had 
mild eczema. 
 
4.1.9 G rowth 
There were no differences noted between groups for childhood growth in terms of 
actual height in cms and weight in kgs and centiles. These centiles were calculated 
accurately using the L-grow® computer programme standardised for the UK 
population of children (LGROW 1998). However there was no software to 
calculate head circumference centiles. The head circumference data was therefore 
based on raw measurement only, but no significant difference between head 
circumference were seen. 
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Table 4.1.9 .Physical development at time of evaluation 
 
 
 
 
 
 
OFC= Head circumference 
4.1.10 Congenital malformation 
 
There was no difference between incidences of congenital malformations, major 
or minor in the PORD and the control groups.  
 
4.1.11 G riffiths Mental Developmental Scales  
 
Data was available from 56 (21 cases and 35 controls) children for the Griffiths 
Mental development Scales. Two children assessed in the PORD group were 
above 7 years 11month (cut off for eligibility of Griffiths). However both these 
children were progressing without any concern and school reports were above 
average which suggested normal development. One child in the PORD group 
scored well below the accepted norms. Two control children did not complete the 
assessment due to lack of cooperation and so could not be included in this 
assessment. 
The data indicates that there was little difference between the groups. The mean 
Griffiths quotient was 106.29 (SD 18.48) for the PORD group and 105.65(SD 
11.60) for the control group which were both within the normal range, and did not 
differ significantly (p = 0.87).  
   Case Control p 
 
Height 
 
N 24 33  
Mean 99.55 97.72 0.69 
SD 21.34 13.79  
 
Weight 
  
N 24 35  
Mean 16.98 15.34 0.29 
SD 7.67 4.23  
 
O F C 
  
N 23 34  
Mean 50.30 50.14 0.85 
SD 3.77 2.60  
 102 
Table 4.1.10 Group differences on the overall and subscale score on the Griffiths 
mental development scales.  
 
G riffiths Scales   Case Control p 
Locomotor subscale N 21 35  
  Mean 108.84 108.91 0.98 
  SD 14.77 17.23  
Personal social subscale N 21 35  
  Mean 105.04 106.77 0.69 
  SD 19.16 13.79  
Hearing speech 
subscale 
N 21 35  
  Mean 107.66 109.60 0.73 
  SD 26.55 16.15  
Eye hand subscale N 21 35  
  Mean 101.02 98.57 0.59 
  SD 18.37 15.58  
Performance subscale N 22 35  
  Mean 107.60 106.06 0.74 
  SD 25.90 14.50  
Practical reasoning 
subscale 
N 15 21  
  Mean 103.01 112.12 0.37 
  SD 43.33 13.31  
G riffiths General 
Quotient 
N 21 35  
  Mean 106.29 105.65 0.87 
  SD 18.48 11.60  
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4.1.12 Child and Family Relationships 
Parental questionnaires were used to assess family functioning. 
Parents were posted the questionnaires once an appointment date had been fixed. 
They were sent out at least a week ago with the details of the appointment. The 
parents were requested to complete the questionnaires before the assessment as 
much as possible. Any queries related to the questionnaires or the completion was 
addressed during the actual assessment. They were requested to bring the 
questionnaires with them for the appointment. 
 The set included the following questionnaires: 
1. General Health Questionnaire: GHQ-28 (Goldberg and Hillier 1979) 
2. The Parental Acceptance and Rejection Questionnaire (Rohner and Khaleque 
2005) 
3. The parenting Stress Index /Short form (Abidin 1990) 
4. The Carey Temperament Scales (Second Edition): of which the following 
were used: 
a. Early Infancy Temperament Questionnaire for 1 to 4 month old 
infants. 
b. Revised Infant Temperament Questionnaire for 4 to 11 month old 
infants. 
c. Toddler Temperament Scale for 1-2 year old children. 
 
5. Child Behaviour Checklist for ages 1½-5 and 6-18 
Response rate: 
Overall there were 4 sets of missing questionnaires in the PORD group. This 
meant an 83 % response rate.  Mothers of two children did not return any of the 
set. This family even though English speaking was actually from Albania and 
possibly had practical difficulties in completing the questionnaires. It was not 
possible to contact the family once the assessment was complete to offer help in 
completing the questionnaires. The other two had 1-3 of the questionnaires 
missing from the set. A second copy of the set or missing questionnaires were 
sent by post. A further telephone reminder was attempted where possible. 
Thereafter it was taken as a non-response. 
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a. Child Behaviour Check L ist (C B C L) 
 
Maternal reports of the child behavioural trends were obtained from 16 children 
from the PORD group and 20 children from the control group. The CBCL 1!- 5 
and 6-18 can be scored in terms of two broad groupings of syndromes designated 
as Internalising and Externalising.  O ther problems (which were obtained from 
open ended question where a parent can list up to three problems which were not 
listed in the actual questionnaire) were also scored and the summative value of the 
Internalising, Externalising and the Other problems score gave us the total 
problem scales. The Internalizing grouping reflects problems within the self such 
as anxiety, depression, somatic complaints without known medical cause and 
withdrawal from social contacts. The Externalising grouping represents conflicts 
with other people and their +ZG+5(2(0"&9) :"-) (,+) 5,0$%'9) *+,280"#-) 9#5,) 29) -#$+)
breaking and aggressive behaviour. 
The total sores of Internalising were not significantly different in the two groups, 
however the T scores were slightly different though not significant (p= 0.087). 
The total and the T scores for Externalising were significantly different between 
the two groups (p< 0.05 and p<0.01). The scores for other problems were also 
significantly different in the PORD and control group (p<0.01). The total problem 
score and the total problem T score were significantly different in the two groups 
(p<0.05) 
The T score is a particular kind of standard score designed to provide a similar 
quantitative metric for scales that have different numbers of items and different 
distributions of scores 
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Table 4.1.11 Group differences on the overall and subscale score on the Child 
Behaviour Check List 
 
b. Carey Temperament Scales 
 
There was no difference in the temperamental characteristics perceived by 
mothers in both the group. The questionnaire is a measure of nine NYLS (New 
York Longitudinal Study) temperament characteristics: activity level, rhythmicity, 
approach-withdrawal, adaptability, intensity, mood, attention span and 
persistence, distractibility and sensory threshold. 
 G roup  
  Case 
Mean 
(SD) 
Control 
Mean 
(SD) 
p 
 Internal 1 7.81 5.15 0.087 
  (5.45) (3.57)  
    
 Internal 2 50.93 45.25 0.051 
  (8.56) (8.24)  
    
 External 1 13.31 7.35 0.017 
  (7.96) (6.28)  
    
 External 2 53.06 43.60 0.008 
  (8.91) (10.73)  
    
 O ther 
Problems 
11.72 5.05 0.001 
  (4.26) (3.36)  
    
 C B C L Total 1 33.81 19.90 0.010 
  (18.60) (11.80)  
    
 C B C L Total 2 52.12 43.80 0.011 
  (9.46) (9.07)  
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Table 4.1.12 Group differences on the overall and subscale scores on the Toddler 
Temperament test.  
 
   Case Control p 
Activity N 5 16  
  Mean 4.43 4.08 0.182 
 SD .13 .54  
Rhythmicity N 5 16  
  Mean 2.49 2.79 0.52 
  SD 1.052 .89  
Approach N 5 16  
  Mean 3.62 3.04 0.12 
  SD .98 .60  
Adaptability N 5 16  
  Mean 3.40 2.92 0.07 
  SD .79 .40  
Intensity N 5 16  
  Mean 4.06 3.80 0.56 
  SD .91 .81  
Mood N 5 16  
  Mean 3.31 2.82 0.18 
  SD 1.035 .55  
Persistence N 5 16  
  Mean 3.30 3.19 0.82 
  SD 1.26 .82  
Distractibility N 5 16  
  Mean 3.56 3.8 0.63 
  SD 1.09 .90  
Threshold N 5 16  
  Mean 4.49 4.34 0.72 
  SD .50 .85  
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c. Parenting stress Index (PSI) 
There was no difference between the reported parental distresses in the two 
groups. 
 
Table 4.1.13 Group differences on the overall and subscale score on the PSI test. 
    Case Control p 
 
PSI parental distress 
 
N 21 37  
Mean 26.48 26.65 0.94 
SD 9.527 8.593  
PSI parent child 
dysfunctional interaction 
 
N 21 37  
Mean 18.76 17.22 0.41 
SD 9.099 5.350  
 
PSI difficult child 
 
N 20 37  
Mean 28.45 25.16 0.11 
SD 7.605 7.377  
 
PSI total clinical score 
 
N 20 37  
Mean 73.80 69.03 0.36 
SD 20.707 17.320  
 
d. Parental Acceptance and Re jection Questionnaire (PA R Q) 
There was no difference in the overall and subscale scores of the Parental 
acceptance and rejection between the PORD and the control groups.  
 
Table 4.1.14 Group differences on the overall and subscale scores on the PARQ 
test.  
   Case Control p 
PA R Q warmth affection N 19 37  
  Mean 23.16 24.22 0.39 
  SD 3.640 4.650  
PA R Q aggression 
hostility 
N 19 37  
  Mean 25.11 27.35 0.29 
  SD 7.031 7.754  
PA R Q neglect 
indifference 
N 19 37  
  Mean 21.00 20.43 0.65 
  SD 5.077 4.207  
PA R Q re jection N 19 37  
  Mean 15.53 14.73 0.56 
  SD 5.501 4.568  
PA R Q total N 19 37  
  Mean 84.79 86.73 0.70 
  SD 18.229 17.508  
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e. General Health Questionnaire (G H Q-28) 
 
No differences were identified between the two groups using the GHQ-28, which 
was designed to detect current mental health problems in the general population. 
The GHQ-28 provides four dimensions, measuring somatic symptoms, anxiety 
and insomnia, social dysfunction and severe depression. 
 
Table 4.1.15 Group differences on the subscale and total score on the GHQ 
General Health 
Questionnaire 
Case 
Mean (SD) 
Control Mean 
(SD) 
p value 
G H Q  somatic symptoms 1.09 (4.78) 1.59 (2.39) 0.59 
G H Q anxiety and insomnia 1.80 (2.24) 1.64 (2.40) 0.82 
G H Q social dysfunction 0.47 (0.81) 1.18 (1.89) 0.10 
G H Q severe depression 0.28 (0.71) 0.35 (.94) 0.78 
G H Q Total score 4.57 (4.95) 4.75 (6.49) 0.91 
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4.2 Results of the PG D study 
 
4.2.1 Children studied 
 
A combined estimate from the four PGD centres suggested that at least 100 
children less than eight years could be recruited for the study. Out of an original 
cohort of 100 qualifying children (children below the ages of 8 years who were 
born following Preimplantation Genetic Screening or Diagnosis were eligible to 
participate), only 70 living within the London Region were eligible for the study. 
The other 30 children were not invited to participate because families had come to 
London solely for PGD from countries like Saudi Arabia, Egypt, or the United 
?-2*)g60-2(+9C)!,+-+) (,+)620&) $2&1#21+)":) (,+)5,0$%-+&)!29&'()g&glish and the 
practicalities of participation were felt to be difficult. Of these 70 a total of 49 
(70% participation rate) born between October 2002 and January 2007 were 
subsequently seen for assessment. This included 4 pairs of twins and 41 
singletons. Out of the total 49 children assessed, 39 children were born after PGD 
for aneuploidy screening (preimplantation genetic screening) and 10 children for 
known genetic disorders in their families. Of these 10 families, 4 families had 
chromosomal translocation, 3 families had Down syndrome occur in a previous 
pregnancy and 3 families had a family history of myotonic dystrophy. Refer to 
figure 4.2 and 4.3: 
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F igure 2 Distribution of PGD children studied 
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Reasons for non-participation were: families had moved abroad, families had 
moved and were not traceable, families were unwilling to travel in order to be 
seen, the family did not attend arranged appointments, family declined but the 
reasons for not doing so were not provided (for ethical reasons it was not possible 
to ascertain reasons for non participation). 
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Naturally conceived children were recruited from local nurseries for the control 
group. The London based Multiple Birth Foundation was approached for 
recruitment of twin controls. Replies were received from 175 parents of control 
children;. 85 of them were ineligible because of age and birth order. Children who 
had emigrated, who were born less than 32 weeks gestation or whose mother 
tongue was not English were not approached. Finally 66 (73 % participation rate) 
control children were assessed (3 pairs of twins and 60 singletons). Families who 
had shown initial interest were often unable to attend due to the distance they 
were required to travel; the family sometim+9) %0%&'() 2((+&%) 6#(#2$$7) 2--2&1+%)
appointments, mother giving birth to new baby in family, ill health of mother 
and/or child etc. 
4.2.2 Matching 
 
Study children were well matched for age, sex, gestational maturity. There were 
similar total number of parents in social classes I, II and III within each 
conception group. 
 
Table 4.2.1 Matching characteristics of study children: 
 PG D Control 
Mean (SD) age at 
assessment (months) 
18.38 (11.43) 18.29 (5.82) 
Boys (%) 28 (57) 32 (49) 
Gestational age (SD) 
at birth (weeks) 
38.24 (2.58) 40.03 (1.40) 
 
There was no significant difference between the study and control groups in terms 
of infant age at evaluation (Mean PGD = 18.4 months, Mean control = 18.3 
months; t = -0.056, df =114, p = 0.995) and the age of evaluation ranged from 3 
months to 56 months. 
 
4.2.3 Maternal socio-demographic data 
 
The PGD mothers were significantly older than the natural conception group. The 
mean age of PGD mothers were 40.40 years (3.74) compared to the control 
 112 
mothers age of 35.39 years (4.30). This is not surprising in view of the history of 
infertility in these women who underwent PGD for aneuploidy screening (PGS). 
There was no significant difference in social class between maternal groups. 
Control group mothers were as likely to have a university entry level education 
and an overall higher educational degree compared to PGD mothers. Only 9 
mothers from the PGD group and 8 mothers in the control had education levels 
below university entry, the difference was not significant (p = 0.375). 
Mothers from the PGD group were more likely to be married (81.6%) compared 
to the control mothers (75.7%) 
The number mothers who smoked were fewer in the PGD group (none) compared 
to the control group (9%). 
Current alcohol consumption was less in the mothers in the PGD group compared 
to the mothers in the control group (PGD 55% vs. Control 78.8%). 
The maternal socio demographic details are summarised in Table 4.2.2 
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Table 4.2.2 Maternal socio demographic details 
 PG D Mothers 
n = 49 
Natural conception 
Control Mothers 
n = 66 
Maternal age in years 
(SD) 
40.4 (3.74) 35.39 (4.30) 
Maternal social class§ No. (%) No. (%) 
1 30 (61) 20 (30) 
2 8 (16) 23 (34) 
3N 11 (23) 18 (27) 
3M 0 0 
4 0 3 (5)* 
Maternal education No. (%) No. (%) 
-University entry exam or 
higher 
40 (82) 58 (88) 
Subgroups:   
-Higher degree 23 (47) 33 (50) 
-Degree  13 (27) 19 (29) 
-University entry 4 (8) 6 (9) 
-A-level 9 (19) 7 (11) 
-GCSE/O-level 0 1 (2) 
-No qualification 0 0 
Maternal smoking No. (%) No. (%) 
-Current smoker 0 6 (9) 
Marital status No. (%) No. (%) 
-married 40 (82) 50 (76) 
-single 2(4) 2 (3) 
-separated 0 0 
-divorced 0 0 
-living together 7 (14) 14* (21) 
-widow 0 0 
Maternal alcohol 
consumption 
No (%) No. (%) 
-current drinker 27 (55) 52 (79) 
*Includes one couple in civil partnership 
§Includes missing data. 
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4.2.4 Paternal socio demographic data 
 
Fathers of PGD children were older than fathers of control children (mean age 
PGD: 41.26 vs. Control: 38.46; p = 0.076), though the difference was not 
significant. There were no significant differences in social class between paternal 
groups. Control group fathers were as likely to have a university entry level 
education and an overall higher educational degree compared to PGD group 
fathers (PGD 83.6% vs. Control 86.3% p = 0.721, not significant). 
There was no significant difference between the numbers of children that the 
fathers in each group had from previous relationships. However, there was a trend 
towards PGD fathers having two or more children from previous relationships. 
Current alcohol consumption differed between groups with PGD fathers possibly 
being more likely to drink than the control group of fathers (PGD 79.6% vs. 
Control 74.24%%; chi-square =.448, df =1, p= 0.503), though the difference was 
not significant. Smoking seemed less common in the PGD group of fathers when 
compared with the control group, although again this was not statistically 
significant (PGD 6.1% vs. Control 16.6%; chi-square=3.35, df =1, p= 0.067). 
In some cases the information regarding paternal socio demographic details were 
provided by the mother of the child. This meant that in a few cases, the data was 
not available.  
The paternal socio-demographic details and missing data are summarised in Table 
4.2.3. 
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Table 4.2.3 Paternal socio demographic detail 
 PG D fathers 
(n=49) 
Natural conception 
Control Fathers (n=66) 
Paternal age in years 
(SD) 
41.26 (5.37) 38.46 (10.02) 
Paternal social class No. (%) No. (%) 
1 36 (74) 26 (39) 
2 9 (18) 21 (32) 
3N 4 (8) 8 (12) 
3M 0 8 (12) 
4 0 3 (5) 
Paternal education No. (%) No. (%) 
-University entry exam or 
higher 
41 (84) 57 (86) 
Subgroups: No. (%) No. (%) 
-Higher degree 25 (51) 30 (46) 
-Degree  9 (18) 
21 (32) 
-University entry 7 (14) 6 (9) 
-A-level 7 (14) 8 (12) 
-GCSE/O-level 1(2) 1 (1) 
-No qualification   
Paternal smoking No. (%) No. (%)* 
-Current smoker 3 (6) 11 (17) 
Paternal alcohol 
consumption 
No (%) No. (%) 
-current drinker 39 (80) 49 (74) 
* Data missing from one control father 
 
4.2.5 Health of PG D mothers in Pregnancy  
 
Illness in pregnancy/obstetric complications: 
The number of illnesses/obstetric complications reported by mothers in pregnancy 
was higher in the PGD group compared to the control group (PGD 40% vs. 
Control 21%; chi-square = 5.19, df = 1, p= 0.022). The PGD mothers reported the 
following common illnesses: chest infection (n=2), diabetes (n=3), bleeding in 
pregnancy, urinary tract infection (n=3), hypertension, gastrointestinal symptoms 
(n=2), anaemia (n=2), hyperemesis (n=4). The control group mothers reported the 
following illnesses: hypertension (n=2), intra uterine growth retardation, bleeding 
in pregnancy, cardiac arrhythmias (Wolff-Parkinson-White syndrome), chest 
infection (n=4), gastrointestinal symptoms (n=2) and septicaemia. There were no 
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statistically significant differences in the pattern of illnesses which were reported 
in pregnancy by both groups of mothers. 
 
Medications used: 
The number of medications used in pregnancy was greater in the PGD group 
compared with control mothers (PGD 73.5% vs. control 32.3%; chi-square=19.51, 
df =1, p= 0.00). The differences were mainly accounted for by use of 
progesterone, aspirin, steroids (hydrocortisone and prednisolone), heparin and 
Immunoglobulins. These medications were an integral part of the IVF process. 
The use of medications like common analgesics, antacids, antibiotics and vitamins 
were similar in each group. 
 
Smoking /Alcohol consumption: 
Smoking in pregnancy was reported in 3 mothers from the control group (4.5%); 
none of the PGD mothers smoked in pregnancy. There was a significant 
difference noted between maternal groups for alcohol consumption in pregnancy. 
None of the PGD mothers were reported to consume alcohol in pregnancy 
compared to 11 (16.6%) mothers in the control group who were reported to drink 
between 1-10 units of alcohol in pregnancy. The study did not specify when in the 
G-+1&2&57)"-)I:"-),"!)$"&1')(,+)6"(,+-9)5"&9#6+%)2lcohol. 
 
Support in pregnancy: 
The number of adults available to support mothers during pregnancy was also 
higher in the PGD group compared to the control group of mothers (PGD 93.8% 
vs. Control 77.7%; chi-square = 0.194, df =1, p = 0.659). Intention to breast feed 
was similar between groups at the time of pregnancy (PGD 91% vs. Control 
89.4%).  
 
Type of labour: 
The PGD mothers were less likely to have spontaneous onset of labour when 
compared with the control group of mothers (PGD 40.8% vs. Control 60.6 %, chi-
square=4.414, df =1, p= 0.035). This difference was significant. Incidence of 
Caesarean sections, planned and emergency was higher in the PGD group. There 
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was no significant difference in the occurrence of instrumental delivery. Control 
mothers were most likely to have a normal vaginal delivery. 
There is some missing data for perinatal results as indicated in the tables. The 
numbers involved are small, often missing data from a single child. This missing 
information is often due to parental difficulty recalling specific information. 
Health of PGD mothers in pregnancy are summarised in tables 4.2.4; 4.2.5 and 
4.2.6 
 
Table 4.2.4 Details of health of mothers in pregnancy 
*Missing data from two PGD mothers & 4 control mothers 
§Missing data from 3 control mothers 
 
 
 PG D mothers 
(n=49) 
Naturally conceived 
control group (n=66) 
No. (%) No. (%) 
I llness in pregnancy 20 (40) 14 (21) 
Medications taken during 
pregnancy 
36 (74) 21 (32) 
Alcohol consumption in 
pregnancy 
      - current drinker 
0 11 (16.6) 
Smoking in pregnancy 0 3 (4.5) 
Intention to breast feed* 
- Yes 
- No 
 
45 (92) 
2 (4) 
 
59 (90) 
3 (5) 
Adult support for mother§ 
- yes 
- No 
 
46 (94) 
3 (6) 
 
49 (78) 
14 (22) 
Labour 
- spontaneous 
- induced 
- no labour 
 
20 (41) 
11 (22) 
18 (37) 
 
40 (61) 
16 (24) 
10 (15) 
Method of delivery 
- vaginal 
- Forceps/ventouse 
- Planned caesarean  
- Emergency 
caesarean 
 
 
13 (27) 
5 (10) 
17 (35) 
14 (21) 
 
 
35 (53) 
12 (18) 
7 (11) 
12 (18) 
Gestational age at birth – 
weeks Mean (SD) 
38.24 (2.58) 40.03 (1.40) 
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Table 4.2.5 Illness in pregnancy/obstetric complications 
 
 
Table 4.2.6 Medications in pregnancy 
 
 
4.2.6 Neonatal Results 
 
There was a significant difference in the distribution of gestational age in the two 
groups studied. The PGD group had a significantly lower gestational age and a 
higher number with gestation age less than 37 weeks (Gestational age for PGD 
38.24 (S.D 2.58) vs. control 40.03 (S.D 1.40); p = 0.000) and gestation < 37 
weeks (PGD 7 (14%) vs. control 1 (1.5%); p = 0.009). The PGD group also had 
lower birth weight, and a higher number with birth weight less than 2500g (birth 
 PG D mothers Naturally conceived 
control group 
Pregnancy induced 
hypertension 
1 2 
Bleeding during pregnancy 1 1 
Infection during pregnancy 5 5 
Gastrointestinal illness 2 2 
Anaemia 2 0 
Hyperemesis 4 0 
Gestational diabetes  3 0 
Any illness in pregnancy 20 14 
 PG D mothers Naturally conceived 
control group 
Antibiotics 3 4 
Asthmatic drugs 0 2 
Aspirin 13 1 
Progesterone 10 1 
Vitamins/Electrolyte 0 7 
Iron 0 2 
Antihypertensive medication 0 1 
Steroids 21 1 
Heparin 20 0 
Immunoglobulins 12 0 
GI medicine 4 1 
Insulin 2 0 
Thyroxine 2 1 
Salbutamol 0 2 
Any medication 36 21 
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weight (gms) PGD 3122 (S.D 915) vs. control 3440 (S.D 453); p = 0.030 and 
birth weight < 2500 gms PGD 12 (24.5%) vs. control 1 (1.5%); p = 0.000). 
PGD children were not more likely to require resuscitation after birth when 
compared to the control group (PGD 4 (8%) vs. control 6 (9%), p = 0.836). The 
proportion of babies admitted to a neonatal unit was slightly different in the two 
groups: 8 babies (16%) born after PGD were admitted to the neonatal unit 
compared to 7 babies in the control group (10.6%). This difference was not 
statistically significant p= 0.391. The number of days spent in the neonatal unit 
did not differ between the two groups. There were inadequate numbers in the two 
groups to compare the significance of stay in a neonatal unit in terms of length of 
9(27) \) m) %279.) >+5,2&052$) 8+ntilation occurred more commonly in the control 
group; however the proportion was not significant. Two babies (4%) born after 
PGD were ventilated. One was ventilated for 4 days because of septicaemia and 
meningitis and the second was ventilated because of meconium aspiration and the 
duration could not be recalled by parents. Three babies in the control group were 
ventilated, one for transient tachypnoea of the newborn (TTN) (duration not 
recalled), one for meconium aspiration for 5hrs and the last could not recall the 
duration or the reason for ventilation. Reasons for admission to a neonatal unit 
included a range of common neonatal problems. There was no difference seen 
between the groups. The types of illnesses that affected the children as neonates 
also varied. These illnesses did not necessarily require admission to the neonatal 
unit. 
Mothers from the PGD group were more like to exclusively breastfeed their 
babies than mothers from the control group (PGD 63% vs. control 53%; chi-
square=1.20, df =1, p=0.272). Of the mothers who chose to breast feed, the length 
of exclusive breast-feeding was similar between the groups. 
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Table 4.2.7 Neonatal details 
 PG D 
(n = 49) 
Naturally conceived 
control (n = 66) 
Male (%) 28 (57) 32 (49) 
Resuscitation  
No. (%) 
Yes 4 (8) Yes  6 (9) 
No 45 (92)  No 60 (91) 
Admission to NNU  
No (%) 
 
Yes  8 (16) Yes  7 (10) 
No 41 (84) No  59 (90)  
Length of stay in NNU 
-not admitted 
<1 day 
-1-7 days 
>7 days 
 
41 
1 
4 
3 
 
59 
0 
8 
1 
Ventilation required 
No. (%) 
 
Yes  2 (4) Yes  3 (4.5) 
No  47 (96) No  63 (95.5) 
Congenital anomalies 
 
2 (4) 3 (4.5) 
Type of breast feeding 
-exclusive breast 
-mixed 
-formula 
 
31 (63) 
15 (31) 
3 (6) 
 
35 (53)* 
20 (30) 
9 (14) 
Length of exclusive 
breast feeding 
-not applicable 
<4 weeks 
-5-8 weeks 
-9-12 weeks 
>12 weeks 
 
 
18 
3 
1 
4 
23 
 
 
29 
3 
2 
4 
26 
Adult support for 
mother 
-Yes 
-No 
 
47 (96) 
2(4) 
 
52 (79) 
14 (21) 
NNU: Neonatal unit 
*2 missing data from control group 
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4.2.7 Physical assessment 
 
Hospital admissions were marginally less common in the PGD group compared to 
the control group (PGD 4(8%) vs. control 9(14%); chi-square =.03, df =1, p = 
0.862). Number of illnesses reported by parents were also similar in each group 
(PGD 25(51%) vs. control 31(47%): chi-square=.18, df = 1, p = 0.667). Illnesses 
were classified into upper respiratory tract, lower respiratory tract, dermatological, 
gastro-intestinal, atopic and other illnesses. Of these, there was trend towards less 
illness in the control group for gastrointestinal and atopic complaints. 
Childhood medication usage was similar between the groups.  
There was no difference between the two groups regarding surgery (PGD 2 (4%) 
vs. Control 3 (5%) chi-square =.01, df =1, p = 0.902). The children in the PGD 
group underwent minor surgical procedures such as circumcision and 
pyloromyotomy. The control group required minor plastic surgical procedures and 
corrective surgery for club foot.  
General examination of both the groups did not reveal any abnormalities apart 
from a single control child with hypospadias. 
 
4.2.8 G rowth 
 
There were no differences noted between groups for childhood growth in terms of 
actual height in cms and weight in kgs and centiles. These centiles were calculated 
accurately using the L-grow® computer programme standardised for the UK 
population of children (LGROW 1998). However there was no software to 
calculate head circumference centiles. The head circumference data was therefore 
based on raw measurement only, but no significant difference between head 
circumference were seen. 
Table 4.2.8 Physical characteristics at time of evaluation. 
 PG D Natural 
Conception 
p 
Age at evaluation months 
(SD) 
18.38 (11.43) 18.29 (5.82) 0.959 
Height (SD) 77.50 (17.06) 81.14 (6.78) 0.136 
Weight (SD) 11.27 (3.31) 11.75 (1.97) 0.356 
Head (SD) 47.75 (6.43) 47.77 (2.06) 0.975 
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There was no significant difference between the groups in terms of infant age at 
evaluation (t = -0.056, df =114, p =0.959). A one-way multivariate analysis of 
variance (MANOVA) was conducted using the two groups as the independent 
variable and height, weight and head circumference as the dependent variables. 
The omnibus test was non-significant (F (3,100) = 0.857, p = 0.466) and all tests 
of between<groups effects were non-significant. A multivariate analysis of co-
variance (MANCOVA) was conducted with age at evaluation entered as a 
covariate and the omnibus test was non-significant (F (3,99) = 2.235, p = 0.089). 
 
4.2.9 Congenital malformation 
 
There was no difference between incidence of congenital malformations, major or 
minor in the PGD and the control groups. Two children (4%) from the PGD group 
had reported two minor malformations (strawberry naevus and abnormality to the 
shape of the pinna) and 3 children (4.5%) from the control group reported two 
62l"-) ;F#2&+'9) 97&%-"6+C) 2) 5"&1+&0(2$) 62$:#&5(0"&) ":) +7+) 6#95$+9) 2&%)
hypospadias) and one minor (plagiocephaly). Some of the children in the PGD 
and the control groups would classify as having major anomalies according to 
definitions used in previous studies (Bonduelle et al.. 2005). However, in this 
study we defined a major malformation as one in which surgery or ongoing 
medical monitoring was needed. 
 
4.2.10 G riffiths Mental Developmental Scales   
 
Data was available from 114 (49 cases and 65 controls) children for the Griffiths 
Mental development Scales. One control child did not complete the assessment 
due to lack of cooperation and so could not be included in this analysis. 
The data indicated that there was little difference between the groups. The mean 
Griffiths quotient was 102.7 (+/- 13.1) for the PGD group and 103.3 (+/- 12.8) for 
the naturally conceived group which were both within the normal range, and did 
not differ significantly (t = 0.265, df = 113, p = 0.791).  
A one-way multivariate analysis of variance (MANOVA) was conducted using 
the two groups as the independent variable and the five Griffiths subscale scores  
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as the dependent variables. The omnibus test was significant (F(5,109)=6.456, 
p=.000).  
The significant differences were for the Locomotor (PGD significantly lower) and 
Hearing and Language subscale (PGD significantly higher). When the analysis 
was conducted with maternal age included as a co-variate the difference on the 
Locomotor scale remained significant (F = 12.28, p = 0.001) but the difference on 
the Hearing and Language subscale became non-significant (F = 0.809, p=.307). 
This suggests that differences on the Hearing and Language subscale are largely 
accountable for by age maternal age differences between the cases and controls. 
 
Table 4.2.9 Group differences on the overall and subscale scores on the Griffiths 
test.  
 
 PG D Natural 
Conception 
p 
Locomotor subscale (SD) 101.00 (14.19) 111.44 (14.39) 0.001 
Personal social subscale (SD) 100.29 (18.92) 103.67 (16.58) 0.311 
Hearing language subscale (SD) 106.42 (15.09) 99.86 (16.45) 0.030 
Eye-hand subscale (SD) 100.66 (15.52) 102.61 (16.31) 0.519 
Performance subscale (SD) 103.97 (16.51) 100.83 (19.70) 0.365 
G riffiths General quotient (SD) 102.70 (13.13) 103.34 (12.81) 0.791 
 
4.2.11 Child and Family Relationships 
Parental questionnaires were used to assess family functioning. 
Parents were posted the questionnaires once an appointment date had been fixed. 
They were sent out at least a week before the appointment. The parents were 
requested to complete the questionnaires before the assessment as far as possible. 
Any queries related to the questionnaires or their completion was addressed 
during the actual assessment. Parents were requested to bring the questionnaires 
with them for the appointment. 
The set included the following questionnaires: 
1. General Health Questionnaire: GHQ-28 (Goldberg and Hillier 1979) 
2. The parenting Stress Index /Short form (Abidin 1990) 
3. The Parental Acceptance and Rejection Questionnaire (Rohner and Khaleque 
2005) 
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4. The Carey Temperament Scales (Second Edition): of which the following 
were used: 
a. Early Infancy Temperament Questionnaire for 1 to 4 month old 
infants. 
b. Revised Infant Temperament Questionnaire for 4 to 11 month old 
infants. 
c. Toddler Temperament Scale for 1-2 year old children. 
This measure was used for children up to 35 months of age 
5. Child Behaviour Checklist for ages 1½-5  
This measure was used for 3 children who were over 35 months of age. 
Response rate: 
Overall there were 5 sets of missing questionnaires. One mother did not return 
any of the set. The other four had 1-3 of the questionnaires missing from the set. 
The response rate was 96%. A second copy of the set or missing questionnaires 
was sent by post. A further telephone reminder was attempted where possible. 
Thereafter it was taken as a non-response. 
 
a. Child Behaviour Check L ist (C B C L) 
 
Maternal reports of the child behavioural trends were obtained in 3 children from 
the PGD group. There were none in the same age range in the control group, so 
comparisons could not be made. The following is the report of the three children: 
Table 4.2.10 Details of CBCL 
Child Internal  External Other + 
Scale 5 
Total 
Case 29 3 0 3 + 1 7 
Case 43 5 1 5 + 4 15 
Case 110 3 4 0 + 1 8 
 
This data could not be used in formal statistical analysis. 
 
b. Carey Temperament Scales 
 
There were no between group differences in the temperamental characteristics 
perceived by the mothers. A one-way multivariate analysis of variance 
(MANOVA) was conducted using the two groups as the independent variable and 
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the nine Toddler Temperament subscale scores as the dependent variables. The 
omnibus test was non-significant (F (9,98) = 0.565, p = 0.823) and all tests of 
between<groups effects were non-significant. 
 
Table 4.2.11 Group differences on the overall and subscale scores on the Toddler 
Temperament test.  
 
 
c. Parenting stress Index (PSI) 
 
There was no difference in reported parental distress between the two groups. 
A one-way multivariate analysis of variance (MANOVA) was conducted using 
the two groups as the independent variable and the three PSI subscales scores as 
dependent variables. The Omnibus test was non-significant (F (3,109) =1.075, p = 
0.363). All tests of between<groups effects were non-significant. An independent 
groups t-test showed no significant difference between the groups in the total 
clinical score (t = 0.709, df =111, p = 0.480). The total clinical score was not 
entered into the MANOVA analysis as its value is derived from the sub-scale 
scores and therefore it would cause excessive co-linearity among the dependent 
variables. 
 
 
 
 
 
 
 
 PG D Natural 
Conception 
p 
Activity 3.963 (.671) 4.035 (.645) 0.571 
Rhythmicity 2.650 (.782) 2.575 (.684) 0.596 
Approach 2.50 (.858) 2.76 (.970) 0.161 
Adaptability 2.85 (.845) 3.03 (.842) 0.273 
Intensity 3.722 (.772) 3.977 (.747) 0.088 
Mood 2.698 (.640) 2.863 (.741) 0.228 
Persistence 3.297 (.959) 3.418 (.681) 0.444 
Distractibility 3.605 (1.162) 3.784 (.905) 0.373 
Threshold 3.67 (.766) 3.62 (.836) 0.760 
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Table 4.2.12 Group differences on the overall and subscale scores on the PSI test.  
 
 PG D Natural 
Conception 
p 
Parental distress 23.70 (7.19) 25.03 (7.83) 0.354 
Parent-child dysfunctional 
interaction 15.96 (3.68) 15.89 (5.10) 
0.934 
Difficult child 20.70 (5.64) 22.27 (6.37) 0.174 
Total clinical score 60.36 (13.41) 62.40 (16.43) 0.480 
 
d. Parental Acceptance and Re jection Questionnaire (PA R Q) 
 
The PGD group had a significantly higher scores on the warmth-affection sub-
scale, and significantly lower scores on the aggression-hostility and rejection sub-
scales.  
A one-way multivariate analysis of variance (MANOVA) was conducted using 
the two groups as the independent variable and the four PARQ subscales scores as 
dependent variables. The Omnibus test was significant (F (4,107) = 4.107, p = 
0.030) and three tests of between<groups effects were significant.  
 
Table 4.2.13 Group differences on the overall and subscale scores on the PARQ 
test.  
 PG D Natural 
Conception 
p 
PA R Q warmth-affection 27.54 (7.94) 25.14 (4.28) 0.04 
PA R Q aggression-hostility 19.46 (5.21) 21.78 (5.77) 0.03 
PA R Q Neglect-indifference 17.73 (4.08) 18.83 (3.95) 0.15 
PA R Q Re jection 11.42 (2.84) 13.25 (3.65) 0.005 
 
e. General Health Questionnaire (G H Q-28) 
 
No differences were identified between the two groups using the GHQ-28, which 
was designed to detect current mental health problems in the general population. 
The GHQ-28 provides four dimensions, measuring somatic symptoms, anxiety 
and insomnia, social dysfunction and severe depression. Results were all within 
the normal range. 
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Table 4.2.14 Maternal GHQ Subscales 
 PG D 
Mean (SD) 
Naturally 
Conceived controls 
Mean (SD) 
p value 
 Somatic 
Symptoms 
1.59 (2.39) 2.00 (2.21) 0.52 
Anxiety and 
insomnia 
1.64 (2.40) 1.80 (2.24) 0.80 
Social dysfunction 1.18 (1.89) 0.47 (0.81) 0.11 
Severe depression 0.35 (0.94) 0.28 (0.71) 0.78 
Total score 3.00 (4.06) 3.34 (4.51) 0.678 
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Chapter 5 
 
5. Discussions 
 
5.1 Discussion of the PO RD study 
 
5.1.1 Matching and socio-demographic details of study families 
 
Maternal ages were similar in both the study and control groups of mothers. This 
reflects appropriate matching of the sample studied. This also reflects that women 
with well controlled mild to moderate renal disease, have uneventful obstetric 
histories which are comparable to mothers who do not have any renal disorder.  
 
Families participating in this study with renal disease were more likely to be from 
socio-economically poorer backgrounds. Chronic kidney disease and the 
subsequent progression of the disease impose a relentless socio economic burden 
on the individuals and families (Norris & Agodoa 2005). Patients with chronic 
renal disease must cope with the demands of their occupation, the changes in their 
life roles, and the challenges and opportunities that life exposes them to while 
balancing the restrictions that chronic renal disease entails. It has been previously 
reported that socio-economic status has a significant impact on the incidence and 
treatment of end stage renal disease (ESRD) Socio-economic factors, such as low 
income, poor education, residence in a low-income areas, and consequently poor 
access to health care, are strong predictors for the development of ESRD (Norris 
& Agodoa 2005). Cukor et al. (Cukor et al.. 2007) have reported that socio-
economic status has a significant impact on the incidence and treatment of chronic 
renal disease. Herd et al. (Herd, Goesling, & House 2007) reported that 
socioeconomic position is not simply a determinant of health differences but 
-2(,+-)09)2)B:#&%26+&(2$)52#9+D)":)(,+9+)%0::+-+&5+9. 
Key evidence is that the relationship between socio-economic position and health 
has not changed over time even as the intervening links between the two have. 
While the major causes of mortality have changed over the 20th century, from 
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infectious disease to chronic conditions, socio-economic health disparities have 
either persisted or increased(Pappas et al.. 1993).  
What remains constant over time, across countries, and across individual lives is 
that socio-economic position shapes access to resources that help individuals 
avoid risk factors for disease and mortality(Phelan et al.. 2004) . 
PORD mothers were as likely to have a university entry level education or a 
higher educational degree compared to control mothers. 
Mothers of PORD children were more likely to be married than control mothers. 
This reflected that the study group were supported women who had mild to 
moderate renal disease which was well controlled. Several studies have 
demonstrated that social support is associated with improved outcomes and 
improved survival in several chronic illnesses, including cancer and end-stage 
renal disease (ESRD). The mechanism by which social support exerts its 
beneficial effects are unknown, but practical aid in achieving compliance, better 
access to health care, improved psychosocial as well as nutritional status and 
immune function, and decreased levels of stress may all play a role (Patel, 
Peterson, & Kimmel 2005). Nairman and colleagues (Naiman et al.. 
2007)reported that being married in the pre-transplant period was associated with 
positive outcome for the graft, but not for recipient survival. When stratified by 
gender, the effect was present in males but was not seen in females, where neither 
graft nor recipient survival had an association with marital status.  
 
The number mothers who smoked were fewer in the PORD group (none) 
compared to the control group. Current alcohol consumption was also less in 
mothers in the PORD group compared to mothers in the control group. Both 
smoking and alcohol consumption have been linked to reduced fertility. Thus this 
trend of reduced consumption of both alcohol and tobacco possibly reflects a 
lifestyle choice. Mothers with renal disease were already in a challenged situation, 
with ill health. It is more likely they will make healthier lifestyle choices; these 
may already have been promoted by their physicians. 
Fathers of PORD children had a trend towards being more likely to smoke, while 
alcohol consumption appeared to be less common in this group when compared to 
the control group. The size of the groups did not provide any statistically valid 
information. 
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5.1.2 Health of PO RD mothers in Pregnancy 
 
PORD mothers reported more illnesses and obstetric complications during 
pregnancy.  
Pregnancy complications are well documented in women with chronic renal 
disease depending on the severity of renal failure.(Chao et al..2002;Davison 
2001;Davison & Bailey 2003;Holley & Reddy 2003;Hou 1999;Hou 2001;Hou 
1994b;Jones & Hayslett 1996;Jungers et al.. 1997;Lindheimer et al.. 
2007;Okundaye et al.. 1998;Williams & Davison 2008). These range from raised 
blood pressure, proteinuria, urinary tract infection, polyhydramnios, deteriorating 
renal function, including significant rise of serum creatinine level, pre eclampsia 
and many suffer significant renal function loss during pregnancy, with an 
accelerated decline post-delivery. Mothers with renal transplants face added risks 
of graft rejection during pregnancy, graft dysfunction during pregnancy, which 
often persist post delivery sometimes leading to permanent graft loss. Bacterial 
and viral infections consequent to immunosuppression and toxic effects of 
immunosuppressant drugs are well reported in mothers who are transplant 
recipients (Report from EDTA1980;Armenti et al.. 1998;Bar etal. 1996;Davison 
& Bailey 2003;Fuchs et al.. 2007;McKay & Josephson 2006;Moon et al.. 
2000;Pahl et al. 1993;Sgro etal. 2002;Sibanda et al.. 2007;Thompson et al.. 
2003;Toma et al., 1999). Very little of the published data on illness and obstetric 
complications have been compared with a control group. The reported maternal 
complications in this study, though modest largely because of small number have 
shown similar complications reported in previous studies. Most important among 
these are hypertension pre- and post-pregnancy, recurrent urinary tract infections, 
and increased incidence of intervention in labour ranging from instrumental 
delivery to planned and emergency caesarean section. The increase incidence of 
illness and complications are accounted for by maternal renal disease and it was 
thus difficult to compare the significance of increased incidence of illnesses and 
obstetric complication between the two groups.  
 
The use of medication was also highest in the PORD group. The differences were 
mainly accounted for by use of immunosuppressant medications that mothers with 
renal transplant were on and also antihypertensive medication that is more 
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commonly used in mothers with renal function impairment. These medications 
were an integral part of the treatment of renal disease. The use of medications like 
common analgesics, antacids, antibiotics and vitamins were similar in each group. 
Smoking in pregnancy was low in both PORD and control mothers even though it 
was lowest in the PORD group. None of the mothers, either in PORD group or 
control group were reported to consume alcohol in pregnancy. This reflects 
lifestyle choices made by both groups of women. Whereas women with renal 
impairment were possibly advised by health care professionals and better 
motivated taking into account their difficult health condition, women who were 
otherwise well, also appeared to be making this a lifestyle choice. 
 
PORD mothers reported they were less likely to be supported by adults in 
pregnancy. This is apparently not in keeping with the fact that all renal mothers in 
the study were either married or cohabiting. However, the families with renal 
disease were from lower socioeconomic background and this could have affected 
the amount of social support available.  
 
The PORD mothers were less likely to have spontaneous onset of labour when 
compared with the control group of mothers. The incidence of induction of labour 
was also higher in the PORD group. Incidence of caesarean sections, planned and 
emergency was higher in the PORD group. The increased incidence of planned 
caesarean section possibly reflects a cautious approach to the management of high 
risk pregnancy. The number of emergency caesarean section was also higher in 
the PORD group. This is likely to reflect maternal complications such as rising 
blood pressure often leading to pre-eclampsia, intrauterine growth restriction, 
deteriorating renal function, premature onset of labour and also fetal 
complications such as poor growth and fetal distress. There was also significantly 
higher number of instrumental deliveries in the PORD group. This reflects the 
increased level of interventions that mothers with renal disease received at 
delivery. Control mothers were most likely to have normal vaginal delivery. There 
are several studies which report increased caesarean section and instrumental 
deliveries in mothers with chronic renal disease.(Davison 2001;Holley & Reddy 
2003;Hou 2001;Lindheimer et al.. 2007;Sibanda et al..e 2007;Thompson et al.. 
2003;Toma et al.. 1999;Williams & Davison 2008). 
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5.1.3 Neonatal results 
 
PORD babies were more likely to be born after a caesarean section (planned and 
emergency) and control babies were more likely to be born by normal (non- 
instrumental) vaginal delivery. It has been discussed earlier that there is a well-
documented increase in the rate of caesarean section in pregnant mothers with 
renal disease. 
The PORD group of infants had a significant lower gestational age and higher 
proportion with gestation age less than 37 weeks, (p<0.01). The PORD group also 
had lower birth weight, and higher proportion with birth weight less than 2500g. 
Previous studies have reported an increase in prematurity and lower birth weight 
in children born to mothers with renal disease. (Davison 2001;Holley & Reddy 
2003;Hou 2001;Lindheimer et al.. 2007;Sibanda et al.. 2007;Thompson et al., 
2003;Toma et al.. 1999;Williams & Davison 2008). A lot of the infants in this 
study were late preterm infants (34-36 weeks gestation). Research in neonatology 
so far has looked into epidemiological, clinical and follow-up aspects of very low 
birth weight newborns who usually have a gestational age less than 34 weeks and 
high morbidity and mortality rates. Only recently has attention turned to the issues 
of preterm infants with higher gestational ages and the expression 'late preterm' 
has been adopted to classify newborns with gestational ages between 340/7 and 
366/7 weeks (Escobar et al.. 2006). 
PORD children were more likely to require resuscitation after birth when 
compared to the control group, though the difference was not statistically 
significant. There is a correlation between caesarean section, prematurity and 
increase in requirement for resuscitation. Parents of PORD children and the 
medical staff responsible for managing the pregnancy may be more anxious about 
the outcome and intervene in labour at an earlier stage or plan delivery by 
caesarean section. Many previous studies (Alsaran & Sabry 2008;Davison & 
Bailey 2003;Holley & Reddy 2003;Hou 2001;Moon et al.. 2000;Okundaye et al.., 
1998;Reddy & Holley 2007;Sgro et al.., 2002;Sibanda et al.. 2007;Thompson et 
al.. 2003;Toma et al.. 1999;Williams & Davison 2008) have reported the 
increased incidence of premature birth and subsequent admission to a neonatal 
unit. Pregnancies in mothers with renal disease are often complicated by maternal 
 133 
high blood pressure, pre-eclampsia and eclampsia, deteriorating maternal renal 
function, compromised graft function of transplanted kidneys, IUGR, poor 
placental function and pre-term labour. It is obvious that in such situations there 
may be a need to intervene and thus the increased incidence of preterm labour, 
prematurity and increase in resuscitation. A recent study from Brazil by de 
Almeida and colleagues (de Almeida et al.. 2007) reported that the chance of 
needing any resuscitative procedure were twice as high in the late preterm group 
compared with the full term group. They also go on to report, that with other 
variables controlled for, being a late preterm infant doubles the chance of 
receiving bag and mask ventilation in the delivery room (de Almeida et al., 2007). 
This group has been identified as a high risk group, who are more likely to receive 
resuscitative facilities in the immediate neonatal life. A significant proportion 
(8%) of this group required supplemental oxygen support for at least 1 hour, 
2$6"9()W)(06+9)(,+)-2(+):"#&%)0&)0&:2&(9)*"-&)2()\)Wm)!++A9)(Escobar et al., 2006). 
 
In this study the proportion of babies admitted to the neonatal unit was different in 
the two groups. 8 babies (33%) born after PORD were admitted to the neonatal 
unit compared to 3 babies in the control group (8%). This difference was 
significant, p<0.01.  
The number of days spent in the neonatal unit appeared to differ in the two groups 
but there were inadequate numbers to compare the significance of stay in neonatal 
#&0()0&)(+-69)":)$+&1(,)":)9(27)\)m)%279.) 
Ventilation appeared more common in the PORD group. Four babies (17%) born 
in the PORD group were ventilated, compared to one (3%) in the control group. 
The difference was approaching significance (p=0.052). Two of the babies in the 
PORD group were ventilated for 1 and 2 days respectively because of 
prematurity. The ventilatory support required was minimal. The other two babies 
were ventilated for 15 and 30 days. These two babies were premature and had 
respiratory distress and sepsis. The baby in the control group who was ventilated 
was delivered prematurely at 31 weeks by emergency section secondary to 
maternal placental abruption and was only ventilated for half a day. These 
findings agree several previous studies where premature babies were more 
commonly ventilated compared with controls. 
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Reasons for admission to a neonatal unit included a range of common neonatal 
problems. There was difference between the two groups. In the control group 10 
(27%) of babies had documented neonatal illness compared to 3 (12.5%) babies in 
the PORD group. The types of illnesses that affected the children as neonates also 
varied. In view of the fact that there was no increase in neonatal illness in the 
PORD group (actually there were fewer reported neonatal illnesses), the increased 
admission to the neonatal unit is most likely due to the increase in prematurity and 
its effects. It may also simply reflect increased parental and/or physician anxiety. 
The number of children in the study was too few to provide statistically robust 
outcome data. 
 
Mothers from the PORD group were less likely to exclusively breastfeed their 
babies than mothers from the control group. Nine (39%) mothers from the PORD 
group did not exclusively breast feed compared to 4 (11%) mothers in the control 
group, p <0.01. 
Of the mothers who chose to breast feed, the length of exclusive breast-feeding 
was similar between groups. One of the most common reasons for this is that a lot 
of the mothers with renal disease (especially the transplant recipients) were often 
strongly advised against breast-feeding, because of the medications they were on. 
The European Best Practice Guidelines (2002) (European Best Practice 
Guidelines 2002a)recommends that immunosuppressive therapy based on 
cyclosporine or tacrolimus with or without steroids and azathioprine may be 
continued in renal transplant women during pregnancy. Because of drug transfer 
into maternal milk, breast feeding is not recommended. A case report by Munoz-
Flores-Thiagarajan (Munoz-Flores-Thiagarajan et al.. 2001), reports that an infant 
of a cyclosporine treated mother was breast-fed exclusively during the first 10.5 
months of life and did not absorb a detectable amount of the drug. Fetal growth 
and development were normal. Moretii et al. (Moretti et al.. 2003)(2003) reported 
that during recent years, cases of uneventful pregnancies and subsequent 
successful breast-feeding have been reported in women on cyclosporine therapy. 
T,+) 0&:2&('9)*$""%)575$"9G"-0&+)5"&5+&(-2(0"&),29)#9#2$$7)*++&)8+-7) $"!.)H29+%)
on these findings and the lack of detectable adverse effects, some investigators 
have suggested that women on cyclosporine may breast-feed; challenging the 
conventional view that cyclosporine is contraindicated during breast-feeding. 
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Similarly possible safety of tacrolimus while breast feeding in transplant recipient 
mothers have been reported in several studies (French et al.. 2003;Gardiner & 
Begg 2006). Based on these findings and the lack of clinically evident adverse 
effects, the conventional view that most immunosuppressants used in transplant 
recipient mothers is contraindicated during breast-feeding, has been challenged 
(Nyberg et al.. 1998;Thiru, Bateman, & Coulthard 1997). However, Moretti et al. 
(Moretti et al.. 2006)also states that whether breast-feeding exposure, and 
intrauterine exposure, to immunosuppressants like cyclosporine and tacrolimus 
alters the immunologic function of the infants awaits further study. The CARI 
guidelines (Grimer 2007) also supports the findings that levels of 
immunosuppressant medication in breast milk and in infant serum is low and thus 
many investigators are continuing the medications but there are no clear 
guidelines as to whether the risk to the infant in breast-feeding is low enough to 
justify the potential benefits of breast feeding. The most recent report from the 
National Transplantation Pregnancy Registry (NTPR) by Armenti et al. (Armenti 
et al.. 2005) stated that breast feeding for female transplant recipient mothers 
remains an area where recommendations are evolving. The report stated that 
mothers were on Sandimmune, Neoral, Tacrolimus for durations ranging from a 
few days or weeks to one to two years. At last follow up there were no reports of 
problems related to breast feeding in the children. In 1987 B L Asselin (Asselin & 
Lawrence 1987)suggested that mothers who have normal or mildly decreased 
renal function can breast feed successfully, whereas mothers with moderate renal 
insufficiency can breast feed if infant and mother were well enough in stable 
condition, thus raising a possibility that there was a risk that health of mother and 
infant might be at risk. Asselin (Asselin & Lawrence 1987)stated that mothers 
with severe renal insufficiency should not breast feed. However, the author 
suggested that renal transplant mothers most like produced immuno-competent 
milk and very little azathioprine was present in breast milk. It was reported that 
the mothers on antihypertensive medication can also successfully breast feed if 
their management is fine tuned (Asselin & Lawrence 1987). Still decades later 
1#0%+$0&+9)2-+)9$"!$7)5,2&10&1)"-),28+&'()5,2&1+%.)T,+)?6+-052&)?99"502(0"&)":)
Paediatrics supports breast feeding in mothers on prednisolone, advises against 
breast feeding by those on cyclosporine and provides no recommendations 
regarding tacrolimus and azathioprine (McKay & Josephson 2006). 
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Previous studies have shown that mothers who were excluded from breast feeding 
often found it difficult to adjust to and most would actually have breast fed. This 
627) ,28+) 2::+5(+%) (,2() !"6+&'9) G+-5+G(0"&) ":) ,+-) 6"(,+-0&1) 9A0$$9) :#-(,+-)
increasing the anxieties which are commonly associated with chronic illness 
(Cukor et al.. 2007;Willis et al.. 2000).Thus in the current climate of promotion of 
breast feeding and also due to social pressures more and more mothers on 
immunosuppressants will choose to breast feed. 
 Another reason for reduction in exclusive breast feeding in the PORD group 
could be due to difficulties in establishing breast feeding after caesarean section 
(Dewey et al.. 2003a). Some of the mothers were unwell after pregnancy and 
found it difficult to establish breast feeding. Practical difficulties such as mother 
being admitted to the hospital ward, high dependency unit and intensive care unit 
may affect breast feeding. Often these areas are not geared to promote ideal breast 
feeding practices. Many of the babies born in the PORD group were premature 
and admitted to a neonatal intensive care unit. Maternal ill health together with 
babies being admitted to the neonatal unit often prevents bonding and may lead to 
difficulties establishing breast feeding. Breastfeeding a premature infant can be an 
additional challenge for a mother. Initiation of breast feeding is often delayed in 
preterm babies. Successful breastfeeding of these infants also depends on many 
other factors, including the mother's physical capacity to produce milk (mothers ill 
health often being an important cause of inadequate milk), and the family, 
institutional and nursing assistance received. 
 
5.1.4 Physical assessments 
 
Hospital admissions after the neonatal period were similar in the PORD group 
compared to the control group. This reflects that children born to mothers with 
renal disease were in no way more prone to illness when compared with controls. 
This finding is supported by data from a previous study by Korsch et al. (Korsch 
et al.. 1980)where health of children born to mothers with renal disease during the 
first year of life was reported as excellent with no documented unusual 
intercurrent illnesses, metabolic disorders or other physical problems. In another 
follow up study of children born to renal transplant mothers, Willis and colleagues 
(Willis et al.., 2000)reported no abnormal medical illnesses. Only minor 
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childhood problems like otitis, urinary tract infection, tonsillitis and a minor 
squint not requiring surgery were reported. None of these studies compared the 
renal children with a control group. There is no published follow up data relating 
to children who are born to mothers with different levels of renal impairment but 
not transplanted. The present study included 16 women whose renal function 
varied from near normal to mild to moderate impairment. Previous studies do not 
report any follow up data regarding children born to women with renal disease. 
 
Frequencies of illnesses reported by parents were higher in the control group. 
Korsch (Korsch et al.. 1980) reported that parents with renal disease were more 
inclined to seek immediate medical attention for minor illnesses in their children, 
*29+%)"&)(,+)BG,0$"9"G,7)":)(2A0&1)&")5,2&5+9D.)o0$$09)2&%)5"$$+21#+9)(Willis et 
al.. 2000) in their follow up study reported increased maternal anxiety about their 
5,0$%-+&'9) ,+2$(,.) d#-) 9(#%7) :0&%0&19) 2-+) %09(0&5($7) %0::+-+&() :-"6) (,+9+) (!")
previous studies. However both the previous studies involved renal transplant 
mothers and their children, while our study mothers had different levels of renal 
function impairment. It is possible that renal transplantation is associated with 
increased maternal worry compared to our mixed group of patients. Illnesses were 
classified into respiratory tract infections, common childhood infections, fractured 
bones, gastrointestinal, atopic (eczema and asthma) and other illnesses. Of these, 
there was trend towards control group children having more atopic illness, 
chicken pox, common childhood infections and fractured bones than the PORD 
group. This trend was not significant. It is possible that there were subtle 
differences relate to differing parental attitudes to reporting illnesses. Childhood 
medications were similar between the groups. This further supports previous 
9#11+9(0"&9)(,2()(,+-+)09)&")0&5-+29+)0&)(,+)#9+)":)6+%052(0"&9)0&)I^dYF')5,0$%-+&.)
This could be objectively viewed as evidence that children from both groups had 
similar rates of illness. 
There was no difference between the two groups in need for surgery.  
Findings of general examination of both the groups did not reveal any major 
abnormalities. Three control group children had undescended testes, 
asymptomatic tight foreskin and eczema respectively. Two children from the 
PORD group had mild eczema. 
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Findings from previous studies of follow up of children of renal transplant are 
summarised in table 2.17. A study by Willis et al. in 2000 looked into the physical 
status and developmental outcome of children born to mothers following renal 
transpalntation (Willis et al.., 2000). This was a cross-sectional, partially 
controlled cohort survey of 48 children born to 34 women transplanted at a single 
centre from 1971 to 1992. Data on maternal renal disease, immunosuppression, 
pregnancy, delivery and child development were collected using hospital records 
and parental questionnaire. Children underwent physical examination, urinalysis 
and urinary tract ultrasound examination (US). The developmental assessments 
considered the child's developmental milestones, scholastic and educational 
achievement. A single urine sample was collected for routine urinalysis, and if 
abnormal, for microscopy and bacteriological examination. Ultrasound 
examination of the child's urinary tract was performed by the one 
ultrasonographer (one of the investigators). Micturating cystourethrograms 
(MCUG) were not performed due to their invasive nature and to the wide age 
range of the children studied. This was the only study which has looked into the 
long term outcome of the children born to mothers with renal transplant. The 
authors concluded that the neonatal outcomes were generally good in the  study 
group despite the high incidence of risk factors such as prematurity and growth 
retardation. The authors were unable to identify any pattern of fetal abnormalities 
related to the use of maternal corticosteroids, azathioprine or cyclosporin A. 
However the possibility of further problems remains. The children in the study 
though born premature and small demonstarted good catch up growth. The 
authors thus concluded that postnatal progress was not adversely affected by 
maternal renal function or maternal immune suppressive medication. Child 
development and general health were normal in the study group but there was no 
direct control group to compare. However this study raises numerous 
psychological issues arising in families where the mother has undergone renal 
transplantation, which may influence the development of a child. These issues 
may be of great significance but have so far not been highlighted in any published 
studies. Barbara Korsch et al. from the Dialysis and Transplant Programme at the 
`,0$%-+&'9) a"9G0(2$) ":) c"9) ?&1+$+9) G#*$09,+%) 2) 9(#%7) 0&) OKLh) ":) G,79052$) 2&%)
psychological follow-up of offspring of renal allograft recipients (Korsch et al.., 
1980) All ten children were in good health at the time of follow up. Growth in all 
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the children was normal. Results of the developmental tests show that all children 
tested were within the normal range 
There are some important observations available from the interviews with families 
relating to parenting from this study: 
a. The majority of children were developing normally without any obvious 
behavioral problems. 
b. Their upbringing was not affected by the graft recipient status of their 
parent. 
c. Parents noted that there was a trend to seek immediate medical attention 
for minor illnesses in their c,0$%-+&)B*29+%)"&)2)G,0$"9"G,7)":)(2A0&1)&")
chances 
The findings in this study are very similar though the mothers had different 
degrees of renal impairment and not only renal transplant. 
 
5.1.5 G rowth  
There were no differences between the groups for growth in terms of actual height 
in cms and weight in kgs and centiles. In the PORD group the mean weight in 
kilograms (SD) was 16.98 (7.67) while that for the control group was 15.34 
(4.23), not reaching statistical significance. In the PORD group the mean height in 
centimetres (SD) was 99.55 (21.34) while that for the control group was 97.72 
(13.79), which were not statistically significant. Sgro et al. (2002) (Sgro et al.. 
2002)reported that the children born to renal transplant recipient mothers were 
significantly heavier for age, and were also significantly shorter for age compared 
to the control group. Willis et al. reported that current height and weight was on 
the 50th centile. Korsch et al. (Korsch et al.. 1980)reported that three children 
were below 25th centile for weight but all were above 25th centile for height. It is 
difficult to compare the current study data with those mentioned mainly because 
they studied a select group of children born to renal transplant recipient mothers 
and also the age range at assessment varied. 
 
5.1.6 Congenital malformation 
 
There was no reported congenital malformation, major or minor either in the 
PORD or the control group. This was most likely because of the small sample 
size. Follow up studies by Sgro et al. (2002)(Sgro et al..  2002) and Willis et al. 
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(2000) (Willis et al.. 2000) reported some minor and major congenital anomalies. 
Sgro et al. (Sgro et al.. 2002)reported bilateral clubfeet, imperforate anus and 
hypospadias (all in a single child) and Willis et al. reported epigastric hernia, 
hydrocoele, cystic hygroma, claw hand, obstructive uropathy, pulmonary 
hypoplasia and hydronephrosis. Korsh et al. (Korsch et al.. 1980)did not report 
any anomalies in their series. 
 
5.1.7 G riffiths Mental Developmental Scales 
 
The data indicated that there was little difference between the groups .The mean 
Griffiths quotient was 106.29 (SD 18.48) for the PORD group and 105.65 (SD 
11.60) for the control group which were both within the normal range, and did not 
differ significantly. Sgro et al. (2002) (Sgro et al.. 2002)in their series assessed 
development using the Denver Development Screening Test. Some families who 
were unable to attend were interviewed over the phone, with the actual children 
not being directly assessed. They reported one child with moderate to severe 
hearing loss (requiring a hearing aid), one child with learning disability and one 
with pervasive developmental disorder. Willis et al.(Willis et al.. 2000) mentioned 
that 98% of their series had normal development (details of assessment not stated 
in the report). The single child with developmental delay in their series was one of 
(,+)(-0G$+(9)!0(,)5+-+*-2$)G2$97.)T,+)5,0$%-+&'9)%+8+$"G6+&()0&)(,+)9(#%7)*7)p"-9,)
et al. (1980) (Korsch et al.. 1980) was carried by a specialist in assessing child 
development. The Stanford-Binet test was used for the two oldest children and 
Gesell Developmental schedules and Bayley Scales of Infant Development was 
used for children under 30months of age. All children tested were within the 
normal range. 
 
5.1.8 Child and Family Relationships 
 
1. Parental questionnaires to assess family functioning 
 
Overall there were 4 sets of missing questionnaires. This was an 83 % response 
rate amongst those who attended. This reflects a good response rate for returning 
of questionnaires. The questionnaires were sent to the parents at least a week prior 
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to the appointment and collected from the parents at the appointment. This 
seemed a practically reliable method of collecting the questionnaires. Recent 
studies by Edwards et al. report that contacting participants before sending 
questionnaires and follow up contact significantly increased response rates 
(Edwards et al.. 2002;Edwards et al.. 2007). The high response rate from both the 
groups may be a courtesy effect: the parents of PORD children were willing to 
cooperate because of the medical support provided by hospitals and the parents of 
the control group were willing because their child received a thorough paediatric 
assessment. 
 
2. Analysis  
 
The power analysis for the PORD study indicated that the likelihood of detecting 
any differences or association would be low. Individual t-tests and chi-squares 
were employed, as the power of larger multivariate test would be too low. 
Therefore caution should be exercised in the interpretation of the PORD results as 
the low power may lead to a Type II error (failing to find a significant effect that 
exists in the population) and the multiple tests may lead to a Type I error (finding 
a significant effect due to chance). 
 
3. Child socio emotional behaviour 
 
a. The Child behaviour check list (C B C L) 1 ½ - 5 and 6-18 
 
The Child behaviour check list (CBCL) 1 ½ - 5 and 6-18 which provides a 
9(2&%2-%09+%) -2(0&1) 2&%) %+95-0G(08+) %+(20$9) ":) 5,0$%-+&'9) :#&5(0"&0&1) 29) 9++&) *7)
parents showed significant differences between the PORD and the control group. 
The mothers in the PORD group reported a significantly higher perception of 
externalising problems like rule breaking and aggressive behaviour in their 
children. The PORD mothers also reported a significantly higher perception of 
other problems when compared with the control group. The total scores of the 
CBCL were also higher in the PORD group reflecting that these mothers 
G+-5+08+%)%0::05#$(0+9)0&)(,+0-)5,0$%-+&'9):#&5(0"&0&1)6"-+)5"66"&$7.)T,+)926G$+)
size of the study was not large enough to provide any statistically significant data, 
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however the finding is interesting as one of the hypotheses of the study was that 
there would be greater occurrence of difficult temperament and emotional or 
behavioural problems in children born to mothers with chronic renal disease 
. 
b. Carey Temperament Scales 
 
The Carey Temperament scales did not report any difference in child 
temperamental characteristics perceived by mothers in either group. Thus the 
mothers with chronic renal illness, in spite of stresses of their illness did not 
perceive their children any differently from mothers who were well. Previous 
studies have also suggested that child temperament development is not 
significantly affected by parental ill health.  
Chronic illness is highly prevalent among adults many of whom have children and 
parental illness may or may not have an impact on affected families. The existing 
literature has provided a framework for how parental illness may influence child 
functioning and normal development (Armsden & Lewis 1993;Rolland 1999). 
Controlled studies examining functional outcomes for children whose parents had 
either a chronic or acute medical illness have yielded mixed results. Hirsch et al. 
(Hirsch, Moos, & Reischl 1985)found that children with an arthritic parent had 
poorer self-esteem than controls but displayed no differences on measures of 
psychiatric symptoms or adjustment. Harris and Zakowski (Harris & Zakowski 
2003) found no differences between children with or without a parent who had 
cancer. As expected, more pronounced differences have been demonstrated for 
children with terminally ill parents (Siegel 1992). Armistead et al. (Armistead, 
Klein, & Forehand 1995) concluded that parental illness does influence child 
functioning and may be particularly associated with internalizing symptoms. 
However, differences between children with and without a sick parent are small 
such that children with sick parents appear within normal limits on measures of 
outcome (Steele, Forehand, & Armistead 1997) .  
Findings thus far have suggested that differences between children with and 
without a sick parent are minimal, but there are individual and familial moderators 
of outcome. Potential moderators of differences included maternal distress, 
parenting variables (aggravation and warmth), functional impairment related to 
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illness, and demographic characteristics. (Annunziato, Rakotomihamina, & 
Rubacka 2007). 
 
4. Parental well being and family functioning 
 
No significant differences were found on the three Parental Stress Index subscales 
and total scores. There was also no difference in the total GHQ scores. Thus so far 
contrary to our expectations mothers with chronic renal disease seem to cope with 
the extra stresses of chronic illness without evidence of ill effects on their well 
being and relationships. 
It was a reassuring finding that chronically ill mothers were facing up to 
challenges of parenthood as ably as well mothers. 
 
Parent –child relationship 
 
There was no difference in the overall and subscale scores of Parental acceptance 
rejection scores between the PORD and control groups. 
The extent, kind and timing of incapacitation faced by the mother will affect the 
degree of family stress. Outcome of the illness that the woman is suffering from is 
also closely related to the family functioning. The course of any chronic illness 
can be progressive, constant and relapsing/episodic. Families are stressed with 
both the frequency of transition between crisis and non-crisis and children 
particularly are affected by the uncertainty of the course and outcome of maternal 
health. The women with chronic illness are themselves sufferers of the above 
stresses and anxieties. 
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health) and threat of loss despite very few actually communicating such fears and 
worries (Rolland 1999). 
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5.1.9 Strengths of the study 
 
1. Comparison groups  
 
Two groups were chosen, the children born after maternal chronic renal disease 
(PORD) and a control group of children born to mothers who did not have any 
-+G"-(+%)-+&2$)06G20-6+&(.)T,+)5"&(-"$)1-"#G)G-"80%+%)2)9(2&%2-%)":)I&"-62$')*7)
which to compare the PORD children. These children were from the same 
geographical area and in this way attention can also be given to the family 
structure and educational status of the parents. 
 
2. Outcome measures 
 
The developmental assessment used in this study was the Griffiths Mental 
Development Scales from birth to 2 years (1996 Revision) and the Griffiths 
Mental Development Scales from birth to eight years (1984). The Griffiths Mental 
Development Scales from birth to 2 years re-standardised in the United Kingdom 
in 1996 to reflect the child rearing practices, social habits, racial groupings and 
other socio-demographic factors pertinent to modern day Britain. The extended 2-
8 years Griffiths scales (subsequently published) were undergoing the most recent 
update and re-standardising for a fairly long time and was not used in this study 
due to delays in publication of the latest testing scales and validation of data. The 
project would be delayed if the latest scales were to be used. 
 
3. Single paediatrician 
 
All the children were assessed by the same paediatrician (IB), providing 
consistency in assessments and negating the inter observer bias. 
 
4. Personal contact and advice lines 
 
After the assessments the parents had a chance to discuss any queries or definite 
concerns with a paediatrician. The parents appreciated this and many were 
reassured. It is worth noting that families who participated in this preliminary 
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study expressed gratitude that their child had been formally assessed indicating an 
unfulfilled medical need, which is likely to provide an acceptable participation 
rate for larger studies- always a challenge in research of this nature. 
 
5. The nature of the study 
 
This preliminary study was the first detailed control matched study published on 
children born to mothers with chronic renal disease. Although the number of cases 
is small the study does provide provisional reassurance that these children do not 
have any overt problems over and above those known to be a risk from being born 
early and with a low birth weight. This preliminary study showed that the 
methodology is viable to assess a larger group of children. 
 
5.1.10 Weaknesses of the study 
 
1. Participation rate 
 
Of the initial 80 children found to be eligible only 35 (44%) responded to the 
invite and finally 24 (30%) of the eligible children were assessed. We identified 
this weakness at the study progressed. The following reasons were possibly 
responsible: 
 
 11 families (14%) even though they responded initially, later did not 
participate. Restriction s on the ethical approval meant we were not 
allowed to investigate reasons of non participation but some mothers wrote 
that even though they saw the need for the research and morally agreed 
they personally found it not suitable to participate. There is a possibility 
that these mothers had a worry about the consequences of their illness on 
the child and did not want to know about it any further. It is also possible 
that they perceived their children as well and did not want to delve any 
deeper into the issues in case a problem did emerge. Every effort was 
made to contact these families, to arrange discussions which might have 
cleared doubts and fears but it was often practically difficult to do so. 
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 Families were less reluctant to reply to an invitation from a Paediatric 
department with whom they had no contact. It was thus felt that an 
invitation from the Renal team would be more appropriate. But 
endeavours at working on this failed due to a severe shortage of man 
power in the renal team and it proved not possible to go forward with this 
plan. 
 Some families were under the care of the Renal team as their tertiary care 
centre and were still mainly under their local hospital on a shared care 
basis. They were attending the Royal Free Hospital only for annual or 
biannual follow up. Such families found it difficult to attend appointments 
even if flexibility of venue, date and time were provided. 
 
2. Observer bias 
 
The paediatrician was not blinded to the maternal disease status. This was for 
practical administrative reasons. At the conception of the study it was thought that 
recruitment could be organised by a renal research nurse. For practical difficulties 
this was not possible to organise. The paediatrician was involved in recruitment of 
children in to the study and arranged appointments. Although the paediatrician 
examined and assessed the children in a standardised manner, it would have been 
more ideal if the paediatrician was also blinded to the maternal disease status. 
However the lack of blinding did give the paediatrician the chance to discuss and 
2%805+)G2-+&(9)!,"),2%)9G+50:05)5"&5+-&9)2*"#()(,+0-)5,0$%'9),+2$(,. 
 
3. Missing cases 
 
An attempt was made to collect information from all families that had been 
recruited, but did not attend. However, in a proportion of cases, families were 
either uncontactable due to change of address or contact details or the family 
declined to participate. Due to ethical constraints we were not able to ascertain 
causes of non participation. Families who had shown interest initially were often 
unable to attend due to the distance they required to travel; the family sometimes 
%0%&'()2((+&%)6#tually arranged appointments, mother giving birth to new baby in 
family, ill health of mother and/or child etc.  
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4. Sample size 
 
The sample size was small and was not adequate to obtain statistically reliable 
outcomes for most of the outcomes measured. Although the study was not 
adequately powered for definite conclusions, it nevertheless provided reassuring 
data that there was no evidence in the children born to mothers with chronic renal 
disease of major health concerns, effects on the mother child relationship or 
neurodevelopment scoring. It also provides a possible model for future studies. 
 
5. G rowth data 
The children were assessed at different ages and thus there was the variability of 
difference of age at assessment. This could have been overcome by a common 
statistical way of standardising data on one scale so a comparison could take 
place. One way to achieve this was to use z-score so that the variability of 
assessment at different age could be overcome. 
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5.2 Discussion for PG D study 
 
5.2.1 Matching and socio demographic details of study families 
 
Maternal and paternal ages were higher in the PGD group than the control 
parents. This is not surprising as many parents who seek assistance to conceive 
will have had a period of unsuccessful attempts to conceive naturally before 
treatment will be considered. It is also well recognised that older mothers have 
reduced fertility and may be more likely to require assistance to conceive. There 
is a definite increase in the number of women bearing children in the 30- and 40-
year-old age groups. In the United States this is projected to increase 42% and the 
percent of births to this age group is projected to increase 37%. This is apparently 
because of a trend to postpone childbearing and first birth due to women's career 
priorities, advanced education, control over fertility, financial concerns, late and 
second marriages, and infertility. Associated with this is an increase in visits to 
fertility specialists by older women who have an intrinsic decrease in fecundity 
with advancing age(Gindoff & Jewelewicz 1986;Lansac 1995). 
The majority of PGD parents were from social class higher than Class 3. This 
finding has been noted before (Bowen et al.. 1998;Sutcliffe et al.. 2001). The 
social class of parents of control group in this study was well matched. There was 
no difference between groups for social class of mothers or fathers. Control group 
mothers were as likely to have a university entry level education and higher 
educational qualifications as PGD mothers. 
Mothers of PGD children were more likely to be married than control mothers. 
Couples are not usually offered investigations for fertility unless they have had at 
least one year of failure to conceive naturally. Parents who are subsequently 
investigated and conceive after assisted reproductive techniques are thus more 
likely to be in a stable relationship compared with parents who conceived 
naturally. 
The number of mothers who smoked was fewer in the PGD group (none) 
compared to the control group. Current alcohol consumption was also less in the 
mothers in the PGD group compared to the mothers in the control group. Both 
smoking and alcohol consumption has been linked to reduced fertility. Thus this 
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trend of reduced consumption of both alcohol and tobacco possibly reflects a 
lifestyle choice.  
There was no significant difference between the numbers of children that the 
fathers in each group had from previous relationships. However, there was a trend 
towards PGD fathers having two or more children from previous relationships. 
Fathers of PGD children were more likely to consume alcohol, while smoking 
was less common in this group when compared to the control group. Smoking in 
males has been demonstrated to reduce fertility (Hassan & Killick 2004). While 
the reduced smoking possibly reflects a lifestyle choice made by the PGD fathers, 
an increased alcohol consumption has been reported in previous studies (Peters 
2005).  
 
5.2.2 Health of PG D mothers in Pregnancy 
 
PGD mothers reported more illnesses and obstetric complications during 
pregnancy. This increase can be accounted for by ovarian hyperstimulation 
syndrome. This syndrome is recognised to be a complication of the assisted 
reproductive technology (ART) procedures to stimulate egg development 
(Olivennes 2003). Thus it is not possible to compare the incidence of these 
symptoms in the PGD mother when compared with the naturally conceived group. 
Even though placenta praevia and associated increased incidence of bleeding is a 
recognised complication of embryo implantation processes (Love & Wallace 
1996;Romundstad et al.. 2006;Tan et al.. 1992;Verlaenen et al.. 1995) it was not 
reported in this study. This perhaps reflected the relatively small number of cases. 
Previous studies have also reported an increase in vaginal bleeding and 
hypertension ( 2008;Romundstad et al.. 2006;Tan et al.. 1992), but no increase in 
hypertension was found in this study.  
The use of medication was also highest in the PGD group. The differences were 
mainly accounted for by use of progesterone, aspirin, steroids (hydrocortisone and 
prednisolone), heparin and immunoglobulins. These medications were an 
integrated part of the IVF cycles. The use of medications like common analgesics, 
antacids, antibiotics and vitamins were similar in each group. 
Smoking in pregnancy was low in both PGD and control mothers even though it 
was lowest in the PGD group. None of the PGD mothers were reported to 
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consume alcohol in pregnancy. The rate in the control group was 16.6%. This 
possibly reflected the desire of the PGD group of mothers to create an optimal 
+&80-"&6+&() :"-) 2) G-+1&2&57C)!,05,)!"#$%&'() *+) 9#-G-090&1) (2A0&1) 0&(") 255"#&()
the history of infertility. 
PGD mothers were more likely to be supported by adults in pregnancy. This could 
be related to the fact that more mothers in the PGD group were married. It might 
be that members of stable social support network are more eager to help couples 
with already a difficult history of infertility.  
The PGD mothers were less likely to have spontaneous onset of labour when 
compared with the control group of mothers. The incidence of labour being 
induced was not different. Incidence of caesarean sections, planned and 
emergency was higher in the PGD group. The incidence of planned caesarean 
section was particularly high possibly reflecting a cautious approach to the 
management of high risk pregnancy. There was no significant difference in 
occurrence of instrumental deliveries. Control mothers were most likely to have a 
normal vaginal delivery. An increased rate of caesarean section after IVF has been 
reported in several studies ( 2008;Allen et al.. 2006;Buckett et al.. 2007;Dhont et 
al..1999;Romundstad et al.. 2006;Sermon et al.. 2007), but this increase in 
emergency section and dysfunctional labour may be secondary to the increased 
maternal age in the ART groups rather than the assisted reproductive process per 
se (Berkowitz et al.. 1990;Cohen, Newman, & Friedman 1980). However, some 
studies where maternal age was controlled for, still report increased incidence of 
caesarean section (Maman et al.. 1998;Ochsenkuhn et al.. 2003;Reubinoff et al.. 
1997), so this finding might reflect obstetric (over)-caution. 
 
5.2.3 Neonatal results 
 
PGD babies were more likely to be born after a caesarean section: planned and 
emergency and control babies were more likely to be born by normal (non- 
instrumental) vaginal delivery. As discussed earlier there is a well documented 
increase in the rate of caesarean section after IVF. 
The PGD group had a significant lower gestational age and higher number with 
gestation age less than 37 weeks, (p=0.01). The PGD group also had lower birth 
weight, and higher proportion with birth weight less than 2500g. Previous studies 
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have reported an increase in prematurity and lower birth weight in children born 
after ART ( 2008;Dhont et al.. 1999;Gissler & Hemminki 1996;Koivurova et al.. 
2002a;Leslie et al.. 1998;Petersen et al.. 1995;Wennerholm & Bergh 2000). 
PGD children were not more likely to require resuscitation after birth when 
compared to the control group. It is possible there is a correlation between the 
increase in caesarean section and the decreased need for resuscitation in this 
group. Parents of PGD children and the medical staff responsible for managing 
the pregnancy may be more anxious about the outcome and intervene in labour at 
an earlier stage or plan delivery by caesarean section. There is a possibility that 
this cautious approach negated the need for later resuscitation. The number of 
babies admitted to the neonatal unit was different in the two groups. 8 babies 
(16%) born after PGD were admitted to the neonatal unit compared to 7 babies in 
the control group (10.6%). This difference was not statistically significant p = 
0.391. The number of days spent in the neonatal unit did not differ between the 
two groups. There were inadequate numbers in the two groups to compare the 
significance of $+&1(,)":)9(27)":)\)m)%279)0&)&+"&2(2$)#&0(9.)>+5,2&052$)8+&(0$2(0"&)
occurred more commonly in the control group; however the difference was not 
significant. Two babies (4%) born after PGD were ventilated; one was ventilated 
for 4 days because of septicaemia and meningitis and the second because of 
meconium aspiration — the duration could not be recalled by the parents. Three 
babies in the control group was ventilated, one for transient tachypnoea of the new 
born (TTN) (duration not recalled), one for meconium aspiration for 5 hours and 
the last could not recall the duration or the reason for ventilation. Reasons for 
admission to the neonatal unit included a range of common neonatal problems. 
There was no difference seen between the groups. The types of illnesses that 
affected the children as neonates were also varied. These illnesses did not 
necessarily require admission to the neonatal unit. In view of the fact that there 
was no increase in neonatal illness in the PGD group the increased admission to 
the neonatal unit may simply reflect an increase in parental or physician anxiety. 
Even though the study was not powered by significant numbers the findings 
support a previous study that also found no difference in neonatal outcomes 
between IVF and naturally conceived children (Leslie et al.. 1998). 
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Mothers from the PGD group were more likely to begin exclusive breastfeeding 
of their babies than mothers from the control group. Of the mothers who chose to 
breast feed, the length of exclusive breast feeding was similar between groups. 
This possibly reflects greater motivation from the PGD mothers. Previous 
findings often suggested decreased rate of breast feeding in IVF mothers 
compared to mothers of naturally conceived children (Leslie et al.. 1998;Peters 
2005). The reason for reduction in exclusive breast feeding in IVF groups could 
be due to difficulties in establishing breast feeding after caesarean section (Dewey 
et al.. 2003b) or to more advanced maternal age. However in this study in spite of 
increased caesarean section, the PGD mothers were more likely to begin exclusive 
breast feeding. This could reflect current increased awareness among both parents 
and medical professionals in promoting the practice of breast feeding. It could 
also reflect the awareness of the belief that breast feeding promotes better 
maternal child bonding about which the PGD group of mothers could have been 
concerned. 
 
5.2.4Physical assessments 
 
Hospital admissions were less common in the PGD group compared to the control 
group. The number of illnesses reported by parents was similar in each group. 
Illnesses were classified into upper respiratory tract, lower respiratory tract, 
dermatological, gastrointestinal, atopic and other illnesses. Of these, there was 
trend towards less illness in the control group for gastrointestinal and atopic 
complaints. This trend was not significant. It is possible that differences were 
secondary to subtle differences in parental attitudes to reporting illnesses. Use of 
childhood medications was similar between the groups. This further supports the 
80+!)(,2()(,+-+)!29)&")0&5-+29+)0&)#9+)":)6+%052(0"&9)0&)(,+)I^bF)5,0$%-+&')2&%)
the control group. This could be objectively viewed as evidence that children from 
both groups had similar rates of illness as the no of reported illness and use of 
medications are not different in the two groups. 
There was a slight difference between the two groups regarding type of surgery 
although rates wee similar. The children in the PGD group required minor 
surgical procedures like circumcision and pyloromyotomy and the control group 
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also required similar procedures like minor plastic surgical procedures and 
corrective surgery for club foot.  
Findings of the general examination of both the groups did not reveal any 
abnormalities apart from a single control child with hypospadias. 
 
5.2.5 G rowth  
 
There were no differences noted between the groups for childhood growth in 
terms of actual height in cms and weight in kgs and centiles. There was no 
previous data relating to the growth of children born after PGD beyond birth. 
However, the hypothesis that the overall health of children born after PGD should 
be similar to that of children born after ART is supported by data from this study. 
These findings support a previous study of children born after assisted 
reproduction and found that the childhood weight was no different between 
groups (Saunders et al.. 1996). This is reassuring in view of the recent concerns 
relating to an increase in Beckwith - Wiedemann syndrome in IVF conceived 
children (DeBaun, Niemitz, & Feinberg 2003;Maher et al.. 2003;Sutcliffe et al.. 
2006) and evidence of overgrowth in other mammals after assisted conception 
(Khosla et al.. 2001;McEvoy et al.. 1998). This study provided some initial data 
about the physical well being of children born after PGD. However numbers were 
too few to provide statistical significance. Further bigger studies would be useful 
to provide such data. 
 
5.2.6 Congenital malformation 
 
There was no difference between the groups for incidence of congenital 
malformations, major or minor. Two children (4%) from the PGD group had 
reported minor malformations (strawberry naevus and abnormality to the shape of 
the pinna) and 3 children (5%) from the control group reported two major 
2*&"-62$0(0+9) ;F#2&+'9)97&%-"6+C)2)5"&1+&0(2$)62$:#&5(0"&)":)+7+)6#95$+9C)2&%)
hypospadias) and one minor (plagiocephaly). 
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5.2.7 G riffiths Mental Developmental Scales 
 
The data indicated that there was little difference between the groups .The mean 
Griffiths quotient was 102.7 (+/- 13.1) for the PGD group and 103.3 (+/- 12.8) for 
the naturally conceived group which were both in the normal range, and did not 
differ significantly (t = 0.265, df = 113, p = 0.791). The only significant 
differences were for the Locomotor (PGD significantly lower) and Hearing and 
Language subscale (PGD significantly higher).  
 
5.2.8 Child and Family Relationships 
 
1. Parental questionnaires to assess family functioning 
 
Overall there were 5 sets of missing questionnaires giving a response rate of 96%. 
This reflects a good response rate in returning questionnaires. The questionnaires 
were sent to the parents at least a week prior to the appointment and collected 
from the parents at the appointment. Thus this proved a practical and reliable 
method of collecting questionnaires. Recent studies by Edwards and colleagues 
report that contacting participants before sending questionnaires and follow up 
contact significantly increased response rate (Edwards et al.. 2002;Edwards et al., 
2007). Golombok has previously hypothesised that where questionnaires are used, 
it is possible that IVF families may wish to portray a more positive picture in 
"-%+-)(")IG-"8+')(,2()(,+7)2-+)1""%)G2-+&(9)(Golombok, MacCallum, & Goodman 
2001).)T,+),01,)-+9G"&9+)-2(+):-"6)*"(,)(,+)1-"#G9)627)*+)2)I5"#-(+97')+::+5(3)(,+)
parents of PGD children willing to cooperate because of the medical assistance 
with their conception (van, Naaktgeboren, & Trimbos-Kemper 1996)and the 
parents of control group willing because their child a thorough paediatric 
assessment. 
 
2. Analysis  
 
Statistical analyses were conducted using SPSS for Windows 15.0. Between 
group differences on continuous variables were analysed using t-tests and means 
and standard deviations are reported. Chi-square tests were used for categorical 
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variables and frequencies and percentages are reported. Where continuous 
variables were expected to be highly correlated, such as separate subscales, 
multivariate analysis of variance (MANOVA) was used and the between<groups 
effects were reported. MANOVA was used to for the analysis of the subscales of 
the Griffiths Scale, the Parenting Stress Index, the Parental Acceptance-Rejection 
Questionnaire, and the Toddler Temperament Questionnaire. The omnibus test 
was used to determine if there were overall effects, and between-subjects tests 
were used to identify those variables where differences were. 
 
3. Child socio emotional behaviour 
 
There was no between group differences in the temperamental characteristics 
perceived by mothers. These findings were contrary to one of the initial 
hypotheses of the study but consistent with an earlier major European study 
(Barnes et al.. 2004). Barnes et al. reported that parents of children born using 
ART techniques reported their children as having similar temperaments and 
similar levels of behaviour problems to the naturally conceived group. It has been 
suggested in earlier studies that parents of assisted conception children have more 
intense relationships with their child and are more over protective (Golombok, 
MacCallum, & Goodman 2001;McWhinnie 1996) and this in turn leads to the 
differences in childhood temperament but the present findings support Barnes et 
al. and the probability that this may not be so. 
Golombok and MacCallum (2003) (Golombok & MacCallum 2003) state that in 
relation to socioemotional development, assisted reproduction children appeared 
to be functioning well. The greater difficulties of IVF infants were based on 
maternal reports and probably resulted from the higher anxiety levels of IVF 
mothers. Studies during the pre-school and school-age years generally did not 
indicate a higher incidence of emotional or behavioural problems among assisted 
reproduction children. 
Thus, overall differences in parental adjustment following infertility management 
do not appear to translate into differences in child psychosocial function (Gibson 
& McMahon 2004). 
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However, there are few studies that have included children at adolescence or 
beyond, and little is known about the consequences of conception by assisted 
reproduction from the perspective of the individuals concerned. Moreover, the 
existing studies are of variable quality 
 
4. Parental well being and family functioning 
 
No significant differences were found on the three Parental Stress Index subscales 
and total scores. There was also no difference in the total GHQ scores. Thus so far 
contrary to our hypotheses parents seem to cope with the extra stresses of PGD 
without evidence of ill effects on there well being and  relationships. 
As assisted reproductive technologies continue to evolve, so too will the 
challenges confronting families and practitioners. It is inevitable that some 
families will pioneer the way in dealing with new issues in parenting and 
relatedness as they arise. In conclusion, despite the fact that these families have 
B5"6G$+Z)*0"1+&+(05)"-010&9)(Burns 1999), their family relationships are more like 
those of naturally conceiving families than not. 
 
5. Parent –child relationship 
 
Overall, the existing literature is reassuring for infertile couples who are 
contemplating assisted reproductive techniques, as well as for parents and health 
professionals: the psychosocial functioning of parents and their children born by 
assisted reproduction is more similar than dissimilar to that of the control families. 
In most cases, no statistically significant differences in child functioning in terms 
of emotions, behaviour, self-esteem, or perceptions of family relationship have 
been found. Parents of children born using assisted reproduction tend to report less 
parenting stress and more positive parent-child relationships than the control 
parents. 
Gibson & McMohan (2004) (Gibson & McMahon 2004)reported that childhood 
parental expressions of more protective attitudes, but not over protectiveness 
towards the child, and greater warmth. The evidence supported the notion that 
protective social factors (e.g. older, educated, financially stable) and parental 
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qualities (e.g. satisfying relationships, adaptive problem solving, desire to have a 
child) may buffer against adverse parental outcomes. 
 
Creating families by means of assisted reproduction has raised a number of 
concerns about potentially adverse consequences for parenting and child 
development. It seems, however, from the evidence available so far, that such 
concerns are unfounded. Parents of children conceived by assisted reproduction 
appear to have good relationships with their children 
 
5.2.9 Strengths of the study 
 
1. Participation rate 
 
An initial estimate of at least 100 children less than eight years from the four PGD 
centres, who could be potentially recruited for the study, was made. Out of an 
original 100 qualifying children only 70 living within the London Region were 
eligible for the study. Of these 70 a total of 49 (70% participation rate) children 
were seen. This is a positive participation rate and could have been better if 
recruitment was extended to other national centres. However, owing to practical 
constraints this could not be done. In previous National studies of other children 
born after precious pregnancies, participation rates of 90% have been reported. 
This could be due to the fact that the mothers are likely to be highly motivated, 
given their good fortune to have been able to bear children (Barnes et al.. 
2004;Sutcliffe et al.. 2001). 
 
2. Comparison groups  
 
Two groups were chosen, children born after PGD and a naturally conceived 
5"&(-"$) 1-"#G.) T,+) 5"&(-"$) 1-"#G) G-"80%+%) 2) 9(2&%2-%) ":) I&"-62$') *7) !,05,) (")
compare the PGD children.  
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3. Outcome measures 
 
The developmental assessment used in this study was Griffiths Mental 
Development Scales from birth to 2 years (1996 Revision) and the Griffiths 
Mental Development Scales from birth to eight years (1984). The Griffiths Mental 
Development Scales from birth to 2 years were re-standardised in the United 
Kingdom in 1996 to reflect the child rearing practices, social habits, racial 
groupings and other socio-demographic factors pertinent to modern day Britain. 
The extended 2-8 years Griffiths scales were undergoing the most recent update 
and re-standardising for a fairly long time. There were delays in publication of the 
updated scales and thus it was not used in this study. This may have exaggerated 
the neurodevelopmental scores of the older children. 
 
4. Single and blinded paediatrician 
 
The blinding of the paediatrician to the mode of conception reduced observer bias 
and added to the strength of the study. A separate researcher approaching families 
for recruitment achieved blinding. The informed consent process also involved 
asking families not to reveal their conception status to the paediatrician. Analyses 
were also done by the statistician (MS) blind to the conception status. In addition 
all the children were assessed by the same paediatrician (IB), providing 
consistency in assessments and negating the inter observer bias. 
 
5. Personal contact and advice lines 
 
After the assessments the parents had a chance to discuss any queries or concerns 
with the paediatrician. The parents appreciated this and they were reassured. It is 
worth noting that families who participated in this preliminary study expressed 
gratitude and were grateful that their child had been formally assessed indicating 
an unfulfilled medical need, which may lead to an improved participation rate for 
later and larger studies. Recruitment is always a challenge in research of this 
nature. 
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6. The nature of the study 
This preliminary study is the first detailed study published on children beyond the 
newborn period following PGD and provides provisional reassurance that these 
children do not have any overt problems over and above those known to be a risk 
from ART conception. This preliminary study showed that the methodology is 
suitable to assess a larger group of children. 
 
7. Lessons learnt from PO RD study that helped the PG D study 
 
The difficulties encountered in the initial study (PORD) helped a lot with the PGD 
study. The recruitment was extended to multiple London fertility centres that 
obviously increased the particioation rate. The initial invitations to participate in 
the PGD study were sent from the respective fertility centres. The parents were 
much likely to respond to this, as they knew the fertility centres very well. The 
case and control recruitmet was also carried out by research assistants leading to 
the blinding of the assessor (IB). 
 
5.2.10 Weaknesses of the study 
 
1. Recruitment 
The recruitment of IVF children was limited by UK law. The Human Fertilisation 
and Embryology Act 1990 doe not allow the HFEA or fertility clinics to disclose 
information about any individual who may have been conceived after assisted 
conception. Therefore any study in the UK must recruit u90&1)2&)I"G(- 0&')6+(,"%.)
We asked clinics to send letters of invitation to families on our behalf, but we only 
became aware of these families if they chose to respond to us and disclose their 
details. We were therefore unable to obtain data on those families that did not 
respond and this could be a possible source of bias within our study.  
 
2. Missing cases 
 
An attempt was made to collect information from all families who had been 
recruited, but who did not attend. However, in a proportion of cases, families were 
either uncontactable due to change of address or contact details or the family 
declined to participate. Due to ethical constraints we were not able to ascertain 
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causes of non participation. Families who had shown interest initially were often 
unable to attend due to the distance they had to travel; the family sometimes 
%0%&'()2((+&%)6#(#2$$7)2--2&1+%)2GG"0&(6+&(9C)6"(,+-)1080&1)*0-(,)(")&+!)*2*7)0&)
family, ill health of mother and/or child etc.  
 
3. Sample size 
 
The sample size was small and was not adequate to obtain statistically reliable 
outcomes for many of the outcomes measured. Although the study was not 
adequately powered for definite conclusions, it nevertheless provided reassuring 
data that there was no evidence in the children born after PGD of major health 
concerns, effects on the mother child relationship or neurodevelopment scoring 
following PGD. 
 
4. G rowth data 
 
The children were assessed at different ages and thus there was the variability of 
difference of age at assessment. This could have been overcome by a common 
statistical way of standardizing data on one scale so a comparison could take 
place. One way to achieve this was to use z-score so that the variability of 
assessment at different age could be overcome. 
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Chapter 6 
 
Summary of thesis findings - main conclusions from the PO RD 
and PG D/S studies.  
 
6.1 PO RD study 
 
The results of this study were generally reassuring for the families where the 
mother have chronic renal disease and have had children. The study had aimed to 
address the following hypotheses: 
Hypothesis 1 Children born to mothers with chronic renal disease are expected to 
have the following complications in comparison to age matched children born to 
well mothers: 
 Reduced longitudinal growth - refuted 
 Possible effects on neurodevelopment - refuted 
Study and control children were comparable for growth parameters and 
neurodevelopmental scores as assessed by the Griffiths scales of mental 
development. 
Numbers were small. However the data does provide reassurance to a group of 
mothers with a variety of renal disease that there was no effect related to maternal 
disease or medications used on growth and development of the children. 
 Greater occurrence of difficult temperament and emotional or behavioural 
problems – not refuted 
The study highlights significant differences in externalising behaviour (e.g. rule 
breaking and aggressive behaviour) between the study and the control groups. The 
numbers involved were small and further studies would be needed to establish 
this. The result might relate to the comparative social disadvantage (as assessed 
by the social class classification) seen in a higher proportion of PORD mothers 
than control mothers. 
 
Hypothesis 2 Families where children are born to mothers with chronic renal 
disease will experience the following 
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 Differences in maternal bonding. 
 More stress in the parent child relationship. 
 O ther difficulties in parenting (related to pressures from renal disease and 
its treatment). 
There was no difference in the temperamental characteristics perceived by 
mothers in study and control groups. There was no evidence of more stress 
amongst mothers with renal disease or evidence of impaired bonding between 
mother and child in comparison with controls.  
The hypothesis was refuted by the findings of the study. There have been 
concerns about psychological health of women with chronic renal disease and 
also how it might affect parenting. The current data is reassuring but numbers 
were small. So further studies are needed. 
 
Hypothesis 3  
 The severity of effects will be directly related to the severity (stage) of 
chronic renal failure. 
 Different effects will be observed in children of renal transplant recipients. 
The number of cases in the study was insignificant to provide strong evidence 
about the relation of severity of renal failure and outcome of the children. This 
was further compounded by difficulties in gathering maternal data from case 
notes. 
Even though there were only eight mothers post transplant and the study provided 
some preliminary data to suggest that the wellbeing of these children were 
comparable with that of children born to well mothers. However further larger 
studies are needed in the future. 
 
6.2 PG D study 
 
This study is the first detailed study of children born after PGD world wide who 
were over a year of age and provides provisional reassurance that these children 
are healthy in comparison to naturally conceived children. The study aimed to 
address the following hypotheses: 
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Hypothesis 1 Children born to couples who had PGD/PGS are expected to be as 
healthy when compared to age matched naturally conceived children. We did not 
expect to see any of the following effects: 
 Reduced longitudinal growth  
 Greater occurrence of difficult temperament and emotional or behavioural 
problems 
 E ffects on neurodevelopment. 
Growth parameters and neurodevelopmental scores were comparable in the study 
and the control group, providing reassuring information for couples who have 
undergone the procedure and also future couples who will be undergoing the 
procedure. The children studied did not show any temperamental, behavioural or 
emotional difficulties. Thus the hypothesis was confirmed within the limited 
number of cases in this study. Further larger studies are required in future. 
Hypothesis 2 Families where children are born post PGD/PGS however may 
experience the following: 
 Differences in maternal bonding. 
 More stress in parent child relationship. 
 O ther difficulties in parenting (related to the pressures of IVF , PGD/PGS 
and treatment). 
The PGD group had significantly higher scores on the warmth-affection sub-scale, 
and significantly lower scores on the aggression-hostility and rejection sub-scales 
than the control group. There was also no indication of increased levels of stress 
related to parenting. 
The findings were contrary to the hypotheses but consistent with an earlier major 
European study which showed that ART families had higher levels of warmth and 
lower levels of hostility towards their children (Barnes et al., 2004). Thus so far 
contrary to our expectations parents seem to cope with the extra stresses of PGD/S 
without evidence of ill effects on these relationships. 
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6.3 Conclusion 
 
The studies and literature reviews in this thesis are generally reassuring, in terms 
of physical, neurodevelopmental and behavioural health of children born to 
mothers who encountered interventions in early life.  
The studies also show evidence of generally positive relationships in families who 
are thought to be under considerable stresses from either chronic illness in the 
mother (chronic renal disease) or the stresses of infertility. 
However, there remain areas of concern. The PORD study families participating 
with renal disease were more likely to be from lower socio-economic 
backgrounds. A significantly lower rate of vaginal deliveries was reported for 
mothers with renal disease and their infants were more likely to experience 
&+"&2(2$)6"-*0%0(7.)T,+)^bF)9(#%7)-+G"-(+%)(,2()I^bF')5,0$%-+&)%0%)&"(),28e any 
overt risk of problems over and above those known to be associated with ART. 
Children born after ART require to remain under continued follow up in view of 
the already known and discussed risks in chapter 2 
Our study groups comprised two different groups of mothers but both the groups 
had one very striking similarity: the children had been exposed to interventions 
very early on in life and there were concerns about the consequences of these 
interventions.  
Normal development may be disrupted by early adverse environmental 
influences; individuals who survive may have to cope with potentially damaging 
consequences. Additionally, the effects of environmental challenges in early life 
and the responses required to deal with them may have long-term effects into 
adulthood (Gluckman et al.. 2005)Barker et al. have clearly shown that the quality 
of fetal life can have profound effects on future well being of offspring (Barker et 
al.. 2002;Barker 2004;Poulter 2001).  
Preimplantation genetic diagnosis is now an established alternative to prenatal 
diagnosis for couples carrying genetic conditions that may affect their offspring. 
In recent years PGD technology has been used increasingly in couples undergoing 
fertility treatment mainly to screen for aneuploidy (PGS). By doing this (PGS) it 
is expected that a variety of IVF outcomes can be improved. However there is 
conflicting evidence about the efficacy of PGS and its role in improving outcomes 
of fertility treatment. The ESHRE PGD consortium data collection VII (Harper et 
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al.. 2008) reporting on cycles up until Dec 2004 reported a steady increase in the 
number of cycles (PGD, PGS etc ), of pregnancies and of babies delivered. It is 
expected that this rise will continue. 
An anonymous editorial published in Lancet 0&)OKmP)&"(+%)B`,0$%-+&)":)!"6+&)
with renal disease used to be born dangerously or not at all E not at all if their 
%"5("-9) ,2%) (,+0-) !27.D) o"6+&) 0&) 82-0"#9) 9(21+9) ":) -+&2$) :20$#-+) !+-+)
discouraged from conceiving because of concerns regarding the wellbeing of the 
off spring and also the wellbeing of the mother. These ranged from effects of 
maternal disease on the pregnancy and the fetus, effects of the medications (used 
to treat the mother), on the outcome of off spring, to effects of the pregnancy on 
the course of disease progression, effects on graft function/dysfunction and graft 
rejection. The author(s) in Lancet in 1975 were probably not prepared to speculate 
on the emerging era of fertility drugs, assisted reproduction techniques, and 
improvements in renal replacement therapy.  
Subsequent progress in management of end-stage renal disease, ultimately by 
means of renal transplantation, has resulted in a lot more women living their lives 
into child bearing years. Having a child is now accepted as a set target of therapy 
success, major outcome of of quality of life and more and more women are going 
ahead with planning and having a family. 
This increasing number of pregnancies may result in increasing problems related 
to the mother and fetus being exposed to interventions of different and changing  
tpyes. Interventions could result from the consequences of maternal health, 
disease management or infertility. True reassurance of the safety of these 
technologies will only be achieved by following a large cohort of these children 
throughout their lives. Findings of the present studies and the areas of concern 
highlighted should be taken into consideration by those undertaking resaerch in 
similar areas. 
 
6.4 A reas for future research 
1. Long term follow up of children born after PG D/PGS 
This preliminary study is the first detailed study published on children born 
following PGD/PGS beyond the newborn period and provides provisional 
reassurance that these children do not have any overt problems. The physical 
health of children and normal developmental and behavioural outcomes was 
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reassuring, but future follow up is warranted. The mean age at assessment was 
18.4 months (range 3- 56 months). It is possible that other problems (health, 
developmental and behavioural) may emerge as the children become older and 
can only be assessed by future studies preferably longitudinal. Development of a 
child is best assessed over a period of time rather than a one-off encounter. This 
study cohort should be followed up to detect any emerging difficulties. 
The analyses did not distinguish between PGD for known genetic problems and 
PGD for aneuploidy screening (PGS) due to the small sample size. A larger study 
with adequate power for sub group analysis would be worthwhile. Another 
refinement although problematic from a control recruitment perspective would be 
to match for maternal age in a larger study. 
 
2. Follow up of children born to mothers with chronic renal disease 
This unique but modest study showed early evidence of wellbeing in mature 
children born to mothers with renal disease in pregnancy. However it also showed 
evidence of increased perinatal risks. A larger registry based study would seem 
one of two ways to confirm the key findings. The registry based study would also 
provide a chance to study children of mothers with different categories of renal 
impairment. Alternatively, the issue could be investigated via a prospective cohort 
study where further evidence of health status can be obtained. It seems important 
to carry out studies with larger number of cases to establish any cause<effect 
relation between severity of renal failure and outcome of the children. The effects 
of medications (especially new generation immunosuppressants) on the developing 
fetus and the children need to be investigated in detail. 
 
j0&2$$74 
Those involved in providing and regulating treatment to families, be it for fertility 
associated problem or chronic renal disease, have an obligation to the patients, 
their children and families to ensure that any risk associated with the procedures 
are elucidated and the families informed. Many couples seeking infertility 
treatment are desperate for a child and similarly women with chronic renal disease 
often want to have a child. These individuals may not be deterred by the 
knowledge of a small increased risk in certain conditions, but they should have the 
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opportunity to be given accurate and robust information. More importantly, the 
children have a right to know of any potential risks that their future may hold. 
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